Choosing healthcare providers. Healthcare consumers' use of comparative performance information by Ketelaar, N.A.B.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/147494
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For reasons of consistency within this thesis, some terms have been standardized throughout the text. As 
a consequence the text may differ in this respect from the articles that have been published. 
 
The  studies  presented  in  this  thesis  have  been  performed  at  the  Scientific  Institute  for  Quality  of 
Healthcare (IQ healthcare). This institute is part of the Radboud Institute for Health Sciences (RIHS), one of 
the approved research institutes of the Radboud university medical center. 
 
The studies in this thesis were financially supported by the CZ Fund [grant AFVV08‐156AFVV08‐156].  
Financial support by IQ healthcare for the publication of this thesis is gratefully acknowledged.  
 
ISBN: 9789462799905 
 
 
Nijmegen, 2015 
 
Cover: Manon den Hartog, Omdat Ontwerp 
Lay‐out: Jolanda van Haren / Nicole Ketelaar 
Print: GVO drukkers en vormgevers B.V. | Ponsen & Looijen, Ede 
 
 
 
 
 
 
 
Choosing healthcare providers 
Healthcare consumers’ use of comparative performance 
information 
 
 
 
 
 
Proefschrift 
 
ter verkrijging van de graad van doctor 
aan de Radboud Universiteit Nijmegen 
op gezag van de rector magnificus 
volgens besluit van het college van decanen 
in het openbaar te verdedigen op woensdag 2 december 2015  
om 10.30 uur precies 
 
 
 
 
 
door  
Nicole Antonia Berendina Maria Ketelaar 
 
 
 
 
geboren op 26 maart 1982 
te Doetinchem 
 
Promotoren:  Prof. dr. G.P. Westert 
  Prof. dr. G. Elwyn (Dartmouth College, Verenigde Staten) 
  
 
Copromotoren:   Dr. J.C.C. Braspenning 
   Dr. M.J. Faber 
 
Manuscriptcommissie: prof. dr. J.W.A. Smit 
   prof. dr. W.J.J. Assendelft 
   prof. dr. D. Delnoij (Tilburg University) 
 
 
 
 
 
Contents 
 
 
 
Chapter Title page 
Chapter 1 Introduction  7 
Chapter 2  Exploring consumer values of comparative performance 
information for hospital choice 
Quality in Primary Care 2014; 22(2): 81-9. 
19 
Chapter 3 Patients’ expectations of variation in quality of care relates 
to their search for comparative performance information 
BMC Health Services Research 2014; 14: 617. 
33 
Chapter 4 Recognition of physiotherapists’ expertise in Parkinson’s 
disease 
BMC Health Services Research 2013; 13: 430. 
47 
Chapter 5 Public release of performance data in changing the behaviour 
of healthcare consumers, professionals or organizations 
(Review) 
Cochrane Database Systematic Review 2011; (11). 
63 
Chapter 6 Comparative performance information plays no role in the 
referral behaviour of GPs 
BMC Family Practice 2014; 15(1): 146. 
119 
Chapter 7  General discussion 135 
 Summary 153 
 Samenvatting 159 
 Dankwoord 165 
 Curriculum Vitae 169 
 Portfolio Radboud Institute for Health Sciences 173 
 
 
Chapter 1 
 
Introduction 
 
 
 
 Chapter 1 
8 
INTRODUCTION  
Patients are increasingly referred to as ‘healthcare consumers’, which acknowledges 
their active position when they are making choices.1 This position has become much 
more prominent since the introduction of demand-driven care and market-based forces 
in the current healthcare system in the Netherlands. An emancipatory movement 
emphasizes an active position as well, which the increased focus on patients’ interests, 
needs, and attributes in the healthcare system reflects.2 Concepts in which the role of 
patients is empathetically defined and acknowledged are patient-centredness, shared 
decision-making and demand-driven care.3,4  
 
In demand-driven healthcare systems consumers are expected to have an active role 
and to choose healthcare providers that offer high quality and ignore the ones that 
provide low quality.5,6 If they do so, consumers can influence the average levels of 
quality of care, provided that they act as rational consumers.7,8 However, as decisions 
become increasingly complicated and consequential, the assumption of a rational 
consumer becomes less realistic. Marshall argues that consumers take more time to get 
the best deal for a hotel stay or a car than for the best healthcare setting.9 Even so, 
encouraging consumers to actively choose a provider can be considered a goal in itself 
because it enhances patient empowerment, consumer activation, and self-
determination.  
 
Active provider choice for consumers leads to an urgent demand for accessible, 
comprehensible information about differences in the performance of healthcare 
providers10-12, the comparative performance information (CPI). Other stakeholders need 
transparency of the quality of the hospital or the provider’s performance as well. 
Payers would like to use CPI for purchasing care based on quality instead of quantity; 
the inspectorate, for monitoring the minimum level of care delivered; and the 
healthcare services and providers, for improving quality of care processes. Whether all 
these goals can be reached simultaneously remains to be seen. However, in this thesis, 
the focus is on the 1 healthcare consumer’s use of CPI. 
 
The basic assumption is that healthcare consumers like to make their own choices in 
healthcare. The existing literature shows that they want more information about the 
quality of care.13,14 Nevertheless, the choice of providers does not seem to be a high 
priority for consumers.15 While a growing mass of CPI is freely available, consumers 
hardly use this information to choose their healthcare provider.11,16-21  
 
At least three relevant topics have emerged from the healthcare reforms and the 
provision of CPI to healthcare consumers. First of all, why a majority of patients ignore 
CPI is unknown. Some research into the presentation of CPI and the patients’ 
1A i l
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understanding of it has been carried out 17,22-24, but little is known about the search 
drivers and factors that affect it. Insight into the design and dissemination is needed to 
overcome these barriers to valuable usage. Second, CPI can empower patients in their 
choice of providers, but how much this affects actual behaviour is still unclear.25 Third, 
healthcare consumers probably need help in interpreting the CPI. CPI has been 
described as not easily accessible.10 Perhaps structural guidance, e.g. from healthcare 
professionals (GPs), can increase the use of CPI. 
 
This thesis studies healthcare consumers’ limited search for and use of CPI for the 
purpose of choosing a healthcare provider. The introduction briefly describes the 
changing position of healthcare consumers, provider choice in the healthcare system, 
the kind of the comparative performance information (CPI) available for consumers, 
and a further description of the three research themes. This chapter ends with the set 
of research questions that have been studied in the five consecutive studies. 
 
Provider choice in healthcare systems 
The way provider choice is structured in a healthcare system directly affects the 
consumer’s actual freedom of choice. There are several ways to organise provider 
choice. One option is to regulate provider choice either via a gatekeeper system or via 
health plans. Another option is free provider choice and patient access to specialised 
care without any interference. Countries differ in this organizational aspect of the 
healthcare system. Within Europe, the regulated form arranged by the gatekeeper 
system and free provider choice are common. The UK and the Netherlands have strong 
systems of primary-care gate-keeping, which means that the general practitioner (GP) 
has an important role in referral and the choice of a provider.26 As a result, consumers 
cannot easily consult a professional or a specialist, or visit a hospital, without seeing a 
GP first. In Sweden, provider choice is based on agreements between the government 
and the federation of county councils.27 In Germany, patients have free access to 
specialists and hospitals of choice. In France, patients are free to visit any GP or 
specialist practising privately or in a hospital.28 In the USA, the gatekeeper system also 
plays a role, but in a different way, as provider choice is mainly regulated by health 
plans.29 Healthcare consumers choose a health plan and pay for the care within the 
network. Plans that restrict provider choice cost less, while flexible plans with an 
extension of provider choice cost more.30 A second form of the American gatekeeper 
system demands that patients see their GP first to avoid excessive out-of-pocket 
payment charged by their health plan.  
 
Provider choice has changed in Western countries (including the USA, UK, Denmark, 
Norway, the Netherlands, and Sweden) in recent years, in favour of free provider 
choice. The wish to empower and activate consumers in healthcare goes hand in hand 
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with these developments. The Dutch healthcare system has been actively encouraging 
consumers to choose a provider since 2006. The Health Insurance Act (HIA) made it 
possible for healthcare consumers to choose their preferred type of health insurance 
and their own healthcare providers. The GPs continued to act as the gatekeepers of 
specialised care. However, dental hygienists and physiotherapists have been freely 
accessible to consumers without an intervening consultation with a GP since the 
implementation of the HIA.31 Box 1 describes how provider choice has been expanded.32 
 
Box 1.  Important elements of the Dutch healthcare system after the introduction of the Health 
Insurance Act in 2006 
 
Important elements of the Dutch healthcare system: 
 Healthcare insurance is now obligatory for every Dutch resident 
 The distinction between private and public healthcare insurance disappeared. All 18+ have to buy 
private insurance 
 Provider choice for healthcare consumers has expanded 
 Healthcare insurers are authorised to selectively contract providers  
 Healthcare organisations must inform the public about price, quality, and other characteristics of 
care 
 Both consumers’ choices and the insurers’ selective contracts are seen as main drivers in healthcare 
providers’ improvement of the quality of care at lower costs 
 
The wish to empower and activate patients in healthcare goes hand in hand with the 
societal demand for accountability in healthcare, transparency about the quality of 
hospital care, and provider performance.33,34 More information about the quality of 
care is becoming available in the public domain, not only for consumers, but also for 
other end-users: the health inspectorate, healthcare providers, and insurance 
companies. Each group has its own goal in using this type of information, and the 
question is whether these goals are compatible (Box 2).25  
 
Box 2.  Users and goals of different end-users of comparative performance information, based on 
Smith et al., 2009 
 
Users of comparative 
performance information 
Goals in using comparative performance information 
Government  Measuring the quality of healthcare 
 Monitoring regulatory effectiveness and efficiency 
Health inspectorate  Ensuring the development of comparative performance 
information 
Healthcare providers  Starting healthcare improvement projects  
 Selectively referring to high-quality providers 
Health insurance   Selectively contracting the best health provider balanced 
against low cost  
Patients and healthcare consumers  Addressing information asymmetry  
 Making an informed provider choice  
 Selecting high-quality providers 
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Theoretically, there are a number of pathways through which the public release of CPI 
may have an impact on providers and the quality of care.35 Berwick and colleagues’ 
framework shows two pathways. The ‘pathway of selection’ implies that healthcare 
consumers drive healthcare quality improvement by using the release of comparative 
performance data to make choices between hospitals or providers. Consumers will 
identify the value of the outcomes, search for performance information about a 
healthcare provider, and then make an informed choice. The assumption is that they 
will try to obtain the best quality or avoid the worst, and select (or reward or 
recognise) the best hospital or provider (Figure 1). In the ‘pathway of change’, the 
extrinsic motivation is necessary to effect changes. Change may occur due to pressure 
to avoid being identified as a provider of poor-quality care or to improve a provider’s 
reputation in relation to other providers.36  
 
Figure 1. Two pathways for improving performance by means of the public release of performance 
data 
 
 
 
 
 
 
 
 
The ‘pathway of change’ assumes that benchmarking healthcare organisations will 
encourage hospitals and healthcare providers to improve their performance. The 
pathways are strongly connected to one other, and for their effects, both mechanisms 
rely on the availability of reliable performance information that all users of the 
healthcare system can use and act upon. We include both pathways, with an emphasis 
on the pathway of selection.  
 
Comparative performance information 
Many different terms have been introduced to refer to information about the quality of 
the care delivered: comparative quality information, performance information, quality 
information, and healthcare information. This thesis uses the term ‘comparative 
performance information’ (CPI) within the following definition:  
 
“Systematically collected, publicly available information about the 
performance of health organizations or healthcare providers that can be 
compared objectively. The purpose of CPI is to inform and enable healthcare 
consumers to make their choices based on their own values”  
1 
Publicly reported performance data  
Selection 
Pathway 1 
  
Knowledge 
Motivation 
Performance 
Change 
Pathway 2 
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This kind of information has been developed in many countries, especially in the USA 
and the UK, where the production and dissemination of such information has been high 
on the agenda since the 1980s.37,38 
 
One can differentiate three types of CPI: information about healthcare provider 
characteristics and services, experiences of healthcare consumers, and performance 
indicators (Table 1).39  
 
Table 1.  Types of comparative performance information 
 
Type Description  Examples  
1 Information about healthcare 
provider characteristics and 
services  
Travelling distance, region, type of provider, provider 
specialties, treatment specialties, costs, waiting times, 
number of hospital beds, and personnel 
2 Information from the 
healthcare consumer’s 
perspective and experience  
Experiences with treatment in a healthcare organisation 
(e.g. hospital and nursing home), satisfaction with food, 
privacy, communication, and the consumer quality index 
3 Performance indicators 
(process, structure, or outcome 
indicators) 
Hip-fracture patients having surgery 24 hours after admission 
(process), number of patients with pressure wounds, 
treatment volumes, methods of anaesthesia, and the 
hospital standardised mortality ratio 
 
These different types of information are often based on various sources and collected 
by a range of instruments. Data can be collected from healthcare providers, patients, 
and insurance companies. The instruments can be observation lists, medical records, 
interview protocols, or surveys. The Dutch government initiated placing CPI on 
websites, including www.kiesbeter.nl (make better choices) in 2005. This website 
includes quality information and assessments of individual hospital performance. It 
started with mainly a combination of types 1 and 2, but in recent years type 3 has also 
been presented on this website (Table 1). Other Dutch websites also offer comparisons 
of hospitals and other healthcare services (www.independer.nl, www.mediquest.nl, 
and www.zorgkaartnederland.nl). The Dutch daily newspaper Algemeen Dagblad 
produces a list of the 100 best Dutch hospitals every year, and the weekly magazine 
Elsevier publishes a list of best hospitals; their assessments are based on various 
indicators. 
 
Three emerging research themes of comparative performance information  
 
Search drivers and the possible determinants  
Discussions about selective provider choice usually start with the assumption that 
healthcare consumers are keen to choose their own healthcare providers. Researchers 
uncritically adopt this assumption, and then begin assessing the availability of the right 
information, the content of such information, and the influence of the way the CPI is 
presented.10,15,40 These elements are, without doubt, important. The debate focuses on 
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understanding how to present quality information in ways that are meaningful to 
consumers.38 However, the basic barriers to consumers using and trusting CPI are 
underexposed. The fundamental questions of how consumers perceive, value, and 
appraise CPI for the purpose of choosing healthcare providers are often neglected and 
poorly understood. An important factor that could influence the value of CPI, and 
therefore the search driver, is the patients’ recognition of quality-of-care differences. 
For this thesis, we studied whether expectations about the quality of care differences 
had an impact on the CPI search behaviour of patients. Since the context of the 
healthcare can affect the results, we did one study about elective surgery in a hospital 
and another about the chronic care setting in primary care.  
 
The impact of comparative performance information on behaviour 
From the time that CPI was first published, there have been doubts whether the 
consumers would use this information and how it would impact their choice 
behaviour.37 Research seems to confirm these doubts: it shows that few consumers 
actually use CPI. For example, the proportion of Americans using comparative data 
about physicians grew from 4% to 6% between 1996 and 2008.18 Research highlighted 
several barriers to the use of CPI. Examples are people’s distrust of hospital ranking 
and the reliability of health information on the internet, in the media, or from the 
government. Consequently, the relevance of CPI consistently ranks far below the 
information from family and friends.11,20,41 Experiences of family and friends reported 
by word of mouth have more impact than objective, measurable performance data.42,43 
Nevertheless, there is still a firm belief that CPI will result in better informed decision-
making. The literature does not support this hypothesis. Except for studies that used 
hypothetical scenarios to examine the effect of public reporting,23,44-48 when this 
research project began in 2009 there were still no systematic data available about the 
effects of public reporting of the actual behaviour regarding the selection of healthcare 
providers, quality improvement, and patient outcomes.49  
 
Support of the consumer’s choice behaviour  
The literature teaches us that not all consumers have the same competencies to deal 
with complex choices50; consumers may need help to interpret such information. The 
availability of someone who provides additional choice expertise can help consumers 
choose.51 Because the primary-care system has a strong position in Dutch healthcare 
and Dutch GPs traditionally act as gatekeepers52, the GPs would be the logical partners 
to help Dutch consumers make choices. They can help consumers exercise their patient 
rights by offering a respectful relationship.2 Research from the UK indicates that GPs 
are sceptical about the use of objective information and prefer to rely on soft 
knowledge such as relationships with providers and the experiences of patients whom 
they had referred previously.53 However, it is not yet clear how GPs view their choice-
1 
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supporting role when it comes to using CPI in consultation time, and in which ways they 
could help consumers.  
 
OBJECTIVES AND AIM OF THIS THESIS 
The aim of this thesis is to make a contribution to the empirical evidence about how 
consumers use CPI and how they choose a provider. The main focus is to make the 
perception of the consumer visible. The research questions for the three research 
themes that this thesis addresses are:  
 What are the barriers and facilitators for healthcare consumers to search and use 
CPI?  
 To what extent does publicly released performance information changes the choice 
behaviour of healthcare consumers, providers, and purchasers? 
 To what extent do GPs advocate and encourage patients to choose providers on the 
basis of CPI? 
 
The research focuses on the effects of public reporting, and the aim is to discover the 
conditions that either constrain or facilitate consumers’ searches and use of 
information that ultimately helps them choose a healthcare provider. In particular, we 
focus on:  
 Identifying the basic values, attitudes, and ideas regarding CPI, as well as choice 
behaviour among healthcare consumers; 
 Exploring whether expectations of quality of care affects consumers’ behaviour in 
their search for CPI;  
 Testing whether expectations of performance and recognition of healthcare 
providers’ expertise can foster the search for CPI and selective provider choice; 
 Assessing how the effects of public reporting changes the behaviour of consumers, 
professionals, healthcare organisations and purchasers of care (insurance 
companies);  
 Exploring GPs’ views of the use of CPI at the point of referral in primary care and 
their views of their own role of choice-supporting behaviour. 
 
OUTLINE OF THIS THESIS 
Chapter 2 reports the results of six focus groups with healthcare consumers. The main 
goal of this study is to clarify the value that CPI gives the consumers. Most research in 
this field is oriented towards the content and the presentation format of CPI, while 
little is known about how consumers value CPI and use this information. This chapter 
considers the awareness of consumers, current sources of decision-making, the value of 
CPI, and the effects of CPI.  
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Chapters 3 and 4 report how consumers’ awareness of the availability of variation in 
quality of care affects their use of CPI to find a hospital or healthcare provider for 
elective surgery or a progressive chronic-care condition. Chapter 3 deals with patient 
expectations about the variation in quality of care. Postal questionnaires were sent to 
475 patients undergoing a total hip or knee replacement in three types of hospitals to 
obtain the necessary data. The objective of Chapter 4 is to explore the ability of 
people with Parkinson’s disease to recognise expertise among physiotherapists and to 
determine to what extent patients selectively choose expert physiotherapists.  
 
Chapter 5 describes a systematic review of the public release of performance data. 
The review concerns the content and effectiveness of determinants of behaviour 
change that prompt the actual behaviour in choosing. 
 
Using the suggestion to provide an advocate who can help consumers with their choice 
of hospital, Chapter 6 investigates how GPs view their role in using CPI during 
consultation time. 
 
The general discussion in Chapter 7 summarises the results in this thesis and discusses 
our findings in view of several methodological issues, implications for practice, and 
aims for future research.  
1 
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ABSTRACT 
Background: In many countries, market orientation in healthcare has resulted in the 
publication of comparative performance information (CPI). Most of the research in this 
field is oriented towards the content and the presentation format of CPI while little is 
known about how consumers value CPI and the use of this information.  
Aim: The aim of this study was to clarify the perceived value that CPI brings for 
consumers of healthcare. 
Methods: Qualitative research using six focus group interviews. Twenty-seven 
healthcare consumers were recruited using a mailing list and by personal invitation. 
Data from focus group interviews were transcribed and thematic analysis undertaken. 
Results: Most participants were unaware of CPI, and valued alternative sources of 
information more than CPI. Through discussion with other consumers and by means of 
examples of CPI, respondents were able to express the values and perceived effects of 
CPI. Numerous underlying values hindered consumers’ use of CPI, and therefore 
clarification of consumer values gave insights into the current nonusage of CPI. 
Conclusions: CPI is marginally valued, partly because of conflicting values expressed by 
consumers and, as such, it does not yet provide a useful information source on hospital 
choice beyond consumers’ current selection routines in healthcare. Future research 
should be more focused on the values of consumers and their impact on the use of CPI. 
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BACKGROUND 
Provider choice for healthcare consumers has emerged as a key policy focus in modern 
Western healthcare systems. The architects of the policy outlined several reasons to 
promote choice among healthcare consumers. First, to encourage competition between 
providers which was expected to improve the efficiency and quality of healthcare;1,2 
and second, to increase patient empowerment and improve the position of consumers 
in healthcare.3,4 It is based on the expectation that patients will choose the best 
healthcare provider once they are informed. 
 
Systematically collected, publically available information about the performance of 
healthcare providers, called comparative performance information (CPI), can be used 
as a tool to inform healthcare consumers to enable them to make informed provider 
choices. The information consists of, for example, patient volumes, treatment 
methods, waiting lists and patient experiences, and can be found in leaflets, 
magazines, books and on the internet.  
 
Despite the efforts and resources that go into the collection, production and 
dissemination of information for the public,5 there is little evidence that CPI affects 
consumer choices. Many people do not understand the information, or do not view the 
information as useful.6 British and American studies have shown that as few as 5–7% of 
consumers use CPI to choose a hospital7,8 and only 12% use CPI to select a primary care 
physician,9 although awareness of the right to choose a provider has increased. The 
overall conclusion is that consumer usage of CPI to make an informed choice is still 
limited. Instead, consumers rely on information from family and friends or base their 
choice of hospital on recommendations from their referring primary care physician.10,11 
The choice is largely driven by familiarity with a certain hospital12,13 or the distance 
between home and hospital.12,14 Using CPI is also a difficult and complex task for 
consumers, which limits its impact on consumer choice even more.14,15 
 
Because provider choice by healthcare consumers is positively associated with 
autonomy and self-determination, both important principles of patient activation,16 the 
need to explain the limited exercise of choice by healthcare consumers might improve 
our understanding of active patient participation in healthcare. 
 
Previous studies have questioned whether this limited usage of CPI is caused by the 
absence of the right information content17 or whether CPI presentation formats do not 
support decision-making tasks.7 Evidence for both assumptions has been found. 
Damman and colleagues conclude that the presentation of CPI facilitates consumers’ 
correct interpretation as well as effective use, meaning the ability to choose the best 
performing provider.18 Although these are without doubt crucial elements in facilitating 
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consumers in using such information, fundamental questions over how CPI is perceived, 
valued and appraised by healthcare consumers for their choice of hospital are 
overlooked. Some theory and evidence suggest that healthcare consumers are 
insufficiently informed about what is important for them.5,19 Current shared decision-
making models for clinical treatment acknowledge the need to clarify patients’ values 
to promote active patient participation in decision-making.20,21 The aim of this study 
was to identify consumers’ values, appraisal, understanding, opinions and judgement of 
CPI. We conducted a series of focus group interviews. 
 
METHODS 
Approach 
The current study was a qualitative focus group study in 2009. The method allows 
researchers to capitalise on communication between participants to generate pertinent 
information.22 The focus group method was chosen because of its flexibility to explore 
unanticipated issues, and to make use of the interaction between group members. We 
encouraged the participants to discuss the subject of CPI, ask each other questions, 
exchange opinions and views, and share experiences.23 We presented the ‘values’ of 
CPI initially using terms such as ‘meaning’, ‘sense’, ‘ideals’ and ‘principles’ to explain 
their meaning for healthcare consumers. We introduced three real-world CPI examples 
to align the mindset of the participants in the discussion (Table 1). The example shown 
in Table 1 combined stars with percentages, the second used different kinds of bullets, 
and the third one showed the availability of a service using ‘yes’ or ‘no’. 
 
Table 1. Example of comparative performance information related to three quality indicators of 
hospital A, B and C 
 
Quality indicator Hospital A Hospital B Hospital C 
Cancelled surgeries (%)a 1.2  3.3  0.7  
Pressure ulcers (%)b 8.1  2.5  1.5  
Electronic personal health record (%)c 9.5  10.0  7.0  
a Surgeries cancelled within 24 hours 
b New patients with pressure ulcers. All patients underwent total hip replacement 
c Availability of electronic personal health record including lab results, medication use, X-rays 
 = hospital performance was less than average;  = hospital performance was average;  = 
hospital performance was better than average 
 
Participants and sampling 
Our initial idea was to approach patients with a specific condition. However, a 
commonly cited concern is that patients predominantly focus on their personal context 
and return to the hospital where they were treated previously.24 Also, those who are 
most dependent on care services and who could benefit most from a ‘good choice’ are 
also those who tend to have more problems associated with the capacity to manage 
informed choices about care providers.25 We therefore decided to recruit a cross-
section of healthcare consumers from the general population. By ‘healthcare consumer’ 
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we mean anybody who is a user or potential user of healthcare. In order to increase the 
potential use of healthcare for themselves, family or friends, we selected respondents 
aged over 35 years. Our participants responded to an invitation letter sent to a random 
sample of 480 people listed at a large health insurance company. We used a 
stratification procedure to include a representative age distribution. We sent 160 
letters to people aged 35–50 years and 320 to people aged 50–65 years (ratio: 1/3 to 
2/3). Because the response rate was low, an additional approach was undertaken, 
namely a personal invitation, made by members of the research team, to healthcare 
consumers, including people sitting in a general practitioner’s (GP’s) waiting room. 
Participants received a small incentive in exchange for their efforts. No medical 
information was asked for, so approval by an ethics committee was not needed. 
 
Data collection 
First, an interview guide was developed by members of the research team (NK, MF, JB) 
and influenced by the available literature about this topic. The interview guide was 
used to guarantee consistency among groups. The interview guide is available in an 
online appendix. 
 
Before beginning each session, the aims and methods to be used were explained by the 
moderator (NK). Participants were asked to give their permission for audiotaping and 
transcribing. At the beginning of the focus group session, the moderator attempted to 
create a thoughtful, non-threatening atmosphere and set the tone for the discussion. 
Participants were encouraged to respond to all the issues raised by the moderator or 
other participants. Every effort was made to create an environment that encouraged 
individuals to participate fully in the discussion. After the introduction and the first 
items of the interview guide, real-world examples were explained by the moderator to 
encourage involvement and to support respondents in their discussion about big themes 
as values. Participants were asked to look at the examples and to answer the following 
questions: 
 Do you understand what the performance information is showing you? 
 Could this information benefit you in any way when you would be in a situation to 
make a comparison between different providers? 
 What benefit could you gain from this information? 
 
All focus group meetings lasted about 1.5 hours and were audiotaped. In addition, an 
assistant made notes during each session. Data saturation, the point at which the 
participants provided no new information to the researchers, was reached after focus 
group five. 
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Analysis 
All audiotaped sessions were transcribed verbatim into a Microsoft Word file. Analysis 
of the transcripts was facilitated by the use of a qualitative software program 
Atlas.ti.5.2 to manage the data.25 Thematic analysis was undertaken to reveal core 
consistencies and meanings in the data by identifying and analysing themes, which are 
abstract categories of meaningful data fragments. In themes, several fragments, known 
as codes are connected to each other and recur in a patterned way.26 
 
Data were collected and transcripts read thoroughly to estimate data saturation. The 
transcripts were read several times by two investigators (NK, MF) and the main themes 
were extracted. Participants’ statements referring to a particular theme were grouped 
by similar codes, and further explored. The analysis followed an inductive approach, 
which was emergent and strongly linked to the data because assumptions were 
datadriven. This means that the process of coding occurs without trying to fit the data 
into a pre-existing model or frame.27 
 
Statements about how many people have said something can leave readers unsure how 
to interpret quantitative numbers in a qualitative study. However, a relatively high 
frequency may also signify the importance of a finding. In describing something in 
between, we avoid actual concrete numbers and used terms such as, for example, 
‘many’, ‘most’ or ‘a minority’. We present the focus groups discussion in sufficient 
detail supported by quotes which can be read in the boxes after every theme, to allow 
readers check the interpretation made during the analysis.26 Every quotation used in 
the boxes is followed by the number of the focus group (FG), the gender and age of the 
participant. 
 
Trustworthiness 
We took several measures to ensure the trustworthiness of this study, including 
multiple methods of recruitment; multiple researches to reflect on the analysis 
process; multiple rounds in which data were read, analysed, compared and contrasted; 
project team meetings to review and explore scientific and organisational aspects of 
the project. 
 
RESULTS 
Thirty-seven consumers agreed to participate in the focus group interviews. Twenty 
people responded to the invitation letter. Seventeen consumers were recruited having 
been approached personally; two in the GP’s waiting room. Of the 37 participants, 27 
finally participated in one of the six pre-planned focus group interviews (7 men and 
20 women). The mean age of the participants was 59 years. We describe four themes 
that emerged from the analysis. 
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Theme 1: awareness (Box 1) 
Most participants were not familiar with CPI as a tool to guide informed choice or to 
compare hospitals. Only a minority said they had seen CPI before. Although they 
believed themselves to be skilled internet users, most participants did not know where 
to find CPI. They said, ‘somewhere on the internet’, but they could not specify. Some 
were aware of the national website presenting CPI for hospitals in the Netherlands, a 
site the Dutch government initiated in 2005 (www.kiesbeter.nl). 
 
Despite a lack of awareness of CPI as a tool to compare hospitals, most participants 
reported that they knew about the possibility of comparing hospitals and were aware of 
their free choice of providers. Nevertheless, they mostly seemed to have a low level of 
interest in CPI. They said that, being in good health, they were not interested in 
hospital choice, and they did not feel a sense of urgency to look for CPI. The 
participants also agreed that if they became ill, they probably would not have the time 
and energy to look for CPI. During the focus group meetings, the participants realised 
that, because of a low level of awareness, there was a vicious circle in which they 
continued to be unaware of the potential value of CPI to help them. 
 
Box 1.  Awareness 
 
 ‘I do not know where to find such information’ (FG6, female, 58). ‘No, I did not know either. And on 
which things do we need to compare? That is also a question for me.’ (FG6, female, age 60) 
 ‘If you feel healthy, you will not start looking for a hospital just in case you might need one.’ (FG1, 
female, age 53) 
 ‘Only, if it is really necessary then is the chance big enough that I would use this kind of 
information’ (FG2, female, 57) ‘For me as well, I have better things to do.’ (FG2, female, age 56)  
 
Theme 2: current sources for decision-making (Box 2) 
Most of the participants said that their hospital choice was fixed: essentially, they 
always went to the same hospital. This hospital was usually the closest one, as distance 
was an important choice attribute. They did not have any reason to change this 
routine, and questioned the added value of CPI. There were other significant sources 
they currently used for their decision making. Consumers said that their own previous 
experiences were important and outweighed the impact of CPI. They also highly valued 
the advice of family and friends. The consumers trusted their own GP as a source of 
information. There was some disagreement about whether to follow the GP’s advice 
and the GP’s role in providing information. In one session, some said they would not 
argue with their GP’s advice because they felt it could damage their relationship with 
their GP. 
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Box 2.  Current sources for decision making 
 
 ‘I think, well I would go to the hospital I always go to. I would not go searching. I am not sure if this 
wise, I have been in the [name] hospital a zillion times.’ (FG2, female, age 57) 
 ‘I just feel save in that hospital.’ (FG3,female, age 75)  
 ‘I have had personal experience with that hospital and I will never go back! And that is the way you 
choose. The list may point out that it is a great hospital, but if your personal experience was 
unpleasant, you simply do not believe the list.’ (FG1, female, age 63) 
 ‘It’s simple, you rely on the experiences of the people you know.’ (FG1, female, age 53a) 
 I don’t know how my PCP would react if I go to a different hospital than what he refers me to. I don’t 
know if it would affect the relationship. I still think you will be tend to listen to your PCP.’ (FG6, 
female, age 63) 
 ‘It would be nice, if my PCP would help me to remember that I have a choice, and that he would 
provide me with an overview or refer me to a website where I could look for it’ (FG4, female, age 
54). ‘But, you can’t expect that the PCP know everything about this.’ (FG1, female, age 53b) 
 ‘If my PCP said, “I have faith in that specialist for these reasons” or “I would not rely on that 
specialist”, then I would indeed switch to another hospital.’ (FG1, female, age 53a). 
 
Theme 3: value of CPI (Box 3) 
Most participants had never seen CPI before attending the focus group interviews. They 
had some doubts and felt a little confused after being confronted with the CPI 
examples. The examples caused a variety of reactions among the participants. The 
inventory of these reactions, including start-up questions, was supportive for 
participants in the discussion that followed. At first, they gave a reaction to the 
examples and their usefulness in general. Some participants immediately tried to 
interpret what they saw, others were primarily looking to see if the examples 
confirmed their ideas or their own experiences. Some consumers questioned the added 
value of such information. 
 
During the discussion, reactions evolved to more specific goals and values by using the 
examples. Participants reported that having the ability to select a healthcare provider 
might involve a significant effort to find and compare information. They argued that 
choosing a hospital introduced a new responsibility for patients, including feelings of 
distrust and anxiety, since they could not foresee the consequences that they might be 
held responsible for. Not using CPI was sometimes explained as a strategy to prevent 
regret for a wrong decision. 
 
The participants pinpointed an important paradox: the more you know, the more 
uncertain you become, especially if information from different sources is inconsistent. 
The participants were afraid of losing their trust in certain aspects of healthcare that 
they had previously assumed to be good. 
 
An important theme was the importance consumers assigned to the reliability and 
trustworthiness of the information. Respondents complemented each other in listing 
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conditions CPI must fulfill before it became of value for them and before they would 
start using this information. The discussion included the objectivity of the information, 
how the information was collected, which groups of patients were compared, and at 
what level the CPI was published. Most participants stressed the importance of the 
reliability of CPI, but at the same time they found it difficult to determine on what 
grounds CPI could be considered reliable and trustworthy. Our participants wished to 
see that sources presenting CPI would include disclaimers about reliability aspects and 
declare any conflicts of interest. Also, up-to-date information was of much value for 
consumers. The remarks regarding to this can be summarised with the question: ‘How 
do I know if what was good then is good for me right now?’ Some participants wanted a 
single composite indicator of overall quality to compare hospitals rapidly and easily. 
Other participants stated that the level of aggregation was too general in the real-
world examples. The examples referred to an entire hospital, whereas participants 
wanted to have information at the level of departments, e.g. cardiology and 
orthopaedics, or at the level of individual doctors. 
 
Box 3.  Values of comparative performance information 
 
 ‘I had to take a look at this for a second. What is this!? All these dots and circles. I'm just amazed by 
the way we are supposed to believe that this is useful for us as patients.’ (FG1, female, age 53a) 
 ‘What happens now is that someone tells me: “you are the patient, so make your own choice.” (..). 
The responsibility is passed on to me, the patient. This fits with the image of the consumer-driven 
health care system, but the question is whether you can deal with this and what happens if 
something goes wrong?’ (FG2 male, age 53) 
 ‘You read something and it stays in your head. But if you had not known it, you wouldn’t have that 
problem. Knowing everything is not that great either.’ (FG2, female, age 57) 
 
Theme 4: perceived effect of CPI (Box 4) 
The values identified stimulated the participants to mention possible effects of CPI: 
patient empowerment, waste, freedom of choice, benchmarking, changed perceptions, 
and a dichotomy in society. Patient empowerment was mentioned in several sessions, 
so was the counterpart that CPI is a waste. Some respondents found that using CPI to 
choose providers went beyond what is necessary in healthcare in terms of good care. 
Increasing freedom of choice was noted as a positive effect, as well as an attitude 
among some participants who felt their perceptions of quality of care had changed. 
They declared raising more awareness about the quality of care after the recent 
introduction of choice for consumers. Consumers supported the effect of 
benchmarking, so that professionals and organisations could compare each other in 
terms of quality of care. Finally, some participants had concerns about whether using 
this information might cause a further dichotomy in society by increasing inequity in 
healthcare. They foresaw that the ability to use information required skills of 
healthcare consumers for which some would be better than others. 
2 
 Chapter 2 
28 
Box 4.  Perceived effect of comparative performance information 
 
 ‘You now look differently. When I, recently, came to the Emergency Room with my mother, you 
start to look around, how is it here? How are the nurses doing things? How do they do that? What are 
the stories of my mother?’ Moderator: ‘Do you now look at things in health care from a different 
perspective?’ ‘Yes, more as a purchaser of care.’ (FG3, female, age 56) 
 [..] ‘So you go on this path, and you might get a dichotomy in society, that is a risk with this market 
in health care’ (female, age 57). ‘Yes’ [approvingly] (female, age 56). ‘You have people who can do 
this’ (female, age 57). ‘Yes, yes’ (female, age 56). ‘People who have the skills, but for others there 
will be less possibilities’ (female, age 57). ‘Yes, I am worry about that too.’ (FG3, female, age 56) 
 ‘I think patients become more assertive. Normally, you would take things for granted if they say ‘go 
to that hospital. While if you later find out you had a choice, you might say: if I could choose, I had 
perhaps done things differently and if I had known, I might have gone elsewhere; so I think this has 
an effect on empowerment of patients.’ (female, age 60) ‘Yes, I do think it is useful information 
that they receive.’ (FG6, male, age 63) 
 
DISCUSSION 
This study explored the values, thoughts, understanding and evaluations of CPI for 
hospital choice among healthcare consumers in the Netherlands. By means of real-
world examples, healthcare consumers were able to express their views about CPI. The 
four themes (awareness, current sources of decision-making, value of CPI and 
perceived effect of CPI) from the data suggest that there are numerous underlying but 
conflicting values, which are important for healthcare consumers relating to their use 
of CPI. The CPI was only marginally valued, due to consumers’ values during their 
processing of CPI, and wider principles that limited consumers even considering the use 
of the information. 
 
Most participants were unaware of CPI, and did not use this kind of information. 
Therefore, participants could not give a direct answer when we asked them what kind 
of information they would like to have or what matters most to them at the beginning 
of the focus group sessions. It seemed that the participants had never reflected on the 
information they would like to have while comparing hospital care. This is a general 
finding in judgement and decision-making research because decision-makers often do 
not know their own values.28,29 The examples were needed to clarify information 
preferences and led to active debates during the focus group session and to a deeper 
understanding of the consumers’ values around CPI. In Moser and colleagues’ study, the 
use of concrete examples led to similar positive results.30 Hibbard et al,5 stressed the 
need for consumers to develop a better understanding of quality of care and current 
measures of quality. A recent study in clinical decision-making31 focuses on the social 
influence of interaction in decision-making. The concept of ‘shared mind’ as an 
underlying process for clarifying individual values between two or more people, in 
which new ideas and perspectives emerge, corresponds with our findings using focus 
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groups. Epstein also underlines the power of multiple perspectives of patients, family, 
physicians or other members of the healthcare team.31 
Our study showed that consumers expressed values on several levels and that these 
values sometimes conflicted with each other. Some values were in favour of the use of 
CPI, while other doubts, concerns and principles negatively affected consumers’ views 
of CPI. Participants relied on previous routines such as consulting GP, family, friends, 
and personal experiences as the basis for choosing a hospital.32,33 Nonetheless, they 
were also keen on having a choice. Respondents also appreciated the increased 
transparency in care, and the effect on patient empowerment.34,35 However, the 
responsibility was difficult, and participants felt that choosing a hospital was a bit of a 
burden. Fear of disrupting existing relationships was another consideration that 
prevented people from using CPI to choose a hospital. The relationship with their GP 
was of much more value to them, which corresponds with UK and Dutch studies.35–37 A 
new perspective that was raised in our study is that not using CPI was explained as a 
strategy to prevent regret for a wrong decision as participants could not foresee the 
consequences of using CPI. Trusted others can help them to clarify the possible 
consequences and compare this with personal values. Finally, as in other studies our 
participants placed much value on reliability and distrust the current CPI.24,30 
 
The use of CPI by healthcare consumers is a complex process in which values, rather 
than rationality, play an important role. Our findings show that consumers need help 
from others to solve conflicting values, to develop a firmer understanding of the quality 
of care concept, and to move forward in making active and informed hospital choices. 
 
Limitations and strengths 
Our study adds to the understanding of the role of values, appraisal and judgement of 
CPI among Dutch consumers. However, the study has a number of limitations that limit 
the generalisability. First, the small sample size. We intended to include more 
participants, but recruitment was problematic, despite the use of various strategies. 
Owing to this difficult recruitment, we were not able to achieve our planned age 
distribution for the study. Moreover, 25% of the recruited participants did not attend 
the focus group session, underlining our finding that current CPI is valued marginally. 
Second, the data collection and analysis took place simultaneously, as the time frame 
of three months for focus group meetings was short. A strength of this study is the use 
of real-world examples, which was very helpful for the discussion. 
 
Implications 
Our results make clear that simply providing information is not enough and will not 
enhance the usage of CPI. CPI is valued only marginally, and as such it is not yet used 
by service users as an additional information source, nor does it challenge healthcare 
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consumers’ current selection of hospitals. Our findings also show that more focus is 
needed on eliciting the underlying values of consumers. Several studies, including ours, 
have stressed the need for an agent that can support healthcare consumers in choosing 
and can coordinate on their behalf when bringing the choice into practice.38,39 Such an 
agent might be able to elicit consumers’ preferences, clarify the values of CPI and 
preferably integrate this into the referral processes of primary care providers. 
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ABSTRACT 
Background: Choice of hospital based on comparative performance information (CPI) 
was introduced for Dutch healthcare consumers at least 5 years ago, but CPI use has 
not yet become commonplace. Our aim was to assess the role of patients’ expectations 
regarding variation in the quality of hospital care in determining whether they search 
for CPI. 
Methods: A questionnaire (for a cross-sectional survey) was distributed to 475 
orthopaedic patients in a consecutive sample, who underwent primary hip or knee 
replacement in a university, teaching, or community hospital between September 2009 
and July 2010. 
Results: Of the 302 patients (63%) who responded, 13% reported searching for CPI to 
help them choose a hospital. People who expected quality differences between 
hospitals (67%) were more likely to search for CPI (OR =3.18 [95% CI: 1.02–9.89]; p 
<0.04) than those who did not. Quality differences were most often expected in 
hospital reputation, distance, and accessibility. Patients who did not search for CPI 
stated that they felt no need for this type of information. 
Conclusion: Patients’ expectations regarding variation in quality of care are positively 
related to their reported search for CPI. To increase the relevance of CPI for patients, 
future studies should explore the underlying reasoning of patients about meaningful 
quality-of-care variation between hospitals. 
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BACKGROUND 
The public release of comparative performance information (CPI) is common in many 
countries.1 The 2006 Healthcare Market Regulation Act led to better availability of CPI 
in the Netherlands. Choice for consumers and providers became a cornerstone of this 
new healthcare system based on market elements and competition. CPI can include 
information about service, patient experiences, and quality indicators for clinical care 
(structure, process, and patient outcomes). The CPI in the Netherlands includes items 
related to the hospital (e.g. ranking of 100 hospitals) and to condition-related factors 
(e.g. patient experiences, waiting lists, and annual patient volumes). The purpose of 
making this information publicly available is to enable healthcare consumers to choose 
high-quality healthcare2 and to empower them to make an informed choice about 
healthcare.3 
 
There is no firm evidence that CPI influences patient choices.4 American and British 
studies have shown that the actual use of CPI for hospital care is restricted to 4–14% of 
the consumers5,6, while the idea of choice appeals to most consumers.7 Several Dutch 
studies of CPI for total hip or knee replacements have been performed.8-11 The patients 
in Moser and colleagues’ study considered CPI to be an additional source of information 
when they were preparing for a doctor’s appointment. They benefited from the 
information most when they had to undergo a total hip or knee replacement for the 
first time.9 American patients who report a lack of hospital choice for total hip or knee 
replacement are more likely to be dissatisfied with their surgery.8 This observation 
suggests that encouraging patients to engage in provider selection based on quality of 
care would improve their satisfaction. 
 
The low level of CPI search behaviour for selecting a hospital is partly due to the 
consumer’s previous experience with a specific hospital12-14 and the unfamiliarity of 
using CPI for hospital selection15,16, as well as the role of the referring physician. Dutch 
research shows that many patients prefer their primary care physician to be involved in 
the choice of hospital so they can either take the physician’s advice or delegate the 
decision.17-19 Furthermore, many consumers are unaware of the opportunity to consult 
CPI.6,20,21 
 
To raise the level of CPI awareness (an important step in a causal chain towards using 
CPI) an attendant motive is required so that consumers feel a need for this 
information.21 One consumer choice model takes awareness as a starting point.18 
Consumers must be aware that there is CPI, and that it is possible to make a choice. 
We presume that patients’ expectations are an important pre-step and have a 
subjective influence on awareness. Studies show that, when consumers start searching 
for information, the questions and expectations already in their minds will drive the 
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direction of their search.22-24 Having expectations about the practice variation of 
hospitals and therefore perceiving a risk of receiving poor care might be a motive for 
using CPI. 
 
Despite on-going efforts and investments in the collection, production, and 
dissemination of CPI for the public15, there is no firm evidence that CPI influences 
patient choices.4 In an attempt to bridge this gap, we hypothesise that consumers who 
expect to find quality differences between hospitals are those who search for CPI. We 
tested whether patients’ expectations of variation in quality of care affect their 
reported search behaviour for hospital performance information, then we adjusted for 
potential confounders. Furthermore, respondents were asked in what ways they 
expected hospitals to differ. We also asked them about the most important reasons why 
they did not search for CPI. We obtained data from patients who had recently been 
admitted to hospital for an elective total hip or knee replacement. Admission to a 
hospital for elective surgery can be planned in advance which gives patients time to 
search for and look into CPI. These replacement procedures are provided at all 87 
hospitals in the Netherlands. 
 
METHODS 
In a cross-sectional study of three types of hospitals, we used a consecutive sampling 
strategy to recruit 475 patients undergoing a total hip or knee replacement, and we 
invited them to participate in a paper-based survey. To make our sample 
representative, we included patients from a university hospital, a teaching hospital, 
and a community hospital. We included adult patients undergoing a primary hip or knee 
replacement because we expected that previous surgical experience (as in the case of a 
secondary replacement) would bias the selection. The annual patient volumes were 53 
for primary hip replacements and 64 for knee replacements in the university hospital; 
232 and 170, respectively, in the teaching hospital; and 236 and 153, respectively, in 
the community hospital. Data collection took from 5 to 9 months (September 2009 
through July 2010). The nurse or anaesthetist who prepared the patient for surgery 
personally gave the survey questionnaire to the patient at the preoperative 
appointment 4 weeks prior to the operation. Reminders were sent 2–3 weeks later in 
the teaching and community hospitals, but no reminders were sent in the university 
hospital because permission for this was not granted. 
 
The institutional ethics committee reviewed the study protocol in accordance with 
local regulations in the Netherlands, and they concluded that the study was not subject 
to the Dutch Medical Research Involving Human Subjects Act. 
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The primary outcome measure was the self-reported search for CPI, i.e. ‘Did you search 
for additional CPI to compare hospitals after it became clear that you needed surgery?’ 
(answer: yes or no). Respondents did not search for CPI were asked to select their 
motive from a list of seven pre-listed reasons with an option to add one. The reasons 
were based on a literature search (unpublished search) and focus group interviews with 
consumers.25 Other measures concerned the previous treatment in the selected 
hospital: consumers’ perception of being well-informed to make a decision, the general 
practitioner’s (GP’s) role in advising a choice of hospital (all dichotomous variables), 
and expectations of variation in quality of care between hospitals (large, small, or no 
difference in quality of care). If respondents expected quality-of-care differences, they 
were asked to specify these differences for 14 pre-listed factors that were available 
from the Dutch internet sites www.kiesbeter.nl (make better choices) and 
www.independer.nl. Both sites based the factors they listed on a set of quality 
indicators that the Health Care Transparency Programme listed in 2009.26 Focus group 
interviews with consumers25 and the annual list of a Dutch magazine, Elsevier27, also 
presented factors to be considered. The factors included the available CPI for hip and 
knee replacements in the Netherlands, which gave the name of the organisation and 
the clinical performance of the care providers. Formally, ‘distance’ and ‘reputation’ 
are not CPI, but they were included because they are important to patients.9,11,28 In this 
sense, such information can be seen as part of the performance of the healthcare 
system. We used a broad definition of performance, as did Van Loon and Tolboom, who 
defined three information types: (1) factual information (names, addresses, and type of 
provider), (2) quality information based on performance, and (3) quality information 
based on consumer experience.29 The questionnaire contained items about 
demographic variables (age, education, and type of replacement [hip or knee]), and 
hospital characteristics (type and patient volumes for hip and knee replacements). 
 
We used descriptive statistics and frequency tables to describe our study population’s 
demographic variables (age, gender, and education), previous treatment in the current 
hospital, awareness that hospital performance information is available for comparison, 
receipt of choice options from GPs, the search for CPI, and expectations of quality 
differences in hospital care (Table 1). To address the issue of representativeness, we 
compared the characteristics of the participants in our study with the characteristics of 
a larger sample of 1508 Dutch patients who underwent a hip or knee replacement.30 
 
We included data only for those respondents who provided valid answers for the core 
items of our study: search for CPI and expectations of quality differences in hospital 
care. The respondents were dichotomised into a group 65 years or younger, and a group 
older than 65 years. The education variable (the level of education) was measured on a 
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four-point scale (none, low, middle, and high), and it was dichotomised for analytical 
purposes into low and high levels of education. 
 
We used logistic regression to analyse the relationship between expectations of quality 
differences (independent variable) and searching for CPI (dependent variable) for 
patients who underwent a hip or knee replacement (Table 2, model 1). In order to 
correct for possible confounders, we also performed this univariate analysis for the 
demographic variables (e.g. age, gender, education, and type of replacement), hospital 
type, GPs’ role in advising choice of hospital, awareness of available information for 
comparing hospital performance, and previous treatment at the current hospital. 
Potential confounders (p <0.2) in univariate analyses were added to the multivariate 
model, and we examined their effects on the beta coefficients. Any variables resulting 
in a change in the beta coefficient of more than 10% were included in the final model. 
We compared the univariate analysis (model 1) with the multivariate analysis (model 2) 
for odds ratios (ORs) with 95% confidence intervals (95% CIs). An association was 
considered statistically significant for p <0.05. 
 
We present descriptive statistics for the factors that we expected to differ between 
hospitals, as well as statistics for the reasons for not searching CPI. In describing these 
reasons, we distinguished between respondents who expected differences in the quality 
of hospitals and those who did not. We used SPSS 18.0 for all analyses. 
 
RESULTS  
Study population 
Of the 475 questionnaires sent out, 302 were returned completed (response rate 63%). 
279 questionnaires had valid answers for the core items: search for CPI and 
expectations of quality differences in hospital care. Table 1 shows a comparison of 
consumer characteristics differentiated by the type of hospital. We compared our 
respondents with a sample of 1508 Dutch patients who underwent a hip or knee 
replacement.30 The age distribution of our respondents was 40% for those aged 65 years 
or less and 60% for those older than 65 years.  
 
For the sample of 1508 patients, the age distribution was 30% and 70%, respectively. 
While this was more or less similar, the samples showed greater differences for gender: 
43% were male in our study versus 28% in the sample of 1508 patients; and for a low 
level education, 19% and 28%, respectively. 
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Table 1.  Characteristics of the participants differentiated by type of hospitala 
 
 Total University 
hospital 
Teaching 
hospital 
Community 
hospital 
n % n % N % n % 
Women 
Men 
158 
121 
57 
43 
45 
37 
55 
45 
65 
49 
57 
43 
48 
35 
58 
42 
Age ≤ 65* 
       >65* 
107 
163 
40 
60 
45 
35 
56 
44 
42 
67 
39 
62 
20 
61 
25 
75 
Low level of education 
High level of education  
222 
  52 
81 
19 
64 
17 
79 
21 
86 
27 
76 
24 
72 
 8 
90 
10 
Total primary hip replacementsb  
Total primary knee replacements 
179 
  97 
65 
35 
58 
23 
72 
28 
69 
44 
61 
39 
52 
30 
63 
37 
Received no previous treatment in current hospital 
Received previous treatment in current hospital 
  59 
217 
21 
79 
27 
53 
34 
66 
18 
98 
16 
84 
14 
68 
17 
83 
Did not receive hospital choice options from GPs 
Received hospital choice options from GPs 
217 
  55 
80 
20 
58 
23 
72 
28 
94 
18 
84 
16 
65 
14 
82 
18 
Unaware that they could compare hospital 
performance 
Aware that they could compare hospital performance 
 67 
 
210 
24 
 
76 
22 
 
60 
27 
 
73 
26 
 
87 
23 
 
77 
19 
 
69 
23 
 
77 
Did not search for CPI 
Searched for CPI 
242 
  37 
87 
13 
68 
14 
83 
17 
97 
17 
85 
15 
77 
 6 
93 
  7 
Expectations of quality differences in hospital care  
    No differences 
    Yes, small differences 
    Yes, large differences 
 
  91 
137 
  51 
 
33 
49 
18 
 
17 
37 
28 
 
21 
45 
34 
 
36 
59 
19 
 
32 
52 
17 
 
38 
41 
  4 
 
46 
49 
  5 
a Data were based on answers from eligible respondents about the search for comparative performance 
information and expectations of quality differences in hospital care 
b Not every score accumulates to 279 because of missing characteristic data  
CPI: comparative performance information; GP: general practitioner 
 
Awareness of hospital comparison information and choice 
Most respondents (76%) reported that they were aware of the possibility of comparing 
hospital quality, and they (72%) were aware that they actually could choose a hospital 
for their surgery. Most respondents (73%) reported that they had a choice option. Most 
(89%) reported being well-informed about the choice of hospital. Of the total group of 
respondents, only 13% said they had searched for hospital CPI before choosing a 
hospital for the operation. Among those who did not have a choice option, a minority 
(14%) searched for information once they knew they needed surgery. It did not seem to 
matter whether patients had a choice option or not; a minority in each group searched 
for information. 
 
Expectations of differences in quality of hospital care 
Most participants (67%) expected to find differences in hospital quality of care. The 
variables gender, type of replacement, GP role in advising a choice of hospital, and 
being aware that they could compare hospital performance contributed to the 
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explanation model with p <0.2. However, these variables did not effect a substantial 
change (>10%) in the beta coefficients, so were excluded from the final model. Table 2 
shows the results of the univariate and multivariate logistic regression analyses for the 
relationship between the quality expectations of hospital care and the reported search 
for CPI.  
 
Table 2.  The relationship between quality expectations and searching for comparative performance 
information by patients who underwent a hip or knee replacement (model 1), controlled for 
patient and hospital characteristics and previous treatment (model 2) 
 
 Model 1a 
Univariate analysis 
Model 2b 
Multivariate analysis 
 OR [95% CI] p  OR [95% CI] p  
Age     
 <65   1.18  [0.55–2.53] 0.66 
 ≥65 (reference)     
Hospital type     
    Teaching   1.27 [0.54–2.95]  0.58 
    Community   0.73 [0.24–2.22] 0.58 
    University (reference)     
Previous treatment in current 
hospital 
    
    Yes    0.32 [0.15–0.70] 0.00c 
 No (reference)     
Expectations regarding quality 
differences in hospital care  
 0.00c  0.04c 
    Yes, small differences 3.71 [1.22-11.27] 0.02c 3.18 [1.02–9.89] 0.04c 
    Yes, large differences 7.44 [2.28-24.30] 0.00c 5.05 [1.44–17.77] 0.01c 
 No, differences (reference)     
a Based on the answers of 279 respondents; b Based on the answers of 263 respondents 
c P < 0.05; OR [95% CI]: odds ratio [95% confidence interval] 
 
Previous treatment in the current hospital also appeared to significantly influence the 
reported search for CPI. 
 
The univariate model shows that respondents who expected small differences in 
hospital quality were more likely to search for CPI than those who did not (OR = 3.71 
[95% CI: 1.22–11.27]). For people who expected large quality-of-care differences, this 
effect was even greater (OR = 7.44 [95% CI: [2.28–24.3]). The adjusted ORs were 3.18 
[95% CI: 1.02–9.89] for the group who expected small differences, and 5.05 [95% CI: 
1.44–17.77] for the group who expected large differences. Respondents with previous 
treatment in the same hospital less often searched for CPI than those who had no 
previous treatment (OR =0.32 [95% CI: 0.15–0.70]). 
The participants’ rating of expected hospital quality differences in reputation, 
distance, and accessibility are ranked the highest (Table 3). 
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Table 3.  Factors influencing choice of hospital for total hip and knee replacementsa 
 
Hospital-related factors   n 
1. Reputation 107 
2. Distance   95 
3. Accessibility    79 
4. Type of hospital (university, teaching, or community)   51 
5. Ranking list of ‘100 hospitals’    41 
6. Hospital size    20 
7. Number of cancelled operations      1 
Condition-related factors    n 
8. Plan for pre-operative schedules on 1 day    51 
9. Orthopaedic specialism   50 
10. Patient experiences    49 
11. PROMs   49 
12. Waiting list    45 
13. Annual patient volume    42 
14. Infection rates    16 
a Data were based on 191 answers from eligible respondents 
PROMs: Patient-Reported Outcome Measures 
 
Reasons for not searching for comparative performance information 
Of the respondents who did not search for additional information, 179 said they felt no 
need for more information. Others gave far less common reasons: 19 had no internet 
access at home, 15 felt more information would create more doubts, 13 said searching 
for information was an extra burden, 7 thought choosing a hospital based on CPI was 
too much responsibility, 8 did not know where to look, 6 had no skills how to look, 8 
had no hospital choice options, and 5 had no time. 
 
Feeling no need was by far the most important reason for not searching for hospital 
CPI. Though, this reason was not significant related to the expectations of quality-of-
care differences. 
 
DISCUSSION 
Thirteen per cent of our study population searched for CPI to compare hospitals. This is 
consistent with the results of American and Dutch studies for similar populations.14,31 
Our hypothesis that patients who expect quality differences are those who search for 
CPI was confirmed. Previous experience with the hospital is another factor influencing 
the search for CPI. Expecting quality of care differences in hospital performance 
appears to be a stimulus for searching for CPI, although respondents who underwent 
previous treatment in the hospital tended to search less for this information. 
 
In our study, the impact of previous experience on hospital choice was consistent with 
Dixon and colleagues’ results.32 They compared the effect of consumer choice during 
the referral process in the Netherlands and England. For Dutch patients, ‘being in the 
neighbourhood’ or ‘having been there before’ were the most important reasons for 
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choosing a hospital: patients usually returned to the same hospital.33 Interestingly, 
patients prefer being treated at their current hospital, even if they could choose a 
better alternative with higher-quality care.34,35 Choosing a familiar hospital instead of 
an unknown one suggests that personal experience is a value in itself. While CPI may 
indicate the best hospitals, patients may optimise the factors they value most rather 
than objectively maximize quality. 
 
Our respondents expected most differences to be in reputation, distance, and 
accessibility. As reported in other studies6,12,19, these are known choice factors in 
decision-making. Our study population expected differences mainly in the general 
performance of the healthcare system rather than in specific condition-related factors 
(total hip or knee replacement). The factors for which consumers expect quality 
differences may change in the future as consumers become more knowledgeable about 
CPI. Dutch studies among patients with a total hip or knee replacement found that both 
interpersonal aspects (conduct of doctors) and more technical ones (for example, the 
prevention of adverse effects of thrombosis and the specialist area of orthopaedists) 
are important to patients.11 Making the concept of quality more meaningful may also 
increase consumer interest and need for CPI.15 Bozic and colleagues have confirmed 
this statement: they have recently found that patients were very motivated to search 
for provider quality. In their study, physician manner and surgical outcomes appeared 
to be the most important considerations for selecting a provider for elective total joint 
arthroplasty.36 
 
Some studies6,18 led us to expect that unawareness is an important reason why hospital 
performance information has little influence on decision-making. An information need 
and a sense of urgency are necessary ingredients for awareness and interest in this type 
of information. Although most of our respondents (76%) were aware that they could 
compare hospital performance and choose a hospital (72%), they still did not use CPI. 
This discrepancy might be due to their feeling no need for such information. Having 
alternative information sources9 or doubt about the trustworthiness of such 
information2 could also contribute to this feeling. This discrepancy also implies the 
need for a more outspoken reporting of hospital quality that emphasizes differences in 
quality. If rational patients assume that these differences are small, then they cannot 
be expected to look for and use such information. The ongoing efforts and investments 
that go into the collection, production, and dissemination of CPI would then be useless. 
 
Implications 
Our study shows that merely making CPI available in the public domain does not result 
in its use. This implies that further action, such as applying an implementation 
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strategy, is necessary. Other studies see the need for an infrastructure that provides 
patients with advice about their choices and helps them in actually choosing.37,38 
Future research should explore the concept of patients’ expectations more 
comprehensively because the fact that patients’ expectations that quality differences 
exist affects their search for CPI, but does not affects their need for CPI. Research 
should use the resulting information to determine how fragile or robust these 
expectations are.39 Whereas CPI is based on measurable factors, consumer expectations 
are more diffuse and individually determined. More development of tailored methods 
to assess the understanding of variation in quality of care as a precondition for 
acquiring awareness, knowledge, and interest is necessary. 
 
Finally, further research should explore whether the sense of urgency for this 
information will increase if the concept of quality of care becomes more meaningful 
and patients start to realise that quality and outcomes of care do vary for both 
treatment and hospital factors. 
 
Limitations 
One strength of our study is the recruitment of respondents in three types of hospitals. 
Consumer characteristics differed somewhat among the three settings (Table 1), which 
confirmed the validity of our decision to include the three types. One limitation of our 
study is that only a minority reported searching for CPI, so we could not make precise 
estimations, as is reflected in the large confidence intervals in Table 2. We would have 
preferred a more balanced dataset for better data modelling. Another limitation is the 
self-reporting of our main outcome, which may have introduced a recall bias. However, 
we limited the time between selecting a hospital and completing the questionnaire by 
giving it to the participants at their appointments with a nurse or anaesthetist before 
surgery. This tactic minimized the time lag between choosing a hospital choice and the 
date of surgery. 
 
Conclusions 
CPI makes the variation in quality of care between hospitals transparent. This study 
shows that the number of people who report having searched for CPI is still limited, but 
may increase if patients become more aware of the quality-of-care variation of 
hospitals. However, this will be difficult to achieve because people who feel no need 
for more information – e.g. based on a lack of expected differences in quality of care – 
do not search for CPI. Awareness as a prerequisite for the use of CPI should not be 
limited to having knowledge about the existence of CPI and where to find it; awareness 
should also extend to the quality-of-care variation of hospitals. 
 
3 
 Chapter 3 
44 
REFERENCES 
1.  Victoor A, Delnoij DM, Friele RD, Rademakers JJ. Determinants of patient choice of healthcare 
providers: a scoping review. BMC Health Serv Res 2012; 12:272. 
2.  Marshall M, McLoughlin V. How do patients use information on health providers? BMJ 2010; 
341:c5272. 
3.  Fasolo B, Reutskaja E, Dixon A, Boyce T. Helping patients choose: how to improve the design of 
comparative scorecards of hospital quality. Patient Educ Couns 2010; 78(3):344–349. 
4.  Ketelaar NABM, Faber MJ, Flottorp S, Rygh LH, Deane KHO, Eccles MP. Public release of 
performance data in changing the behaviour of healthcare consumers, professionals or 
organisations. Cochrane Database Syst Rev 2011; 11:CD004538. 
5.  Fung CH, Lim YW, Mattke S, Damberg C, Shekelle PG. Systematic review: the evidence that 
publishing patient care performance data improves quality of care. Ann Intern Med 
2008;148(2):111–123. 
6.  Harris KM, Buntin MB. Choosing a Health Care Provider: The Role of Quality Information. Princeton, 
NJ: Robert Wood Johnson Foundation, 2008. 
7.  Coulter A. Engaging Patients in Healthcare. London: Open University Press, 2011. 
8.  Losina E, Plerhoples T, Fossel AH, Mahomed NN, Barrett J, Creel AH, Wright EA, Katz JN. Offering 
patients the opportunity to choose their hospital for total knee replacement: impact on 
satisfaction with the surgery. Arthritis Rheum 2005;53(5):646–652. 
9.  Moser A, Korstjens I, Van der Weijden T, Tange H. Patient’s decision making in selecting a hospital 
for elective orthopaedic surgery. J Eval Clin Pract 2010;16(6):1262–1268. 
10.  Moser A, Korstjens I, van der Weijden T, Tange H. Themes affecting healthcare consumers’ choice 
of a hospital for elective surgery when receiving web-based comparative consumer information. 
Patient Educ Couns 2010;78(3):365–371. 
11.  Zwijnenberg NC, Damman OC, Spreeuwenberg P, Hendriks M, Rademakers JJ. Different patient 
subgroup, different ranking? Which quality indicators do patients find important when choosing a 
hospital for hip- or knee arthroplasty? BMC Health Serv Res 2011;11:299. 
12.  Kolstad JT, Chernew ME. Quality and consumer decision making in the market for health insurance 
and health care services. Med Care Res Rev 2009;66(1 Suppl):28S–52S. 
13.  Marang van de Mheen PJ, Dijs-Elsinga J, Otten W, Versluijs M, Smeets HJ, Vree R, van der Made 
WJ, Kievit J. The relative importance of quality of care information when choosing a hospital for 
surgical treatment: a hospital choice experiment. Med Decis Making 2011;31(6):816–827. 
14.  Schwartz LM, Woloshin S, Birkmeyer JD. How do elderly patients decide where to go for major 
surgery? Telephone interview survey. BMJ 2005;331(7520):821. 
15.  Hibbard JH, Greene J, Daniel D. What is quality anyway? Performance reports that clearly 
communicate to consumers the meaning of quality of care. Med Care Res Rev 2010; 67(3):275–293. 
16.  Trigg L. Patients’ opinions of health care providers for supporting choice and quality improvement. 
J Health Serv Res Policy 2011;16(2):102–107. 
17.  Damman OC, Spreeuwenberg P, Rademakers J, Hendriks M. Creating compact comparative health 
care information: what are the key quality attributes to present for cataract and total hip or knee 
replacement surgery? Med Decis Making 2012;32(2):287–300. 
18.  Faber M, Bosch M, Wollersheim H, Leatherman S, Grol R. Public reporting in health care: how do 
consumers use quality-of-care information? A systematic review. Med Care 2009;47(1):1–8. 
19.  Lako CJ, Rosenau P. Demand-driven care and hospital choice: Dutch health policy toward demand-
driven care: results from a survey into hospital choice. Health Care Anal 2009;17(1):20–35. 
20.  Jha AK, Epstein AM. The predictive accuracy of the New York State coronary artery bypass surgery 
report-card system. Health Aff 2006;25(3):844–855. 
21.  Wilson TD. Trends in…a critical review: information behaviour: an interdisciplinary perspective. 
Inform Process Manag 1997;33(4):551–572. 
22.  Adam JA, Khaw FM, Thomson RG, Gregg PJ, Llewellyn-Thomas HA. Patient decision aids in joint 
replacement surgery: a literature review and an opinion survey of consultant orthopaedic 
surgeons. Ann R Coll Surg Engl 2008;90(3):198–207. 
23.  Brashers DE. Communication and uncertainty management. J Commun 2001;51:477–497. 
24.  Kivits J. Researching the ‘informed patient’. Information, Communication & Society 2004;7(4):510–
530. 
25.  Ketelaar NABM, Faber MJ, Westert GP, Elwyn G, Braspenning JC. Exploring consumer values of 
comparative performance information for hospital choice. Qual Prim Care 2014; 22(2):81–89. 
 Patients’ expectations of variation in quality of care  
45 
26.  Health Care Transparency Programme. Kwantitatieve Analyse Indicatoren Zichtbare Zorg. 
Ziekenhuizen - 2008 Data. Den Haag: Healthcare Inspectorate, 2009:1–443. 
27.  Elsevier. The Best Hospitals 2008. In Elsevier, Volume 74. Amsterdam: Reed Elsevier, 2008. 
28.  Epstein AJ. Effects of report cards on referral patterns to cardiac surgeons. J Health Econ 2010; 
29(5):718–731. 
29.  Van Loon AJM, Tolboom RAL. Design Report “Choose Better” 2006–2007 [In Dutch: Ontwerprapport 
KiesBeter.nl 2006–2007]. Bilthoven: RIVM, 2005. 
30.  Stubbe JH, Gelsema T, Delnoij DM. The Consumer Quality Index Hip Knee Questionnaire measuring 
patients’ experiences with quality of care after a total hip or knee arthroplasty. BMC Health Serv 
Res 2007; 7:60. 
31.  de Groot IB, Otten W, Smeets H, Marang-van de Mheen P, The Choice 2 Study Group. Is the impact 
of hospital performance data greater in patients who have compared hospitals? BMC Health Serv 
Res 2011; 11:214. 
32.  Dixon A, Robertson R, Bal R. The experience of implementing choice at point of referral: a 
comparison of the Netherlands and England. Health Econ Policy Law 2010;5(3):295–317. 
33.  Dijs-Elsinga J, Otten W, Versluijs MM, Smeets HJ, Kievit J, Vree R, van der Made WJ, Marang-van 
de Mheen PJ. Choosing a hospital for surgery: the importance of information on quality of care. 
Med Decis Making 2010;30(5):544–555. 
34.  Boonen LH, Donkers B, Schut FT. Channeling consumers to preferred providers and the impact of 
status quo bias: does type of provider matter? Health Serv Res 2011;46(2):510–530. 
35. Laverty AA, Smith PC, Pape UJ, Mears A, Wachter RM, Millett C. High-profile investigations into 
hospital safety problems in England did not prompt patients to switch providers. Health Aff 
2012;31(3):593–601. 
36.  Bozic KJ, Kaufman D, Chan VC, Caminiti S, Lewis C. Factors that influence provider selection for 
elective total joint arthroplasty. Clin Orthop Relat Res 2013;471(6):1865–1872. 
37.  Meinow B, Parker MG, Thorslund M. Consumers of eldercare in Sweden: the semblance of choice. 
Soc Sci Med 2011;73(9):1285–1289. 
38.  Schlesinger M. Choice cuts: parsing policymakers’ pursuit of patient empowerment from an 
individual perspective. Health Econ Pol Law 2010; 5(3):365–387. 
39.  Bowling A, Rowe G, Lambert N, Waddington M, Mahtani KR, Kenten C, Howe A, Francis SA. The 
measurement of patients’ expectations for health care: a review and psychometric testing of a 
measure of patients’ expectations. Health Technol Assess 2012;16(30):i–xii. 1–509. 
 
3 
 
Chapter 4 
 
Recognition of physiotherapists’ expertise in 
Parkinson’s disease 
 
 
 
Nicole Ketelaar 
Marten Munneke 
Bas Bloem 
Gert Westert 
Marjan Faber 
 
 
BMC Health Services Research 2013; 13: 430. 
  Chapter 4 
48 
ABSTRACT 
Background: Publicly available information comparing performance across quality and 
costs has proliferated in recent years, both about individual healthcare professionals 
and hospitals. This type of information is now becoming increasingly available for 
physiotherapists with expertise in Parkinson’s disease (PD). Our study aimed to explore 
the ability of people with Parkinson’s disease to recognise expertise, and to what 
extent respondents selectively choose such expert physiotherapists. 
Methods: We used claim data from the period 2009–2010 to select customers with PD 
who claimed physiotherapy. A random sample of 500 eligible respondents received a 
paper-based survey. We used descriptive statistics to compare the respondent 
characteristics, a qualitative programme to analyse the qualitative items, and 
univariate and multivariate regression. 
Results: Most respondents (89%) took their referring physician’s advice when selecting a 
physiotherapist, although this advice rarely was supported with arguments. The 
remaining respondents (11%) searched for comparative performance information about 
physiotherapists. Respondents who recognised the added value of PD expertise among 
physiotherapists were 3.28 times as likely to search for comparative performance 
information as those who did not understand. Respondents were willing to switch to an 
expert physiotherapist (68%), and this willingness increased if they recognised the value 
of PD expertise (p < .001). 
Conclusion: The participants were able to recognise certain aspects of expertise. 
Though they showed relatively few signs of selectively choice behaviour for expert 
physiotherapists. Both respondents and referring professionals need more 
understanding about the added value of an expert physiotherapist, to foster selective 
provider choice. 
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BACKGROUND 
The release of information in the public domain about the performance of healthcare 
providers has become a strategy for improving the quality of healthcare.1 Providing 
such comparative performance information (CPI) may empower and enable patients to 
identify and choose high-quality providers.2,3 While we have an increasing 
understanding of motivating factors for selective provider choice regarding elective 
conditions4-6, or primary care physicians7 there is no knowledge available about 
whether this evidence also applies to people with a chronic disorder such as Parkinson’s 
disease (PD). Our aim is to explore whether people are aware of, and able to recognise 
expertise, as an expression of quality of care, in PD among physiotherapists. 
 
There are an estimated 1.2 million people with Parkinson’s disease (PwP) in Europe.8 
Physiotherapy is part of the treatment for many PwP.9 In the Netherlands and the 
United Kingdom, 54–60% of all PwP receive physiotherapy.10,11 In the former, 
physiotherapy is mainly provided in community-based settings, in provider-owned 
practices. The reimbursement of the first 21 physiotherapy sessions, on annual basis, 
depends on the consumers additional insurance package. Though, for the treatment of 
PD there is an unlimited reimbursement out of the basic insurance after these twenty-
one treatments. Dutch patients have free access to physiotherapy since 2006 so they 
can self-refer to a physiotherapist, which is considered to be a structure premise for 
selective provider choice.12 
 
More than 75% of the Dutch allied health professionals report a lack of PD-specific 
expertise. More than half of them were unfamiliar with the treatment options of other 
professionals, and they had not participated in relevant educational programmes.9 In 
response to this gap of knowledge, a Dutch multidisciplinary network, ParkinsonNet, 
was developed and implemented to increase the PD expertise of physiotherapists.13 
ParkinsonNet is a multifaceted intervention that includes several elements (Table 1). 
 
Table 1. Five core elements of ParkinsonNet14 
 
1. Delivering care according to evidence-based guidelines 
2. Continuous education and training of therapists (including physiotherapists, occupational therapists, 
and speech therapists) 
3. Structured and preferred referral to ParkinsonNet therapists by neurologists, enabling each therapist 
to attract a large volume of patients to increase expertise 
4. Encouraging communication and regional collaboration with referring physicians 
5. Promoting visibility of the available expertise for both patients and professionals 
 
Launching of the sixty-fifth regional ParkinsonNetnetwork in 2010, national coverage 
was achieved. Currently, about 2700 professionals are connected throughout the 
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Netherlands.14 Although, physiotherapists can be expert in PD without being connected 
to this multidisciplinary network, the term ‘expert physiotherapist’ is exclusively used 
throughout this paper for physiotherapists who are connected to ParkinsonNet. An 
expert physiotherapist received additional training in treating PwP. Evidence shows 
that specific treatment options provided by expert physiotherapists are more beneficial 
to patients.15,16 Also, expert physiotherapists show better guideline adherence scores 
compared to generically active physiotherapists and their PwP volume is larger.9  
 
Awareness of referral options for other professional disciplines17 and knowledge and use 
of the Dutch PD guideline13 are necessary to attain expertise in PD. The implementation 
of ParkinsonNet increased the number of PwP treated by each physiotherapist.18 
However, approximately 70% of the PwP are still treated by a general physiotherapist.18 
This raises the questions whether PwP are aware of PD expertise in physiotherapy and 
whether they understand its value, i.e. these are, apart from free provider choice, two 
additional relevant conditions for selectively choosing a provider.  
 
This paper focuses on ability of PwP to recognise expertise in PD among 
physiotherapists, as a potential indicator of selective provider choice. We consider this 
in several ways: by seeking the perspective of PwP about the PD expertise of their 
physiotherapist, by ascertaining the descriptions of PD expertise from the perspective 
of PwP in a qualitative way, and whether physiotherapists’ PD-related expertise 
influences the search for CPI among PwP. In addition, we examine the role of referring 
physicians. We take into account factors that might affect provider selection such as 
consumer characteristics (e.g. age, education, and internet use), knowing where to 
search for CPI, the willingness to switch, and respondents’ expectations regarding 
variation in quality of care. 
 
METHODS 
Design and study population 
Our paper-based survey focused on the selective provider choice for expert 
physiotherapists in a cohort of people with PD. We selected PwP on the basis of claim 
data in the period 2009–2010 of a Dutch healthcare insurance company that accounts 
for 20% of the Dutch insurance market. We approached eligible candidates, that is, 
people who were registered as having PD in the diagnosis–treatment combination 
(Dutch version of diagnosis related groups) combined with an episode of physiotherapy 
in the year prior to our survey. Only consumers who received physiotherapy treatment 
for PD were included because we wanted to focus on peoples’ capacity to recognise 
physiotherapists’ PD expertise. People who had had physiotherapy for PD for several 
years were excluded; the decision-making process (deliberate or not) had to be recent 
to exclude recall bias. A total of 886 patients met these eligibility criteria. We sent 
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surveys to 500 participants randomly selected from this group. Due to privacy 
legalities, the insurance company drew the sample. According to local regulations in 
the Netherlands (Commission involving human subjects research) (CMO) region Arnhem-
Nijmegen this study did not need approval of the ethical review board. 
 
Measures and data collection 
The survey consisted of 37 items. The first items ascertained the treatment with 
physiotherapy for PD in the past year to satisfy our inclusion criteria. We used five 
items to operationalise the recognition of physiotherapists’ PD expertise. Two items 
explored the level of awareness and the descriptions of PD expertise from the 
perspective of the participants: awareness of the existence of expert PD 
physiotherapists (dichotomous variable), and participants were asked to estimate 
whether their physiotherapist was an expert in PD. This latter item was answered on a 
three-point scale: yes, no, or do not know. We compared the participants’ views of 
physiotherapists’ expertise on the basis of claim data with the ParkinsonNet data to see 
if they correlated. The respondents answered an openended question that dealt with 
their assessment of physiotherapists’ expertise. We categorised the answers into eight 
core themes based on a framework for patient centeredness in PD19 and quality of care 
domains as formulated by the Institute of Medicine.20 We estimated the search for CPI 
by addressing the last two aspects used to operationalise the recognition of 
physiotherapists’ PD expertise: recognition of the added value of PD expertise, and 
whether participants paid attention to PD expertise among physiotherapists when they 
selected a provider (all dichotomous variables). Knowing where to look for CPI was a 
dichotomous variable. Expectations of variation in the quality of care between a 
generic physiotherapist and an expert physiotherapist formed a categorical variable, 
determined on a four-point scale: yes, large differences; yes, small differences; do not 
know; or no differences. The willingness to switch to an expert physiotherapist was 
determined on a five-point scale: most likely, likely, unlikely, most unlikely, and do not 
know. We dichotomised this into likely (most likely, likely) versus unlikely (most 
unlikely, unlikely, do not know) because the distribution of this variable was positively 
skewed.  
 
We assessed the role of referring physicians with the following questions: do referring 
physicians provide you multiple choice options for physiotherapists about where you 
could go to? Did your referring physicians give you an advice to which provider you 
should go for the best treatment? If so, is this advice accompanied by arguments and by 
CPI, and do you take this advice? (All of these are dichotomous variables).  
 
We asked the participants which attributes they searched for when choosing a 
physiotherapist, and for which of these attributes referring providers supplied them 
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with information. The attributes contain items about services and quality of care. The 
first three items were available for PwP at the time the survey was send out, we added 
items 4 and 5 because we expected that these items soon become available as well 
and/or these items were common items with other (elective) conditions. 
1. ParkinsonNet membership, e.g. practices connected to this network 
2. Information regarding the added value of being treated by an expert PD 
physiotherapist 
3. Distances to physiotherapy practices 
4. Physiotherapists with PD expertise 
5. Experiences of PwP who were treated by an expert physiotherapist.  
 
We also ascertained the demographics of the study participants. We treated age as a 
continuous variable. The variable of educational level was described as none/low, 
average, or high. We used the stages defined by Hoehn and Yahr21 to describe the self-
reported disease characteristics. 
The Hoehn and Yahr (HY) stages range from no PD signs in stage 0 to needing a 
wheelchair or being bedridden in the most severe stage 5. Patients’ disease severity 
was classed as mild (HY stages 0–1), moderate (HY stages 2–3), or severe PD (HY stages 
4–5). The survey was field tested and optimised by ten patients and four PD 
researchers. The final survey was sent by post, and a reminder was posted 2 weeks 
later. Data were collected in October and November 2010. 
 
Analysis 
The survey contained four qualitative questions. The filled-out paper-copy surveys were 
scanned and transcribed into an electronic format, by means of an automated process 
(Teleform). We did not use a separate programme for the qualitative analysis, such as 
Atlas.ti, as it did not bring much benefit for the rather small amount of qualitative 
data. Though we did apply the principles of thematic analysis (conducted by NK and 
MF), supported by the PD-specific framework for patient centeredness19 and a general 
framework for quality of care.20 Descriptive statistics were calculated for each survey 
item and compared with respondent characteristics. We explored the association 
between how patients value PD expertise and the search for CPI (treated as a 
dependent variable determined by ‘yes’ or ‘no’). We used univariate logistic regression 
analysis to separately examine the associations between the independent variables and 
the search for CPI. The independent variables were: age, education, internet use, 
awareness of the existence of expert PD physiotherapists, an understanding of the 
added value of an expert PD physiotherapist, prior attention to physiotherapists’ 
expertise, knowing where to search, expected quality differences between generic 
physiotherapists and expert physiotherapists, willingness to switch, and the provider 
options named by referring physicians. Statistically significant variables (p < 0.05) were 
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included in the stepwise forward multivariate logistic regression analysis. We 
calculated the outcomes separately for each independent variable while controlling for 
the other variables in the model. We presented these outcomes with odds ratios (ORs) 
and 95% confidence intervals (CIs). We used SPSS 18.0 to carry out the analyses. 
 
RESULTS 
Demographics 
In total, 380 respondents completed the survey (gross response rate=76%), and 
320 surveys were analysed (net response rate=64%). The 60 participants whose surveys 
were excluded had not received physiotherapy for PD, but for another medical 
condition. Table 2 presents the background characteristics of the study population. 
 
Table 2. Background characteristics of study population 
 
General characteristics n % 
Gender Male 147 56 
Mean age in years ± SD    72 ±9 
Level of education    
 None/low 165 56 
Average   91 31 
High   39 13 
Residential status    
 Alone   55 18 
Together 211 71 
Other situation   36 11 
Internet use Yes   85 28 
Specific Parkinson’s disease characteristics 
Diagnosis    
 Parkinson’s disease 292   95 
Atypical parkinsonism   10    3 
Unknown    4    2 
Hoehn and Yahr stage (self-reported)    
 Mild (0–1)   83   30 
Moderate (2–3) 127   41 
Severe (4–5)   87   29 
Use of physiotherapy in the past year Yes 320 100 
Because of missing data in the background characteristics, not every score accumulates to the total of 
320 
 
Quality of care for Parkinson’s disease 
Sixty percent of the study population expected quality differences in the care provided 
by generic physiotherapists and expert physiotherapists, and 34% of them expected 
these variations would be large. A minority of participants (5%) expected no quality 
differences, and the remaining respondents (35%) said they did not know. Of those who 
expected quality differences, 33% did not know what kind of value an expert 
physiotherapist could add. In total, about half the study population (51%) did not know 
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the added value of an expert physiotherapist. Participants who expected to find quality 
differences were younger than participants who did not expect quality differences (71 ± 
10 years versus 74 ± 8 years, p = .009). 
 
More than two-thirds of the respondents (68%) were willing to switch to an expert 
physiotherapist if it turned out that their current physiotherapist had no PD expertise. 
The distance the participants were willing to travel to see an expert physiotherapist 
was 5 km (interquartile range: 2–11 km). Respondents who had previously heard about 
expert physiotherapists were more willing to switch (82% versus 54%, p < .001) and 
respondents expecting differences in the quality of care were also more likely to switch 
(87% versus 31%; p < .001). 
 
Recognition of physiotherapist expertise in Parkinson disease  
Most participants (74%) had already heard about expert physiotherapists. Fewer 
participants (46%) said they had previously paid attention to whether the 
physiotherapist was an expert in PD before selecting a physiotherapist. Participants 
who had previously heard about physiotherapists with PD expertise had a higher 
educational level than those who did not know about expert physiotherapists (p = 
.001). Awareness of expert physiotherapists was also related to age. Participants who 
were aware of expert physiotherapists were younger than those who were unaware 
(71 ± 10 years versus 76 ± 8 years, p = .001). 
 
We asked those who had already heard about expert physiotherapists whether they 
were treated by an expert PD physiotherapist (n=229). More than 70% asserted they 
were treated by an expert, 12% stated that they were not, and 17% said they did not 
know. A comparison of the answers of our study population with ParkinsonNet data 
showed that 28% of our respondents were being treated by a ParkinsonNet-affiliated 
physiotherapist. 
 
Participants reported various themes describing what physiotherapists’ expertise and 
knowledge stands for. Table 3 presents the core themes and the underlying descriptions 
that the respondents gave. Thirty percent of the respondents said that 
physiotherapists’ treatment, exercises, and information express a degree of expertise. 
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Table 3. Themes related to the perceived expertise of physiotherapists from the patients’ 
perspective 
 
  n 
Treatment and exercises    69 
 ‘Expertise is related to the good exercises I have to do 
at home’  (Woman, 82 years old) 
 
 ‘Right exercises for posture and movement’ (Man, 
76 years old) 
 
Tailored information and communication   66 
Information about the disease, (practical) 
advice, counselling, and communication 
with physiotherapist 
‘All arguments with the given instructions are correct’ 
(Man, 64 years old) 
 
‘He tries to find matching exercises for me in person’ 
(Man, 70 years old) 
 
‘She knows a lot of Parkinson Disease, I receive good 
answers to my Parkinson Disease related questions’ 
(Woman, 74 years old) 
 
Knowledge of Parkinson disease    34 
Knowledge about and expertise in 
Parkinson disease symptoms. Noticing 
changes of condition 
‘He knows exactly what to do’ (Man, 78 years old)  
‘He knows the Parkinson disease signs and tries the 
recommended treatment’ (Man, 57 years old) 
 
‘She knows the limitations Parkinson disease imposes 
on me, and gives useful suggestions’ (Woman, 82 years 
old) 
 
‘Works with several patients who have Parkinson 
disease’ (Man, 60 years old) 
 
Effectiveness    25 
Improved condition, increased mobility, 
decreased freezing 
‘I can to move better and my muscles are less stiff 
since the treatment’ (Woman, 82 years old) 
 
‘My condition has improved since this treatment’ (Man, 
75 years old) 
 
Cooperation with caregivers    19 
Need for interdisciplinary care. Working 
within a network with allied healthcare 
providers 
‘He works with the neurologist’ (Man, 73 years old)  
‘He is involved in the Park fit studies’ (Man, 71 years 
old) 
 
Emotional support, empathy, and respect   16 
 ‘Shows great interest’ (Man, 74 years old)  
 ‘Shows interest, takes me seriously’ (Woman, 77 years 
old) 
 
 ‘Is very patient’ (Man, 88 years old)  
Unable to define the expertise of the physiotherapist    4 
Difficult to access the providers’ expertise ‘I do not know which exercises are the best for 
patients with Parkinson disease’ (Man, 61 years old) 
 
Treatment evaluation    2 
Providers ask questions about the 
treatment 
‘Takes the time to evaluate the treatment process’ 
(Man, 70 years old) 
 
Accessibility of healthcare     2 
Treatment or physiotherapy at home ‘Treats me at home’ (Man, 70 years old)  
Total  103 
 
The role of referring physicians  
The respondents were referred by: neurologists (49%), general practitioners (GPs; 18%), 
and specialist Parkinson’s nurses (18%). Another 15% of the respondents saw a 
physiotherapist on their own initiative. About half the participants who received a 
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referral were provided with additional information regarding expert PD 
physiotherapists. Only a minority of the respondents (25%) received multiple choice 
options for a physiotherapist. Although 85% of the participants found it important to 
choose their own physiotherapist, most (89%) of those with a physician referral took 
their physician’s advice when selecting a physiotherapist.  
 
The search for comparative performance information  
Most respondents (89%) reported not having searched for CPI when it became clear they 
needed physiotherapy. Some respondents gave more than one reason for not searching. 
The most important reason was not perceiving any need for more information (60%). 
Other reasons were: no internet access at home (29%), not knowing where to search 
(15%), not knowing how to search (9%), lack of motivation (13%), not knowing how to 
look for information (12%). A smaller group found that more information led to more 
doubt (7%), some felt that it was too much responsibility (4%), and some had no time 
(3%). 
 
Participants who searched for information (11%) wanted to know about: practices 
connected to ParkinsonNet (n=13, 4%), expert PD physiotherapists (n=18, 6%), 
physiotherapist practices close to home (n=19, 6%), experiences of patients who 
received treatment from an expert physiotherapist (n=7, 2%), and what added value 
physical treatment from an expert physiotherapist can give a person with PD (n=11, 
3%). Some declared they did not find the information they would have like to have. 
Others reported that the information was too general and not trustworthy.  
 
Univariate logistic regression analyses revealed that several variables are associated 
with the search for CPI. Respondents’ awareness of expert PD physiotherapists, an 
understanding of the added value of an expert physiotherapist, and the willingness to 
switch to an expert PD physiotherapist were statistically significant, as were consumer 
characteristics (age and internet use). These variables were included in the 
multivariate regression analysis. 
 
The stepwise multivariate logistic regression analysis revealed that recognising of the 
added value of an expert PD physiotherapist was the most important predictor for the 
search for physiotherapists’ CPI (Table 4). The likelihood of people who recognised the 
added value searching for information was 3.28 times as great as the likelihood for 
those who did not recognise (OR=3.28 [95% CI 1.42–7.58]). 
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Table 4. Univariate and forward stepwise multivariate regression relationship of searching for 
comparative performance information versus background characteristics, awareness, and 
understanding physiotherapists’ expertise in Parkinson’s disease 
 
 Univariate analyses Multivariate analyses 
OR [95% CI] P OR [95% CI] P 
Age 0.96 [0.93–0.99] 0.02*   
Educational level     
 Low (reference)     
 Middle 1.49 [0.69–3.23] 0.32   
 High 0.73 [0.20–2.61] 0.62   
No internet use 2.12 [1.02–4.39] 0.04*   
Not aware of expert PD physiotherapists 3.76 [1.11–12.70] 0.03*   
No recognition of added value of expert 
physiotherapist 
3.29 [1.47–7.31] 0.01* 3.28 [1.42–7.58] 0.01* 
No prior attention to physiotherapist expertise 0.57 [0.18–1.82] 0.34   
Not knowing where to look for CPI 1.13 [0.30–4.16] 0.86   
Quality differences between generic and expert physiotherapists    
 No differences (reference)    
 Yes, large differences 1.41 [0.29–6.80] 0.67   
 Yes, small differences 0.91 [0.17–4.73] 0.92   
 Do not know 0.26 [0.04–1.56] 0.14   
Not willing to switch 3.86 [0.89–16.78] 0.07   
Received provider options from referring physician 1.79 [0.77–4.14] 0.17   
The total number of respondents included in the analysis was 279. *p < 0.05 
CI: Confidence interval; CPI: comparative performance information; OR: odds ratio; PD: Parkinson’s 
Disease 
 
DISCUSSION 
The ultimate goal of releasing CPI about the quality of expert physiotherapists is to 
improve quality of care for people with PD. Consumers of health care have the power 
to make a contribution to quality of care in competitive health care system by selective 
provider choice. This study shows that PwP identify aspects of expertise that appeared 
to align with the IOM-framework for quality of care, and mostly with patient 
centeredness. Moreover, the majority of participants (74%) were aware of expert and 
non-expert PD physiotherapists. Participants were able to describe what the PD-specific 
expertise and knowledge of their physiotherapist means to them. However, we found 
little evidence suggesting that the influence on how patients value expertise among 
physiotherapists influences the search for CPI and selective provider choice. 
Recognition of the additional value of a PD physiotherapist was a strong predictor of 
such a CPI search. Yet, about half the patients (51%) had this understanding; therefore, 
this situation can be improved. Our study shows that PwP hardly ever selectively chose 
a physiotherapist with PD expertise. Most took the physicians’ referral advice (89%), 
and the influence of CPI in the decision-making process was limited because only a 
minority searched for such information (11%). 
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In terms of the way forward, we first discuss the selective referral behaviour of 
physicians. Currently, very few physicians’ selective referrals to expert physiotherapists 
occur. Only half the participants were given additional information regarding expert PD 
physiotherapists. A King’s Fund publication22 shows that most GPs in the United 
Kingdom did not give information about their referrals either. Knowing and recognising 
PD expertise are necessary conditions for providers’ selective referrals. Without these 
conditions, it is difficult to provide patients with information. It is also important that 
referring physicians (e.g. neurologists and GPs) proactively recall this knowledge when 
they advise and refer patients to a physiotherapist. Referring physicians should support 
consumers choose selectively by discussing their referral options, so that the choice 
becomes a matter of shared decision-making. 
 
Second, we focus on the consumers’ selective choice behaviour. Previous studies 
suggest that, although consumers value quality information23,24, the use of CPI is 
limited1,25,26 among different populations and for a diversity of conditions. Our study 
confirms this discrepancy. The respondents valued free provider choice as important, 
but usually followed the referring provider’s advice and did not use CPI to choose their 
physiotherapist. Previous research shows that once people understand the concept of 
quality of care, they give a higher value to the measures of quality performance.27 
Further research should address in what way this discrepancy can be countered, for 
example by improving the circumstances so that consumers’ intentions and their 
behaviour coincide. 
 
Characteristics of expertise, as they were perceived and expressed by PwP in their own 
words (Table 3), are connected with the definition of patient-centred care for PD.19 
Other quality criteria, like a large PwP volume, having followed specific training in 
treating PD and a connection to an expert network, which is important for the members 
of ParkinsonNet, were less frequently mentioned. We therefore conclude that the 
definition of expertise among respondents was rather narrow. The aspects that were 
less frequently mentioned by respondents, might need more attention since recent 
evidence shows that PwP allocated to multidisciplinary PD care have better quality of 
life, better motor scores, and less depression.28 
 
Moreover, at a time when cost control dominates the health policy agenda, it is more 
urgent than ever to support consumers become a force for improving the quality of 
healthcare.29 Since the concept of ParkinsonNet is cost-effective guiding patients to 
physiotherapists that are connected to ParkinsonNet, might contribute to the 
containment of costs in our health care system. In regions where ParkinsonNet was 
active, PwP received more physical therapy, there were fewer admissions to nursing 
homes, fewer people needed revalidation treatment, and the reimbursed costs were 
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lower.30 These are all reasons for supporting initiatives that enhance knowledge among 
PwP about the added value of expert physiotherapists, by means of CPI that covers a 
broad definition of expertise and a range of quality of care criteria. 
 
Twenty-eight percent of our study population received treatment from ParkinsonNet- 
affiliated physiotherapists, while 70% claimed treatment from expert physiotherapists. 
This percentage of 28 is in line with previous evidence.18 Physiotherapists can be expert 
in PD without being connected to the multidisciplinary network, but the chance of 
being treated by an expert outside the network is smaller. Moreover, the 
multidisciplinary network has been implemented across the entire country. It is most 
likely that respondents overestimate their physiotherapists’ expertise in PD, otherwise 
they would have to admit receiving treatment from a physiotherapist who might not 
provide them with the best possible healthcare. Their overestimation makes switching 
to a physiotherapist with PD knowledge unlikely, as in their view, physiotherapists are 
already experts in PD. More consumer knowledge and recognition of expert 
physiotherapists might lead to an adjustment of consumers’ views towards the level of 
PD expertise among their physiotherapists and eventually to a search of CPI. 
 
Implications 
Demonstrating the value of expert PD physiotherapists to referring physicians is 
necessary. Further research should explore whether this will encourage selective 
referral behaviour. In terms of patient participation, more attention is required to 
clarify physicians’ decisions to refer to an expert physiotherapist. 
 
A practical implication is that CPI should be extended and made more accessible for 
PwP and their informal caregivers (family and friends). For example by spreading the 
information through the patient organisations for PwP on their website or magazine, or 
flyers in the waiting room of primary care practices. Further research is needed to 
explore how to encourage consumers to use the information. The CPI should also 
emphasise in more detail how and in what ways expert PD physiotherapists distinguish 
themselves from generic physiotherapists. Both the added value of expert 
physiotherapy and the multidisciplinary element should be emphasised. 
 
Limitations 
This study is not without shortcomings. First, as the understanding of the added value 
of an expert physiotherapist is related to the search for CPI, it would have been better 
to have more detailed questions about the perception of added value. For this purpose, 
future studies should focus on the perceived added value of PD expertise in a more 
extensive way. 
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Second, we do not know whether the participants’ overestimation of the expertise of 
their physiotherapist correlates with their satisfaction with their treatment and 
physiotherapist in general. We did not take the element of consumer satisfaction into 
account. Future work should replicate these findings and control for consumer 
satisfaction when asking about physiotherapist expertise in PD. A recent paper shows 
that consumers are generally very satisfied with their physiotherapeutic care.31 
 
Third, only a minority searched for CPI so that the influence of the variables could not 
always be estimated precisely, which the large confidence intervals reflect. 
 
Fourth, information about the number of physiotherapy episodes respondents had in 
the past year would brought us more insight whether the choice for a physiotherapist 
was temporally or more on and on. Future research should use items about the number 
of episodes, the length of the episodes and number of physiotherapists by whom they 
were treated during these episodes.  
 
A strength is that our sample is representative: the mean age of 72 ± 9 years is in line 
with the data based on the Dutch system of diagnosis-treatment combination (71 ± 
10 years). The gender proportion (56% men) was also consistent with the national 
number.32 According to the Dutch Parkinson guideline, there are no data available 
regarding the severity of the disease. 
 
Conclusions 
This study shows that recognition of the added value of an expert physiotherapist was 
found to be the strongest predictor for the search for CPI. The definition of expertise 
expressed by PwP was in line with patientcenteredness, though in a rather narrow 
manner, as only certain characteristics of PD expertise were recognised. In order for 
PwP choosing high-quality care, improvements are needed. There is a lack of 
recognition of expertise caused by a mismatch in the current available CPI. As PwP 
showed relatively few signs of selectively choosing expert physiotherapists, CPI should 
include additional and crucial quality of care information that matters for PwP. After 
this, it is expected that expert physiotherapists become more easier recognisable for 
those who want to make a selective provider choice. Furthermore, PwP heavily rely on 
their referring providers, meaning that referring providers have a responsibility to act 
as a coach for their patients. This fact should be used advantageously by involving the 
professionals in a more active way. 
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ABSTRACT 
Background: It is becoming increasingly common to release information about the 
performance of hospitals, health professionals or providers, and healthcare 
organisations into the public domain. However, we do not know how this information is 
used and to what extent such reporting leads to quality improvement by changing the 
behaviour of healthcare consumers, providers and purchasers, or to what extent the 
performance of professionals and providers can be affected. 
Objectives: To determine the effectiveness of the public release of performance data 
in changing the behaviour of healthcare consumers, professionals and organisations. 
Search strategy: We searched the Cochrane Central Register of Controlled Trials 
(CENTRAL), Cochrane Effective Practice and Organisation of Care (EPOC) Trials 
Register, MEDLINE Ovid (from 1966), EMBASE Ovid (from 1979), CINAHL, PsycINFO Ovid 
(from 1806) and DARE up to 2011. 
Selection criteria: We searched for randomised or quasi-randomised trials, interrupted 
time series and controlled before-after studies of the effects of publicly releasing data 
regarding any aspect of the performance of healthcare organisations or individuals. The 
papers had to report at least one main outcome related to selecting or changing care. 
Other outcome measures were awareness, attitude, views and knowledge of 
performance data and costs. 
Data collection and analysis: Two review authors independently screened studies for 
eligibility and extracted data. For each study, we extracted data about the target 
groups (healthcare consumers, healthcare providers and healthcare purchasers), 
performance data, main outcomes (choice of healthcare provider and improvement by 
means of changes in care) and other outcomes (awareness, attitude, views, knowledge 
of performance data and costs). 
Main results: We included four studies containing more than 35,000 consumers, and 
1560 hospitals. Three studies were conducted in the USA and examined consumer 
behaviour after the public release of performance data. Two studies found no effect of 
Consumer Assessment of Healthcare Providers and Systems information on health plan 
choice in a Medicaid population. One interrupted time series study found a small 
positive effect of the publishing of data on patient volumes for coronary bypass surgery 
and low-complication outliers for lumbar discectomy, but these effects did not persist 
longer than two months after each public release. No effects on patient volumes for 
acute myocardial infarction were found. 
One cluster-randomised controlled trial, conducted in Canada, studied improvement 
changes in care after the public release of performance data for patients with acute 
myocardial infarction and congestive heart failure. No effects for the composite 
process-of-care indicators for either condition were found, but there were some 
improvements in the individual process-of-care indicators. There was an effect on the 
mortality rates for acute myocardial infarction. More quality improvement activities 
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were initiated in response to the publicly-released report cards. No secondary 
outcomes were reported. 
Authors’ conclusions: The small body of evidence available provides no consistent 
evidence that the public release of performance data changes consumer behaviour or 
improves care. Evidence that the public release of performance data may have an 
impact on the behaviour of healthcare professionals or organisations is lacking. 
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BACKGROUND 
It is becoming increasingly common to release information about the performance of 
healthcare systems into the public domain. In the present era of accountability, cost-
effectiveness, quality improvement and demand-driven healthcare systems, policy and 
decision-makers such as governments, regulators, purchaser and provider organisations, 
health professionals and consumers of health care are becoming more interested in 
measuring performance.1 The measurements may appear in consumer reports, provider 
profiles or report cards. It is not always clear who the information users are or what 
the release of data is expected to achieve. However, it is often assumed that the 
information will affect and facilitate the decisions and behaviours of various 
stakeholders and ultimately result in health system improvements.1-3 
 
The stakeholders in this review include healthcare consumers, professionals, providers 
and purchaser organisations. Accountability relationships connect all the stakeholders. 
These relationships have two prominent elements, namely the ‘provision of 
information’ about performance and the ‘sanctions or rewards for the accountable 
party’.1 The main role of performance measurement is to keep the various agents 
accountable by enabling stakeholders to make informed decisions.1 Various suggested 
uses of performance measurements are linked to the accountability perspective. 
Examples of underlying objectives are (1) the use of performance measurements to 
promote more efficient and demand-driven healthcare4,5 and (2) applying the results as 
a marketing tool.6 One user goal is to use the public disclosure of performance 
measurements to encourage providers to focus on quality problems and to stimulate 
performance improvement.5,7,8 From a healthcare consumer’s perspective, the data can 
encourage patients to preferentially choose high-quality health care, i.e. the best 
health plan or provider9-11 or to assess the performance of individual professionals.12,13 
Other proposed user goals for performance measurements have been linked to 
controlling costs,14,15 regulating the healthcare system16,17 and influencing the decisions 
of healthcare purchasers.18-20 
 
Consumers must overcome barriers to the use of performance data. Examples of such 
barriers are the complexity of the performance data,21 lack of skills to comprehend and 
use performance data22-25 and the way data are presented.8,26-28 A negative 
consequence of such barriers might be related to the impact of choice on equity in 
healthcare. Consumers from poorer backgrounds and with lower educational levels will 
be less likely to be given a choice, less able to choose and less able to afford travel to a 
better performing, but more distant, provider.29 
 
Professionals focus on the barriers to accessibility,30 the validity of the performance 
measures themselves,31,32 and the validity of implicit or explicit comparisons of 
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performance.33,34 There are concerns that failure to adequately adjust for the case mix 
in the data sets may lead to hospitals or clinicians who treat higher-risk patients being 
labelled as poor performers, or to providers preferentially selecting lower-risk 
patients.35-37 In healthcare systems where providers charge for their services, the 
‘better’ performing providers may charge more,20 thereby restricting access to better 
care. Publicly releasing performance data may have other unintended consequences as 
well. There is a risk that the release may lead to improved reporting without 
necessarily improving performance. It has been said that the care tasks that are easiest 
to measure are often those least important in a quality improvement context and that 
other task measurements will be neglected.38 
 
Thus, the impact of public release of performance data may have various mechanisms. 
Most commentators seem to consider the most important goal of publishing 
performance data to be to cause providers to improve their performance. This goal can 
be achieved in a selection pathway or a change pathway.3 Consumers, patients and 
purchaser organisations that are in a position to do so can select the best healthcare 
professionals and organisations. This type of selection will not change the quality of the 
delivered care by itself, but it can be a stimulus for quality improvement. In a change 
pathway, healthcare professionals and organisations can improve performance by 
changing their work procedures or professional culture, and organisations can make 
structural changes. 
 
Description of the intervention 
Public release of performance data is the release of information about the quality of 
care so that patients and consumers can better decide what health care they wish to 
select and healthcare professionals and organisations can better decide what to 
provide, to improve or to purchase. This mechanism excludes the use of auditing and 
feedback as a tool for improving professional practice and healthcare outcomes. This 
subject has been reviewed elsewhere.39 
 
Why it is important to do this review 
Some systematic reviews2,8,40,41 have suggested positive effects of publicly releasing 
performance data. However, none of them focuses on identifying and synthesising only 
the most robust evidence available; this systematic review will do so. 
 
Objectives 
To estimate the effects of publicly releasing performance data on changing the 
behaviour of three target groups: healthcare consumers (patients), providers of 
healthcare (health professionals) and purchasers of healthcare. 
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METHODS 
Criteria for considering studies for this review 
Types of studies 
•  Randomised controlled trials (RCT), including cluster-randomised controlled trials 
(ClRCTs) 
•  Quasi randomised trials (QRT), including cluster quasi randomised trials (ClQ-RCTs) 
using methods of allocation such as alternation or allocation by case note number. 
•  Interrupted time series (ITS) studies with at least three data points before and three 
data points after the intervention. 
•  Controlled before-after (CBA) studies, with at least two intervention sites and two 
control sites that are chosen for similarity of main outcome measures at baseline. 
 
Types of participants 
Patients or other healthcare consumers and healthcare providers, including 
organisations (e.g. hospitals, practices and individual healthcare professionals) without 
any restriction by type of healthcare professional, provider, setting or purchaser. 
 
Types of interventions 
We included interventions that contained the following elements. 
•  Performance data about any aspect of the healthcare organisations or individuals, 
including process measures (e.g. waiting times), healthcare outcomes (e.g. 
mortality), structure measures (e.g. presence of waiting rooms), consumer or patient 
experiences (e.g. Consumer Assessment of Healthcare Providers and System (CAHPS) 
data) and/or expert or peer-assessed measures (e.g. certification, accreditation and 
quality ratings given by colleagues).42 The data presented may or may not provide 
comparisons with similar providers or quality standards and may or may not be 
adjusted for case mix. Performance data may be prepared and released by any 
organisation, such as the government, insurers or consumer organisations. 
•  The release of performance data into the public domain in written or electronic 
form, with varying degrees of accessibility, such as a report in a publicly accessible 
library or more active dissemination directly to consumers in newspapers, leaflets, 
personal mailings, broadcasting media, etc. 
The data may be presented numerically, graphically or pictorially. 
 
Comparators 
The following comparisons were planned.  
1. Public release of performance data compared to control (the control intervention 
should consist of the usual practice in that setting, which may include other 
interventions aimed at quality improvement, such as the internal use of the same 
performance data). 
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2. Different types of public release of performance data compared to each other. 
 
We excluded studies that did not expose participants to performance data concerning 
process measures, healthcare outcomes, structure measure, consumer/patient 
experiences or expert or peer assessed measures. We also excluded studies that 
reported only hypothetical choices. 
 
Types of outcome measures 
Main outcome measures 
We planned to the primary outcome measures according to two important aims of those 
publicly releasing performance data. 
 
1. Improvement by selection 
•  Changes in the healthcare utilisation decisions of consumers (public and patients) 
•  Changes in the healthcare utilisation decisions of healthcare providers (professionals 
and organisations) 
•  Changes in the healthcare utilisation decisions of purchasers 
2. Improvement by changes in care 
•  Objective measures of provider performance, including those that were made public 
and others that were not 
•  Valid measures of staff morale or behaviour (‘valid’ defined as having the 
development of the assessment tool reported in a peer-reviewed journal) 
 
Other outcome measures 
If a study reported at least one main outcome measure we also collected those 
concerning awareness, attitude, views, knowledge of performance data in all target 
groups and cost data. Where possible, we planned to collect data about the extent to 
which outcome measures varied with participant characteristics. We excluded studies 
that reported awareness, knowledge, attitude or costs in the absence of objective 
measures of provider performance or decision behaviour of healthcare consumers, 
providers or purchasers. Where possible, we planned to collect data about the extent 
to which outcome measures varied with participant characteristics. 
 
Search methods for identification of studies 
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE 
Ovid (from 1966), EMBASE Ovid (from1979), CINAHL, PsycINFO Ovid (from1806) and 
DARE up to 2011. For MEDLINE, we used subject headings and the relevant quality of 
healthcare MeSH terms, such as ‘process assessment’, ‘outcome assessment’, ‘quality 
indicators’, ‘quality assurance’ and ‘benchmarking’. We also used text words and 
phrases such as ‘performance outcome‘, ‘report card’, ‘criteria’, ‘standard’, 
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‘disclosure’, ‘quality information’ and ‘public information’. We combined these terms 
with forms of decision-making such as ‘choice behaviour’, ‘patient preferences’, 
‘patient acceptance’ and ‘consumer satisfaction’. We searched the other databases 
using the appropriate controlled vocabulary. In addition, we identified potentially 
relevant studies in the reference lists of key articles. Appendix 1 to Appendix 5 give full 
details of the search terms. 
 
Data collection and analysis 
Selection of studies 
We downloaded all titles and abstracts (N=6839) retrieved in the electronic search to a 
reference management database. We removed the duplicates, then two review authors 
independently examined the remaining references. All review authors recorded their 
assessments of abstracts with points: ‘0’ for exclusion, ‘1’ for doubtful and ‘2’ for 
inclusion. Two review authors independently rated each abstract, therefore a minimum 
score of ‘0’ and a maximum score of ‘4’ was possible. Abstracts with a combined score 
of 0 or 1 were excluded. Studies with a combined score of 3 or 4 were included. 
 
Two review authors resolved the fate of studies with a combined score of 2 by 
discussion. A third review author (ME) decided any disagreements that remained 
unresolved. We documented the reasons for exclusion. We obtained full-text copies of 
papers taken from references for inclusion. Two authors of our review independently 
assessed the eligibility of these papers. 
 
Data extraction and management 
After the first selection round, relevant studies were retrieved for full-text reading 
(Figure 1). We distributed these studies to our authors in such way that they did not 
receive studies for text reading that they already evaluated in the first round. We 
extracted the data about the study design, patient and provider characteristics, 
interventions, outcome measures, and healthcare choices to a form specially designed 
for our review (Appendix 6). We used another form (Appendix 7) for the studies we 
retrieved for a more detailed evaluation. The two review authors resolved 
disagreements by discussion if possible. A third review author (ME or MF) dealt with 
disagreements that the two review authors could not resolve. 
 
Assessment of risk of bias in the included studies 
We assessed the risk of bias on the basis of the Cochrane Collaboration criteria43: (i) 
adequate sequence generation, (ii) concealment of allocation, (iii) blinding, (iv) 
incomplete outcome data, (v) selective reporting and (vi) no risk of bias from other 
sources. We used three additional criteria that the Cochrane Effective Practice and 
Organisation of Care (EPOC) Group specifies44: (vii) baseline characteristic similarity, 
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(viii) reliable primary outcome measures and (ix) adequate protection against 
contamination. We used these nine standard criteria for ClRCTs, ClQ-RCTs and CBA 
studies. We used seven criteria for ITS studies: (i) the intervention is independent of 
other changes, (ii) the shape of the intervention effect is pre-specified, (iii) the 
intervention is unlikely to affect data collection, (iv) knowledge of the allocated 
interventions is adequately prevented during the study, (v) the outcome data are 
incomplete, (vi) reporting is not selective and (vii) there is no risk of bias from other 
sources. Two review authors independently examined the risk of bias assessment and 
resolved disagreements by discussion. There were some disagreements about the rating 
of the criterion as ‘yes’ instead of ‘unclear’ or vice versa. Sometimes the rating was 
based on a different phrase in the text. A third review author (MPE or MF) dealt with 
any disagreements that the two review authors could not resolve. 
 
Unit of analysis issues 
We noted whether studies randomised patients or healthcare providers. If analysis did 
not allow for clustering of patients within healthcare providers, we recorded a unit of 
analysis error, because such analyses tend to overestimate the precision of the 
treatment effect. 
 
Data synthesis 
We report the effect sizes for each outcome for each study. Quantitative synthesis was 
not possible. 
 
RESULTS 
Description of studies 
See: Characteristics of included studies; Characteristics of excluded studies. 
See table 1 ‘Characteristics of included studies’ and table 3 ‘Characteristics of 
excluded studies’. 
 
Results of the search 
The searches found 6839 references; we excluded 6786 references because the titles 
and abstracts did not meet our inclusion criteria. We retrieved the full texts of 
publications listed in 53 references. Four citations were irretrievable and could not be 
considered for inclusion in the review. An additional search brought two more 
references to light. Altogether, we retrieved full text versions of 51 papers. Forty-two 
of these papers did not fulfill the inclusion criteria. 
We evaluated nine papers in more detail, and subsequently we excluded another five 
papers. We reported the reasons for exclusion of these 51 studies (including the four 
irretrievable citations) in the ‘Characteristics of excluded studies’ table. Four papers 
met the inclusion criteria of the review. Figure 1 presents the study flow chart.45 
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Figure 1. Flowchart for Study Selection  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Included studies 
Characteristics of setting and patients/consumers 
See tables 1 and 2.  
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 c
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 c
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 c
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 C
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at
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ra
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ra
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 b
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t f
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ra
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 b
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 d
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 c
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w
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 c
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 c
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at
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 r
is
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ra
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 C
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 b
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 b
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is
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 m
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 b
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is
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 b
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 r
is
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 b
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 p
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 c
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re
ce
iv
ed
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 c
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 r
is
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 p
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 p
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p.
 9
94
).
 N
o 
re
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re
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m
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 d
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O
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d 
do
es
 
no
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un
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pe
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 m
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m
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ev
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 f
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le
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 s
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 p
ro
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at
io
n 
of
 
re
po
rt
 
ca
rd
 
fo
r 
ea
ch
 
ho
sp
it
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ra
ct
io
n 
be
tw
ee
n 
st
at
e 
vo
lu
m
e 
an
d 
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re
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 b
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 p
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 f
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at
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 d
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at
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 c
at
eg
or
y;
 e
st
im
at
e 
95
% 
co
nf
id
en
ce
 i
nt
er
va
ls
 
(C
I)
 f
or
 p
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 C
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 m
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re
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at
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 m
od
el
s 
w
er
e 
al
so
 t
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ra
te
d 
ve
ry
 s
im
ila
r 
re
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re
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 f
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at
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 d
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ra
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re
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at
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at
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 m
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 f
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at
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l c
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 d
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 p
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 f
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 m
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 m
on
th
s 
af
te
r 
N
ew
 Y
or
k:
 h
os
pi
ta
l r
at
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 C
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 c
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at
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ra
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m
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 b
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 r
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ra
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 b
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at
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 b
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en
t 
D
is
ch
ar
ge
 D
at
a 
Se
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 N
ew
 Y
or
k 
an
al
ys
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 b
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ed
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ew
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an
ni
ng
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nd
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ea
rc
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-o
pe
ra
ti
ve
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ys
te
m
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).
 T
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 n
um
be
r 
of
 d
ro
p-
ou
ts
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pl
ic
ab
le
 h
er
e,
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in
ce
 t
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 d
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es
 a
nd
 s
ev
er
al
 in
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pe
nd
en
t 
va
ri
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le
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w
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e 
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 t
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ed
ic
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 h
os
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' p
at
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 b
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 r
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 r
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l p
ri
m
ar
y 
an
d 
se
co
nd
ar
y 
ob
je
ct
iv
es
 a
re
 r
ep
or
te
d.
 
O
th
er
 b
ia
s 
H
ig
h 
ri
sk
 
M
ai
n 
an
al
ys
is
 b
as
ed
 o
n 
th
e 
as
su
m
pt
io
n 
of
 s
am
e 
tr
en
d 
be
fo
re
 a
nd
 a
ft
er
 in
te
rv
en
ti
on
. 
D
if
fe
re
nc
e 
fr
om
 p
re
di
ct
ed
 v
al
ue
s 
w
as
 r
ep
or
te
d,
 r
at
he
r 
th
an
 c
ha
ng
e 
in
 t
re
nd
 a
nd
 le
ve
l.
 
Sh
ap
e 
of
 in
te
rv
en
ti
on
 e
ff
ec
t 
pr
e-
sp
ec
if
ie
d?
 
Lo
w
 r
is
k 
Q
uo
te
: 
“W
e 
pr
ed
ic
te
d 
w
ha
t 
ea
ch
 o
ut
lie
r 
ho
sp
it
al
’s
 v
ol
um
e 
sh
ou
ld
 h
av
e 
be
en
 i
n 
ea
ch
 o
f 
th
e 
12
 m
on
th
s 
af
te
r 
pu
bl
ic
at
io
n 
of
 a
 r
ep
or
t 
ca
rd
. 
Th
es
e 
pr
ed
ic
te
d 
vo
lu
m
es
 w
er
e 
ag
gr
eg
at
ed
 f
or
 
al
l 
ho
sp
it
al
s 
as
si
gn
ed
 t
o 
th
e 
sa
m
e 
ri
sk
-a
dj
us
te
d 
pe
rf
or
m
an
ce
 c
at
eg
or
y 
(e
.g
. 
hi
gh
er
-t
ha
n-
ex
pe
ct
ed
 A
M
I m
or
ta
lit
y)
 in
 t
ha
t 
re
po
rt
 c
ar
d”
. 
(p
.3
71
) 
In
te
rv
en
ti
on
 is
 in
de
pe
nd
en
t 
of
 
ot
he
r 
ch
an
ge
s?
 
U
nc
le
ar
 r
is
k 
It
 is
 n
ot
 s
ur
e 
th
at
 t
he
 in
te
rv
en
ti
on
 o
cc
ur
re
d 
in
de
pe
nd
en
tl
y 
of
 o
th
er
 c
ha
ng
es
 o
ve
r 
ti
m
e 
or
 
th
at
 t
he
 o
ut
co
m
e 
w
as
 n
ot
 in
fl
ue
nc
e 
by
 o
th
er
 c
on
fo
un
di
ng
 v
ar
ia
bl
es
 e
ve
nt
s 
du
ri
ng
 s
tu
dy
 
pe
ri
od
 
In
te
rv
en
ti
on
 u
nl
ik
el
y 
to
 a
ff
ec
t 
/ 
bi
as
 d
at
a 
co
lle
ct
io
n?
 
Lo
w
 r
is
k 
So
ur
ce
s 
an
d 
m
et
ho
ds
 o
f 
da
ta
 c
ol
le
ct
io
n 
w
er
e 
th
e 
sa
m
e 
be
fo
re
 a
nd
 a
ft
er
 t
he
 in
te
rv
en
ti
on
 
Kn
ow
le
dg
e 
of
 t
he
 in
te
rv
en
ti
on
s 
ad
eq
ua
te
ly
 p
re
ve
nt
ed
 d
ur
in
g 
th
e 
st
ud
y?
 
Lo
w
 r
is
k 
D
at
a 
co
lle
ct
io
n 
ba
se
d 
on
 a
dm
in
is
tr
at
iv
e 
da
ta
ba
se
 a
nd
 p
er
fo
rm
ed
 r
et
ro
sp
ec
ti
ve
ly
 
Re
lia
bl
e 
ou
tc
om
e 
m
ea
su
re
m
en
ts
 
U
nc
le
ar
 r
is
k 
Th
e 
ou
tc
om
e 
m
ea
su
re
s 
w
er
e 
ba
se
d 
on
 a
 c
on
ce
pt
ua
l f
ra
m
ew
or
k 
an
d 
hy
po
th
es
es
. 
H
yp
ot
he
se
s 
w
er
e 
ba
se
d 
on
 a
 v
al
id
at
ed
 a
ss
um
pt
io
n 
(p
.3
68
).
 N
o 
cl
ea
r 
as
se
ss
m
en
t 
ab
ou
t 
th
e 
re
lia
bi
lit
y 
of
 
ou
tc
om
es
 m
ea
su
re
s 
w
er
e 
re
po
rt
ed
 in
 t
he
 M
et
ho
d 
se
ct
io
n.
  
    
  Tu
 2
00
9 
 
M
et
ho
ds
 
D
es
ig
n:
 C
lu
st
er
-r
an
do
m
is
ed
 t
ri
al
 
U
ni
t 
of
 a
ll
oc
at
io
n:
 H
os
pi
ta
ls
 w
er
e 
ra
nd
om
is
ed
 t
o 
re
ce
iv
e 
ei
th
er
 e
ar
ly
 o
r 
de
la
ye
d 
fe
ed
ba
ck
 o
f 
a 
pu
bl
ic
ly
 r
el
ea
se
d 
re
po
rt
 c
ar
d 
(p
. 
23
31
).
 T
he
 r
an
do
m
is
at
io
n 
w
as
 s
tr
at
if
ie
d 
by
 t
yp
e 
of
 
ho
sp
it
al
s 
(p
. 
23
32
).
 T
yp
es
 o
f 
ho
sp
it
al
s 
w
er
e 
cl
as
si
fi
ed
 a
s 
te
ac
hi
ng
 h
os
pi
ta
ls
, 
la
rg
e 
co
m
m
un
it
y 
ho
sp
it
al
s,
 s
m
al
l h
os
pi
ta
ls
 (
p.
 2
33
2)
. 
U
ni
t 
of
 a
na
ly
si
s:
 P
at
ie
nt
s 
tr
ea
te
d 
fo
r 
ac
ut
e 
m
yo
ca
rd
ia
l i
nf
ar
ct
io
n 
(A
M
I)
 a
nd
 c
on
ge
st
iv
e 
he
ar
t 
fa
ilu
re
 (
CH
F)
, 
ta
ki
ng
 h
os
pi
ta
l c
lu
st
er
in
g 
in
to
 a
cc
ou
nt
 in
 t
he
 a
na
ly
si
s 
Sa
m
pl
e 
si
ze
 c
al
cu
la
ti
on
: 
Th
e 
st
ud
y 
ha
d 
84
% 
po
w
er
 t
o 
de
te
ct
 5
% 
ab
so
lu
te
 d
if
fe
re
nc
e 
on
 t
he
 
co
m
po
si
te
 q
ua
lit
y 
in
di
ca
to
rs
. 
Th
e 
po
w
er
 c
al
cu
la
ti
on
 a
ss
um
ed
 a
 b
as
el
in
e 
pe
rf
or
m
an
ce
 r
at
e 
on
 
ea
ch
 c
om
po
si
te
 in
di
ca
to
r 
of
 7
0%
 (
st
an
da
rd
 d
ev
ia
ti
on
 1
0%
) 
in
 e
ac
h 
st
ud
y 
gr
ou
p,
 a
nd
 t
ha
t 
th
er
e 
w
ou
ld
 b
e 
a 
se
cu
la
r 
im
pr
ov
em
en
t 
of
 7
5%
 (
SD
 7
.5
%)
 in
 t
he
 c
om
po
si
te
 i
nd
ic
at
or
, 
in
de
pe
nd
en
t 
of
 
th
e 
st
ud
y 
in
te
rv
en
ti
on
 (
p.
 2
33
2)
. 
Pa
rt
ic
ip
an
ts
 
86
 h
os
pi
ta
l c
or
po
ra
ti
on
s 
w
er
e 
ra
nd
om
is
ed
: 
44
 h
os
pi
ta
ls
 in
 t
he
 e
ar
ly
 f
ee
db
ac
k 
re
po
rt
 c
ar
d 
re
le
as
e 
an
d 
42
 h
os
pi
ta
ls
 in
 t
he
 d
el
ay
ed
 
fe
ed
ba
ck
 r
ep
or
t 
ca
rd
 r
el
ea
se
 (
Fi
gu
re
 1
, 
p.
 2
33
1)
 
Ch
ar
ac
te
ri
st
ic
s 
of
 h
os
pi
ta
ls
 i
n 
th
e 
ea
rl
y 
fe
ed
ba
ck
 r
ep
or
t 
ca
rd
 r
el
ea
se
: 
At
 b
as
el
in
e,
 5
67
6 
pa
ti
en
ts
 w
er
e 
ad
m
it
te
d 
w
it
h 
AM
I a
nd
 5
07
3 
pa
ti
en
ts
 w
er
e 
ad
m
it
te
d 
w
it
h 
CH
F 
Ch
ar
ac
te
ri
st
ic
s 
of
 h
os
pi
ta
ls
 i
n 
th
e 
de
la
ye
d 
fe
ed
ba
ck
 r
ep
or
t 
ca
rd
 r
el
ea
se
: 
At
 b
as
el
in
e,
 5
07
0 
pa
ti
en
ts
 w
er
e 
ad
m
it
te
d 
w
it
h 
AM
I a
nd
 4
22
0 
pa
ti
en
ts
 w
er
e 
ad
m
it
te
d 
w
it
h 
CH
F 
Se
tt
in
g:
 T
he
 s
tu
dy
 w
as
 c
on
du
ct
ed
 i
n 
O
nt
ar
io
, 
Ca
na
da
. 
Al
l 
13
0 
ac
ut
e 
ho
sp
it
al
s 
w
er
e 
as
se
ss
ed
 
fo
r 
el
ig
ib
ili
ty
 a
nd
 8
6 
ho
sp
it
al
s 
w
er
e 
in
cl
ud
ed
. 
In
te
rv
en
ti
on
s 
Ba
se
li
ne
 a
ss
es
sm
en
t:
 A
t 
ea
ch
 p
ar
ti
ci
pa
ti
ng
 h
os
pi
ta
l 
a 
ta
rg
et
 s
am
pl
e 
of
 1
25
 c
ha
rt
s 
(o
r 
al
l 
pa
ti
en
ts
 i
f 
< 
12
5 
pa
ti
en
ts
 w
er
e 
tr
ea
te
d)
 f
or
 p
at
ie
nt
s 
re
ce
iv
in
g 
ca
re
 f
or
 A
M
I 
an
d/
or
 C
H
F 
be
tw
ee
n 
1 
Ap
ri
l 
19
99
 a
nd
 3
1 
M
ar
ch
 2
00
1 
w
as
 a
bs
tr
ac
te
d.
 T
he
 b
as
el
in
e 
pe
rf
or
m
an
ce
 w
as
 
ba
se
d 
on
 a
 s
et
 o
f 
12
 p
ro
ce
ss
 o
f 
ca
re
 in
di
ca
to
rs
 f
or
 A
M
I a
nd
 6
 in
di
ca
to
rs
 f
or
 C
H
F.
 
Ea
rl
y 
fe
ed
ba
ck
 r
ep
or
t 
ca
rd
 r
el
ea
se
: 
Th
e 
ho
sp
it
al
s 
re
ce
iv
ed
 t
he
ir
 b
as
el
in
e 
pe
rf
or
m
an
ce
 d
at
a 
in
 O
ct
ob
er
 2
00
3 
fo
r 
in
te
rn
al
 v
al
id
at
io
n 
an
d 
th
e 
re
su
lt
s 
w
er
e 
pu
bl
ic
ly
 r
el
ea
se
d 
at
 a
 p
re
ss
 
co
nf
er
en
ce
 a
nd
 o
n 
th
e 
W
eb
 in
 J
an
ua
ry
 2
00
4 
(p
. 
23
32
) 
D
ur
at
io
n 
of
 in
te
rv
en
ti
on
: 
Ja
nu
ar
y 
20
04
 t
o 
1 
Ap
ri
l 1
 2
00
4 
(i
nc
lu
si
ve
 t
he
 f
ol
lo
w
-u
p 
pe
ri
od
: 
Ja
nu
ar
y 
20
04
 t
o 
31
 M
ar
ch
 2
00
5)
 
D
el
ay
ed
 f
ee
db
ac
k 
re
po
rt
 c
ar
d 
re
le
as
e:
 T
he
 h
os
pi
ta
ls
 r
ec
ei
ve
d 
th
ei
r 
ba
se
lin
e 
pe
rf
or
m
an
ce
 
da
ta
 i
n 
Se
pt
em
be
r 
20
05
 f
or
 i
nt
er
na
l 
va
lid
at
io
n 
an
d 
th
e 
re
su
lt
s 
w
er
e 
al
so
 p
ub
lic
ly
 r
el
ea
se
d 
on
 
th
e 
in
te
rn
et
 i
n 
Se
pt
em
be
r 
20
05
 (
p.
 2
33
2)
. 
N
o 
ex
te
ns
iv
e 
m
ed
ia
 o
r 
as
so
ci
at
ed
 p
re
ss
 w
as
 
co
ve
re
d.
 
D
ur
at
io
n 
of
 
in
te
rv
en
ti
on
: 
N
ot
 
ap
pl
ic
ab
le
, 
as
 
th
e 
de
la
ye
d 
fe
ed
ba
ck
 
gr
ou
p 
re
ce
iv
ed
 
th
e 
in
te
rv
en
ti
on
 a
ft
er
 f
ol
lo
w
-u
p 
da
ta
 w
er
e 
co
lle
ct
ed
 
 
5 
 
 
 
In
te
rv
en
ti
on
 d
el
iv
er
er
: 
Th
e 
Ca
na
di
an
 C
ar
di
ov
as
cu
la
r 
O
ut
co
m
es
 R
es
ea
rc
h 
Te
am
, 
w
hi
ch
 i
s 
a 
na
ti
on
al
 t
ea
m
 o
f 
ca
rd
io
va
sc
ul
ar
 o
ut
co
m
es
 r
es
ea
rc
he
rs
 f
ro
m
 a
cr
os
s 
Ca
na
da
. 
Th
e 
te
am
 a
ls
o 
w
as
 i
nv
ol
ve
d,
 t
og
et
he
r 
w
it
h 
th
e 
Ca
na
di
an
 C
ar
di
ov
as
cu
la
r 
So
ci
et
y,
 i
n 
th
e 
de
ve
lo
pm
en
t 
an
d 
en
do
rs
em
en
t 
of
 t
he
 s
et
 o
f 
qu
al
it
y 
of
 c
ar
e 
in
di
ca
to
rs
, 
as
 u
se
d 
in
 t
hi
s 
st
ud
y.
 
So
ur
ce
 o
f 
fu
nd
in
g 
fo
r 
st
ud
y:
 T
he
 E
FF
EC
T 
st
ud
y 
w
as
 s
up
po
rt
ed
 b
y 
a 
Ca
na
di
an
 I
ns
ti
tu
te
s 
of
 
H
ea
lt
h 
Re
se
ar
ch
 
te
am
 
gr
an
t 
in
 
ca
rd
io
va
sc
ul
ar
 
ou
tc
om
es
 
re
se
ar
ch
 
to
 
th
e 
Ca
na
di
an
 
Ca
rd
io
va
sc
ul
ar
 O
ut
co
m
es
 r
es
ea
rc
h 
Te
am
 
O
ut
co
m
es
 
M
ai
n 
ou
tc
om
e:
 T
he
re
 w
as
 n
o 
si
gn
if
ic
an
t 
im
pr
ov
em
en
t 
in
 t
he
 c
om
po
si
te
 A
M
I 
or
 C
H
F 
pr
oc
es
s-
of
-c
ar
e 
in
di
ca
to
r.
 
O
ne
 
ou
t 
of
 1
2 
in
di
vi
du
al
 
pr
oc
es
s 
of
 
ca
re
 
AM
I 
in
di
ca
to
rs
 
im
pr
ov
ed
 
si
gn
if
ic
an
t 
m
or
e 
in
 t
he
 e
ar
ly
 f
ee
db
ac
k 
gr
ou
p 
co
m
pa
re
d 
to
 t
he
 d
el
ay
ed
 f
ee
db
ac
k 
gr
ou
p.
 O
ne
 
ou
t 
of
 6
 o
f 
th
e 
in
di
vi
du
al
 p
ro
ce
ss
 o
f 
CH
F 
in
di
ca
to
rs
 i
m
pr
ov
ed
 s
ig
ni
fi
ca
nt
ly
 m
or
e 
in
 t
he
 e
ar
ly
 
fe
ed
ba
ck
 
gr
ou
p.
 
Re
ga
rd
in
g 
m
or
ta
lit
y 
ra
te
s,
 
as
 
an
 
ou
tc
om
e 
in
di
ca
to
r,
 
30
-d
ay
 
m
or
ta
lit
y 
si
gn
if
ic
an
tl
y 
de
cr
ea
se
d 
in
 t
he
 e
ar
ly
 f
ee
db
ac
k 
gr
ou
p 
fo
r 
AM
I,
 w
hi
le
 3
 o
th
er
 m
or
ta
lit
y-
re
la
te
d 
m
ea
su
re
s 
fo
r 
AM
I a
nd
 C
H
F 
di
d 
no
t 
ch
an
ge
. 
Th
e 
su
rv
ey
 s
ho
w
ed
 t
ha
t 
th
e 
ea
rl
y 
fe
ed
ba
ck
 g
ro
up
 r
ep
or
te
d 
si
gn
if
ic
an
tl
y 
m
or
e 
of
te
n 
th
e 
st
ar
t 
of
 o
ne
 o
r 
m
or
e 
qu
al
it
y 
im
pr
ov
em
en
t 
in
it
ia
ti
ve
s 
fo
r 
AM
I c
ar
e 
an
d 
fo
r 
CH
F 
ca
re
 
N
ot
es
 
 
Ri
sk
 o
f 
bi
as
 
 
Bi
as
 
Au
th
or
s’
 j
ud
ge
m
en
t 
Su
pp
or
t f
or
 j
ud
ge
m
en
t 
Ra
nd
om
 s
eq
ue
nc
e 
ge
ne
ra
ti
on
 
(s
el
ec
ti
on
 b
ia
s)
 
Lo
w
 r
is
k 
Th
e 
ho
sp
it
al
s 
w
er
e 
ra
nd
om
ly
 a
ss
ig
ne
d 
to
 t
he
 e
ar
ly
 f
ee
db
ac
k 
gr
ou
p 
or
 t
he
 d
el
ay
ed
 f
ee
db
ac
k 
gr
ou
p 
Al
lo
ca
ti
on
 c
on
ce
al
m
en
t 
(s
el
ec
ti
on
 
bi
as
) 
Lo
w
 r
is
k 
Q
uo
te
: 
“T
hi
s 
ra
nd
om
 a
ss
ig
nm
en
t 
w
as
 s
tr
at
if
ie
d 
by
 t
yp
e 
of
 h
os
pi
ta
l a
nd
 p
er
fo
rm
ed
 b
y 
a 
st
ud
y 
st
at
is
ti
ci
an
” 
(p
. 
23
32
) 
In
co
m
pl
et
e 
ou
tc
om
e 
da
ta
 (
at
tr
it
io
n 
bi
as
) 
U
nc
le
ar
 r
is
k 
O
ne
 h
os
pi
ta
l w
it
hd
re
w
 f
ro
m
 t
he
 b
as
el
in
e 
ph
as
e,
 a
ft
er
 r
an
do
m
is
at
io
n 
an
d 
4 
w
it
hd
re
w
 f
ro
m
 
th
e 
fo
llo
w
-u
p 
ph
as
e,
 a
ll 
du
e 
to
 r
es
ou
rc
e 
co
ns
tr
ai
nt
s 
(p
. 
23
31
).
 N
o 
in
te
nt
io
n-
to
-t
re
at
 a
na
ly
si
s 
w
as
 p
er
fo
rm
ed
. 
Ad
di
ti
on
al
 e
xc
lu
si
on
s 
of
 p
at
ie
nt
s 
w
er
e 
no
t 
re
po
rt
ed
, 
bu
t 
ca
nn
ot
 b
e 
ve
ri
fi
ed
. 
Se
le
ct
iv
e 
re
po
rt
in
g 
(r
ep
or
ti
ng
 b
ia
s)
 
Lo
w
 r
is
k 
Re
su
lt
s 
fr
om
 a
ll 
in
di
ca
to
rs
, 
in
di
vi
du
al
 a
nd
 c
om
po
si
te
, 
ar
e 
re
po
rt
ed
 a
s 
w
el
l a
s 
th
e 
ho
sp
it
al
 
ou
tc
om
e 
in
di
ca
to
rs
 
O
th
er
 b
ia
s 
Lo
w
 r
is
k 
 
Ad
eq
ua
te
 b
lin
di
ng
 o
f 
pa
rt
ic
ip
an
ts
, 
pe
rs
on
ne
l a
nd
 o
ut
co
m
e 
as
se
ss
or
s?
 
H
ig
h 
ri
sk
 
Q
uo
te
: 
“I
t 
w
as
 n
ot
 p
os
si
bl
e 
to
 b
lin
d 
th
e 
ho
sp
it
al
s 
to
 t
he
ir
 s
ta
tu
s”
 (
p.
 2
33
2)
. 
Q
uo
te
: 
“W
e 
co
ul
d 
no
t 
bl
in
d 
th
e 
de
la
ye
d 
fe
ed
ba
ck
 g
ro
up
 t
o 
th
e 
m
ed
ia
 c
ov
er
ag
e 
an
d 
as
so
ci
at
ed
 p
ub
lic
it
y 
su
rr
ou
nd
in
g 
th
e 
st
ud
y 
re
su
lt
s”
 (
p.
 2
33
6)
. 
Q
uo
te
: 
“P
at
ie
nt
 c
ha
rt
s 
w
er
e 
ab
st
ra
ct
ed
 b
y 
an
 e
xp
er
ie
nc
ed
 r
es
ea
rc
h 
nu
rs
e”
 (
p.
23
32
),
 b
ut
 it
 is
 
un
cl
ea
r 
w
he
th
er
 o
r 
no
t 
sh
e 
w
as
 b
lin
de
d 
fo
r 
al
lo
ca
ti
on
 
    
  Pr
ot
ec
ti
on
 a
ga
in
st
 c
on
ta
m
in
at
io
n 
H
ig
h 
ri
sk
 
Q
uo
te
: 
“T
he
re
 w
as
 e
xt
en
si
ve
 m
ed
ia
 c
ov
er
ag
e 
fo
llo
w
in
g 
th
e 
re
le
as
e 
of
 t
he
 b
as
el
in
e 
pe
rf
or
m
an
ce
 f
or
 t
he
 e
ar
ly
 f
ee
db
ac
k 
ho
sp
it
al
s”
(p
. 
23
32
).
 T
he
 a
ut
ho
rs
 m
en
ti
on
 t
ha
t 
“o
ne
 
un
an
ti
ci
pa
te
d 
ob
se
rv
at
io
n"
 w
as
 t
ha
t 
se
ve
ra
l h
os
pi
ta
ls
 in
 t
he
 d
el
ay
ed
 f
ee
db
ac
k 
gr
ou
p 
re
po
rt
ed
 t
ha
t 
th
ey
 a
ls
o 
in
it
ia
te
d 
so
m
e 
qu
al
it
y 
im
pr
ov
em
en
t 
ac
ti
vi
ti
es
 a
ft
er
 b
ec
om
in
g 
aw
ar
e 
of
 t
he
 p
ub
lic
ly
 r
el
ea
se
d 
ea
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Table 2.  Characteristics of settings and consumers (recorded as patients and Medicaid enrolees) 
 
Study Methods Patients/consumers 
Setting of 
care 
Farley 2002a46 Design: ClRCT 
Unit of allocation: new cases (household 
units) 
Power calculation: not done 
Medicaid beneficiaries: 13077 
Age: unclear 
Gender: unclear 
Health plans: 
HMOs 
Farley 2002b47 Design: ClQ-RCT 
Unit of allocation: new cases (household 
units) 
Power calculation: unclear 
Medicaid beneficiaries: 5878  
Age: Unclear 
Gender: men and women  
Health plans:  
HMOs 
Romano 200448 Design: ITS 
Unit of allocation: not applicable 
Power calculation: unclear 
Patients: Given CABG in New 
York, and treated for AMI or 
given post discectomy surgery 
in California 
Number of patients: unclear 
Age: children younger than 
18 years were excluded 
Gender: men and women 
Hospitals: non-
federal 
hospitals  
Tu 200949 Design: ClRCT 
Unit of allocation: hospitals 
Power calculation: the study had 84% 
power to detect 5% absolute difference in 
the composite quality indicators. The 
assumptions were a baseline performance 
rate of 70% (SD 10%) for each composite 
indicator in each study group, and a 
secular improvement of 75% (SD 7.5%) in 
the composite indicator, independent of 
the study intervention. 
Patients: 15997 patients 
treated for AMI or CHF 
Age: no restriction 
Gender: men and women 
Hospitals: 
teaching, 
community or 
small  
CIRT: cluster-randomised controlled trial; ClQ-RCT: cluster quasi-randomised trial; ITS: interrupted time 
series; HMOs: health maintenance organisations; CBAG: coronary artery bypass grafting; AMI: acute 
myocardial infarction; CHF: congestive heart failure; SD: standard deviation 
 
We included four studies46-49 comprising more than 35,000 consumers (recorded as 
patients, and Medicaid enrollees), and 1560 hospitals. Three studies were conducted in 
the USA and one study was conducted in Canada. Farley46 took place in Iowa and 
Farley47 in New Jersey; both studies were set in health plans. Romano48 was set in 
hospitals in California and New York. Tu49 was set in hospitals in Canada. Farley46 
conducted their study in 35 of the 99 Iowa counties. These counties represented 60% of 
the total Iowa Medicaid population. The study included MediPass and two types of 
health maintenance organisations (HMOs) that differed in their performance as assessed 
with CAHPS surveys scores: one high and one low-rated. The counties were subdivided 
into three health plan options: type I (MediPass and two HMOs), type II (MediPass and 
one HMO with a high rating) and type III (MediPass and one HMO with a low rating). The 
CAHPS survey measures several dimensions of health plan performance including ratings 
of health plans, primary doctors and reports of experiences with using a health plan. 
The ratings are for individual items using response scales ranging from 0 to 10. The 
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reports of experiences are composite scores that are averages of responses to sets of 
individual items with four-category response options. 
 
Farley47 was based on the New Jersey Medicaid programme. There was a mandatory 
HMO enrolment period for Aid for Dependent Children and other welfare-related 
beneficiaries in 17 of its 21 counties. In February 1998, 91% of these beneficiaries were 
enrolled in Medicaid HMOs. 
 
Romano48 was based on the California Hospital Outcomes Project (CHOP). In California 
and the Cardiac Surgery Reporting System (CSRS) in New York. Trends in hospital 
volumes for certain diagnoses after publication of report cards were evaluated. In 
California the CHOP report published in 1993 evaluated acute myocardial infarction 
(AMI) mortality at 394 hospitals, complications after lumbar discectomy at 344 
hospitals, and complications after cervical discectomy at 277 hospitals. In New York, 
the CSRS report evaluated 30 hospitals in December 1992 and 31 hospitals in December 
1993 and June 1995. 
 
In Canada, Tu 200949 evaluated the public release of performance data of 12 process-
of-care indicators for AMI and six indicators for congestive heart failure (CHF) in 
86 hospitals. The hospitals were categorised by either early (2004) or delayed (2005) 
feedback of a publicly released report card about their baseline performance. The 
Canadian Cardiovascular Outcomes Research Team and the Canadian Cardiovascular 
Society developed the indicators. 
 
Excluded studies 
In total, we excluded 47 studies after assessing full copies of the papers. The main 
reasons for exclusion were: design (study was not a ClRCT, ClQ-RCT, CBA or ITS (34)), 
interventions did not contain process measures, health care outcomes, structure 
measures, consumer or patient experiences, expert- or peer-assessed measures (18), no 
objective outcome data were recorded or available for one or both arms (seven), 
and/or the study was about hypothetical choices (six). We excluded four studies 
because we were unable to obtain the full-text articles (Table 3). 
 
Table 3. Characteristics of excluded studies 
 
Study  Reason for exclusion  
Alteras 2000 50 Unable to retrieve  
Beaulieu 2002 51 Studydesign  
Beaulieu 2002 52 Studydesign  
Bundorf 2009 53 Studydesign  
Dawson 2007 54 Studydesign  
Dranove 2008 36 Studydesign  
Ettinger 2008 55 Studydesign/outcome measure  
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Study  Reason for exclusion  
Fanjiang2007 56 Studydesign  
Fine 1998 57 Unable to retrieve  
Fong 2008 58 Studydesign  
Fotaki 2008 13 Studydesign  
Fox 2001 59 Studydesign  
Goldstein 2001 60 Studydesign  
Goss 2006 61 Studydesign  
Hannan 2003 62 Studydesign, controlled before-after, 2 intervention sites, only1 control site  
Harris 2002 42 Studydesign  
Harris-Kojetin 2007 
26 Outcome measure/types of intervention  
Hibbard 1996 63 Outcome measure  
Hibbard 2000 64 Outcome measure  
Hibbard 2001 22 Unable to retrieve  
Hibbard 2002 65 Studydesign  
Hibbard 2002 66 Outcome measures/hypotheticaldata  
Hibbard 2003 67 Outcome measures  
Hibbard 2005 68 Studydesign  
Hibbard 2005 69 Studydesign;2 intervention and 1 control group/raw data was not reported  
Hollenbeak 2008 70 Studydesign  
Jensen 2004 71 Studydesign  
Jha 2006 72 Studydesign  
Jian 2009 73 Studydesign  
Knutson 1998 74 Studydesign  
Krupat 2004 75 Types of intervention/outcome measures, design;2 intervention groups, 1 control group  
Lindenauer 2007 7 Studydesign  
Mannion 2003 76 Studydesign  
McCormack 2001 77 Outcome measures  
McCormack 2001 78 Outcome measures  
Moscucci 2005 79 Study design, controlled before-after design; no information reported from the 
2 included registries. Not enough information was reported regarding the 
baseline data  
Norem 2004 80 Studydesign/outcome measures  
O’Connor 1991 81 Unable to retrieve  
Peters 2007 27 Types of intervention/ outcome measures/hypotheticaldata  
Peters 2009 82 Studydesign  
Schoenbaum 2001 83 Outcome measures/hypothetical data  
Scott 2006 84 Studydesign  
Spranca 2000 85 Outcome measures/hypothetical data   
Spranca 2007 86 Studydesign/outcome measures  
Swaminathan 2008 87 Studydesign  
Tai-Seale 2004 88 Studydesign/interventions/outcome measures  
Uhrig2002 89 Types of intervention/hypothetical data  
Uhrig2006 90 Outcome measures/hypotheticaldata  
Wedig2002 91 Studydesign, not enough data point for interrupted time series criteria  
Werner 2005 35 Studydesign  
Werner 2005 92 
Studydesign, a single control and single intervention before and after 
comparison  
 
Risk of bias in included studies 
We included three study designs (ClRCT, ClQ-RCT and ITS) which we rated on different 
risk of bias items, we applied items as appropriate for the relevant study design. 
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Allocation concealment (selection bias) 
One study46 provided insufficient information about allocation of concealment to allow 
judgement of the degree of the risk of bias. One study47 described a non-random 
method of concealing allocation: research investigators enrolling participants could 
possibly foresee assignment, therefore there is a high risk of bias. In Tu49 a statistician 
randomised participating hospitals stratified by type of hospital, we rated this as a low 
risk of bias. 
 
Adequate sequence generation (selection bias) 
One study46 provided insufficient information about the sequence generation for 
judging the degree of the risk of bias. One study47 described a non-random method of 
sequence generation (sequence determined by odd or even case record numbers), so it 
is possible that selection bias occurred. A third study49 used a random method of 
sequence generation to assign the hospitals to the early feedback group or the delayed 
feedback group. 
 
Blinding 
Blinding of the participants was impossible because they had to see what they 
received.46,47 Analysis was based on computerised discharged abstracts, for which 
participants could not be blinded.48 It was also impossible to blind hospitals to their 
randomisation status.49 
 
Incomplete outcome data 
Three studies46-48 had complete outcome data for the primary outcomes. The results for 
the entire sample are presented. In Tu49 one of 86 hospitals withdrew from the baseline 
phase after randomisation, and four withdrew from the follow-up phase, all due to 
resource constraints, although they did not report a reason for the drop-out. We rated 
this item as having an ‘unclear risk of bias’: five hospitals dropped out, and this 
affected both intervention and control groups. 
 
Selective reporting 
We have checked two study protocols, the published reports include the expected 
outcomes.46,47 As far as the other two studies were concerned,48,49 we were not able to 
check whether the publications included the expected outcomes. 
 
Other potential sources of bias 
Three studies46,47,49 were free of other bias. The ITS study48 had a potential bias since 
the collection periods were temporally moved about dependent upon when the hospital 
became an outlier. 
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Baseline characteristics 
In two studies46,47 the risk of bias regarding the baseline characteristics is unclear, since 
they did not report demographic variables for the intervention and control groups. One 
study49 reported the baseline characteristics across their two groups of hospitals. 
 
Reliable outcome measures 
Two studies46,47 achieved appropriate methods for the outcome measurements, and one 
study49 did not. The primary outcomes measures were developed in a national team of 
experts, but the measures were not field-tested. The last step in the validation process 
was not undertaken, thus the reliability of the measures was impossible to determine. 
 
Protection against contamination 
The risk of contamination in one study was unclear.46 In another study, the risk of 
contamination was low because the enrolling participants received the enrolment 
materials in their homes.47 It is likely that a few respondents would discuss the CAHPS 
material with others, but the reality is that the risk of contamination cannot be 
managed in such cases, simply because of the nature of public reporting. The third 
study did not provide an explicit statement regarding the methods used to prevent 
against contamination.49 There was extensive media coverage following the release of 
the baseline performance data for the intervention group. The control group also 
initiated some quality improvement activities after becoming aware of the release of 
the performance data, which could indicate that the control group had been affected. 
As in Farley,47 this is difficult to prevent because of the nature of public reporting. 
However, Tu49 might have seen that the extended media coverage would affect the 
hospitals in the control group. 
 
Intervention independent of other changes 
In the ITS study48 it is unclear whether the intervention occurred independently of 
other changes over time or whether that the outcome was influenced by other 
confounding variables and events during the study period. 
 
Shape of intervention effect pre-specified 
The Romano 2004 study adequately pre-specified the shape of the intervention effect. 
 
Knowledge of the allocated interventions adequately prevented during the study 
The Romano 2004 study dealt with the knowledge of the allocated interventions 
suitably. 
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Intervention unlikely to affect data collection 
The Romano 2004 study appropriately managed the risk of affecting the data 
collection. 
 
Effects of interventions 
See: Summary of findings for the main comparison. 
 
Characteristics of interventions 
In Farley46 conducted between February and May 2000, the control group received 
standard enrolment materials by personal mailing post, including items such as 
Medicaid benefits, instructions about the enrolment process, and available information 
sources. The experimental group received this standard enrolment material plus the 
Consumer Assessment of Healthcare Providers and System (CAHPS) report. Health plans 
were categorised on the basis of their CAHPS performance, defined as high and low 
performance plans. The CAHPS measures and report template used bar charts rating 
the overall health plan, overall healthcare and the personal doctor. Additional charts 
reported respondents’ views on five aspects of service: ‘getting needed care’, ‘getting 
care without long waits’, ‘how well doctors communicate’, ‘courtesy, respect and 
helpfulness’, and ‘health plan customer service’. A three-point scale (sometimes/ 
never, usually and always) was used. The Iowa Medicaid programme did not offer 
additional proactive support to the intervention group participants for making health 
plan choices. 
 
In Farley47 conducted in March and April 1998, the control group beneficiaries received 
the standard mailing of Medicaid enrolment materials. The experimental group 
received the standard enrolment material plus the CAHPS report. Following the CAHPS 
convention for comparative rating, a three-star rating was used with one star for plans 
with survey results that scored significantly lower than average, two stars for those 
that were not significantly different from the average for all other Medicaid plans in 
New Jersey, and three stars for plans that scored significantly better than average. The 
participants were asked to choose one HMO and sometimes a primary care case-
management plan. The state contracted a private firm to manage the enrolment 
process and assist participants in choosing their plans. They were able to call a free 
phone number and ask questions about plans. The contractor also sent ‘health benefit 
co-ordinators’ into county welfare offices and the community to assist participants in 
choosing. The Medicaid office automatically assigned participants who did not make to 
a health plan by the Medicaid office. 
 
In Romano 2004,48 report cards were published by agencies in California and New York, 
reporting on patient outcomes for coronary artery bypass grafting (CABG), acute 
5 
 Chapter 5 
88 
myocardial infarction (AMI) or postdiscectomy complications. The California data began 
in 1991 with the California Hospital Outcomes Project. The first report, released in 
California, December 1993, used a two-category rating and classified hospital mortality 
for AMI and complication rates for cervical and lumbar discectomy as either ‘better’ 
and ‘not better’ than expected. The second report, released in May 1996, classified 
hospital mortality for AMI into three categories as ‘better’, ‘worse’ or ‘neither better 
nor worse’ than expected. The analysis for California was based on the California 
Patient Discharge Data Set.  
 
The New York Cardiac Surgery Reporting System(CSRS) began in 1989 with the creation 
of a special data system for cardiac surgery. In New York hospital-specific, risk-
adjusted mortality rates using a three-category classification have been released every 
12 to 24 months since December 1990. The analysis for New York is based on the 
Statewide Planning and Research Co-operative System. 
 
In Tu 2009,49 conducted between April 1999 and April 2005, the early feedback group 
(42 hospitals) received their baseline performance data of 12 process-of-care indicators 
for AMI and six indicators for congestive heart failure (CHF) for internal validation 
checks. The results were publicly released at a press conference and on the internet in 
January 2004. The early feedback hospitals were encouraged to develop standardised 
admitting orders and discharge plans, based on the baseline performance. Baseline 
performance results of the delayed feedback group (N=41 hospitals) were publicly 
released on the internet in September 2005 after internal validation. To determine the 
effect of the public release and feedback, clinical information was collected from chart 
reviews during the follow-up (1 April 2004 to 31 March 2005 inclusive 15,997 patients) 
and compared with the baseline performance data (1 April 1999 to 31 March 2001 
inclusive 20,039 patients). The primary outcome measures were defined as being the 
difference in the mean hospital-specific performance between the two study groups on 
two composite indicators, i.e. one for AMI and one for CHF. 
 
Main outcome measures  
Interventions targeting improvement through selection: changes in healthcare 
utilisation decisions of consumers or healthcare providers 
In Farley 200246 22.6% of the participants switched from the default health plan to 
another health plan. Participants in the type I counties with three plan choices were 
less likely to switch (19.9%) than those in the type II or type III counties with only two 
choices (25.4% overall). Availability of CAHPS data had no effect on the switching rate; 
individuals not receiving information moved from lower to higher quality plans as often 
as those who did receive CAHPS data (Table 4). 
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Table 4. Estimated effects of CAHPS information on enrolment choices by new beneficiaries enrolled 
in the Iowa Medicaid programme  
 
 Percentages 
(unadjusted frequenties) 
   
 
Control 
(No CAHPS) 
Intervention 
(CAHPS) 
Odds ratio (95% CI) 
for the CAHPS group 
Lower CI Upper CI 
Type I counties      
Assigned to high-rated HMO N=1717 N=1693    
Stayed in HMO 84.0% 85.7%    
Switched to MediPass 13.2% 10.6% 0.80 0.58 1.09 
Switched to low-rated HMO 2.7  % 3.8  % 1.36 0.75 2.45 
Assigned to low-rated HMO N=1614 N=1679    
Stayed in HMO 76.0% 74.7%    
Switched to MediPass 14.1% 14.4% 1.03 0.75 1.39 
Switched to high-rated HMO 9.9% 11.0% 1.13 0.79 1.60 
Type II counties      
Assigned to high-rated HMO N=1087 N=1037    
Stayed in HMO 70.5% 71.8%    
Switched to MediPass 29.5% 28.2% 0.92 0.68 1.24 
Type III counties      
Assigned to low-rated HMO N=2097 N=2153    
Stayed in  HMO 76.3% 76.4%    
Switched to MediPass 23.7% 23.6% 0.99 0.79 1.23 
CAHPS: Consumer Assessment of Health Plans Study; CI: Confidence Intervals; HMOs: health maintenance 
organisations; MediPass: Medicaid primary care case management programme 
High, low-rated: the reports or experience are composite scores that are averages of response to sets of 
individual items using four-category response options. Farley 200246 
 
Farley 200247 did not find any significant differences between the plan choices of the 
enrollees in the intervention and control groups. Sixty-eight percent of the intervention 
group and 69% of the control group chose a plan. The standardised CAHPS rating for 
those who chose a plan were -0.03 for the intervention and 0.03 for the control groups; 
28% and 27% respectively chose the dominant HMO. For those not selecting the 
dominant HMO, the standardised CAHPS ratings of the selected plan were 1.80 and 1.73 
respectively (Table 5). 
 
Table 5. Plan choices for April enrollees 
 
 Mean or proportion  
 Reports (n=2649) Control (n=2568) 
Proportion choosing a plan 0.68 0.69 
Farley 200247 
 
Romano48 estimated time series models using ordinary least squares (OLS) data from the 
states of New York and California. They re-analysed the California data with 
autoregressive integrated moving average (ARIMA) methods. In autoregressive models 
there were no clear patterns of effect developed between AMI report cards and 
subsequent hospital volume for either AMI or related AMI conditions. There was a small 
and temporary increase in volume in low complication rate hospitals for lumbar 
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discectomy. Romano48 only report OLS results from New York because autocorrelation 
was minimal in that state. The study also found a significant increase in CABG volume 
for low-mortality hospitals in New York within the first month after publication and a 
significant decrease in volume for high-mortality outliers in the second month after 
release of the information (Table 6 and Table 7). 
 
Table 6. Mean differences between actual and predicted monthly patient volume for the average 
outlier hospital, over 4 consecutive months in New York. After publication of a risk-
adjusted outcome study, using ordinary least-squares regressiona  
 
   Actual minus predicted monthly patient volume (95% confidence interval) 
State Condition or 
procedure 
Outlier 
groupb Month 1 (NY) Month 2 (NY) Month 3 (NY) Month 4 (NY) 
NY CABG 
(target) 
Better 
(D=1.92) 
13.4d (4.3 to 22.6) 5.5 (-3.5 to –14.7) 6.7 (-1.5 to –15.0) 3.0 (-5.0 to 11.0) 
Worse 
(D=1.91) 
-4.0 (-9.0 to –1.0) -7.1d (-12.3 to -1.9) -2.7 (-8.0 to –2.7) -0.9 (-5.9 to 4.1) 
NY CABG-
related (AMI) 
Better 
(D=1.96) 
-4.9 (-12.3 to –2.4) -1.4 (-8.7 to –5.9) -1.9 (-8.7 to –4.8) 0.5 (-6.1 to 7.2) 
Worse 
(D=1.38) 
-4.5c (-8.5 to -0.6)  -1.2 (-5.2 to –2.8) -1.6 (-5.4 to –2.2) -6.0d (-9.8 to -2.2) 
NY CABG related 
(PTCA) 
Better 
(D=2.14) 
3.7 (-3.2 to –10.8) 1.1 (-6.0 to –8.3) 0.6 (-6.1 to –7.4) -1.2 (-7.8 to 5.5) 
Worse 
(D=1.34) 
-2.6 (-7.0 to –1.8) -1.4 (-6.0 to –3.1) 0.4 (-4.2 to –4.9) -2.1 (-6.6 to 2.5) 
NY CABG-
related 
(CHF) 
Better 
(D=1.74) 
-2.8 (-8.7 to –3.1) -4.0 (-9.9 to –2.0) -0.5 (-6.0 to –5.0) -1.7 (-7.1 to 3.7) 
Worse 
(D=2.14) 
-1.0 (-5.8 to –3.9) -2.0 (-7.1 to –3.1) -1.7 (-6.6 to –3.2) -0.1 (-4.8 to 4.7) 
a Positive numbers indicate that hospitals in that category had more admissions than predicted; negative 
numbers indicate that hospitals in that category had fewer admissions than predicted 
b The Durbin-Watson statistics in this column represent the magnitude of autocorrelation affecting OLS 
models. Values close to 2 indicates the absence of autocorrelation 
c Two-tailed p < 0.005; d Two-tailed p < 0.01 
AMI: Acute myocardial infarction; CABG: coronary artery bypass grafting; PTCA: percutaneous 
transluminal coronary angioplasty; CHF: congestive heart failure. Romano48 
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Table 7. Mean differences between actual and predicted monthly patient volume for the average 
outlier hospital in California, over 4 consecutive quarters after publication of a risk-
adjusted outcome study, using autoregressive modelsa (ARIMA)  
 
   Actual minus predicted monthly patient volume (95% confidence 
interval) 
State Condition or 
procedure 
Outlier 
groupb Quarter 1 (CA) Quarter 2 (CA) Quarter 3 (CA) Quarter 4 (CA) 
CA 
  
AMI (target) Betterb 1.9 (-0.1 to -3.9) -1.1 (-3.2 to –0.9) -0.6 (- 2.7 to -1.6) 1.1 (-1.3 to 3.6) 
Worseb  0.7 (-1.6 to –3.0) 1.0 (-1.4 to –3.5) 0.0 (-2.3 to –2.4) 0.6 (-2.0 to 3.3) 
CA AMI-related Better  -1.1 (-4.9 to –2.7) 4.2 (-0.1 to –8.5) -3.8 (-0.8 to –8.3) -0.1 (-4.6 to 4.5) 
Worse 1.0 (-1.5 to –3.6) 0.4 (-2.5 to –3.2) 0.4 (-3.2 to –2.5) -1.0 (-4.1 to 2.2) 
CA Cervical 
discectomy 
(target) 
Better 0.2 (-1.1 to –1.5) -0.3 (-1.8 to –1.3) -1.6c (0.0 to –3.2) -0.6 (-2.2 to 1.0) 
Worse -1.1c (-2.0 to -0.0) 0.3 (-0.9 to –1.6) 1.1 (-0.1 to –2.3) 0.9 (-0.4 to 2.1) 
CA Lumbar 
discectomy 
(target) 
Betterb 0.6 c(0.0 to –1.1) 0.3 (-0.3 to –0.9) 0.5 (-0.2 to –1.2) 0.8c (-0.1 to 1.5) 
Worse -0.1 (-0.8 to –0.6) -0.1 (-0.9 to –0.7) -0.3 (-1.2 to –0.6) -0.5 (-1.4 to 0.3) 
CA Discectomy-
related 
Betterb 0.4 (-0.1 to –1.9) -0.9 (-2.4 to –0.7) -1.1 (-2.7 to -0.4) 0.4 (-1.4 to 2.1) 
Worse  -1.4c (-2.4 to -0.3)  0.2 (1.1 to –1.4)  0.0 (-1.2 to –1.2) 0.2 (1.0 to 1.5) 
a Positive numbers indicate that hospitals in that category hadmore admissions than predicted; negative 
numbers indicate that hospitals in that category had fewer admissions than predicted. To estimate the 
total difference in patient volume for the average California hospital in each quarter, the numbers shown 
should be multiplied by 3 
b The Durbin-Watson statistics in this column represent the magnitude of autocorrelation affecting OLS 
models. Values close to 2 indicates the absence of autocorrelation 
c Two-tailed P < 0.005 
ARIMA: autoregressive integrated moving average; AMI: Acutemyocardial infarction; CABG: coronary 
artery bypass grafting; PTCA: percutaneous transluminal coronary angioplasty; CHF: congestive heart 
failure. Romano48 
 
Interventions targeting improvement through changes in care: objectives measures 
of provider performance 
Tu 2009 did not find significant differences in either the composite AMI indicator 
(absolute change 1.5%; 95% CI -2.2% to 5.1%; P=0.43) (Table 6) or composite CHF 
indicator (absolute change 0.6%; 95% CI -4.5% to 5.7%; P=0.81) (Table 7) in the early 
feedback group compared with the delayed feedback group. Regarding individual 
process-of-care indicators, one of the 12 for AMI and one of the six for CHF improved 
significantly in the early feedback group (Table 8 and Table 9). The AMI 30-days 
mortality rate was significantly lower in the early feedback group than in the delayed 
feedback group (absolute change -2.5%; 95% CI -0.1% to -4.9%; P=0.045), while the one-
year mortality rates of the early, and delayed feedback groups were comparable. The 
30-days and one-year CHF mortality rates did not differ significantly. In addition to the 
release of a public report card, there was a hospital survey. The early feedback group 
initiated more quality improvement activities in response to the publicly released 
report card (for AMI 73.2% versus 46.7%; P=0.003 and for CHF 61% versus 50%; P=0.04). 
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Other outcome measures 
Awareness, attitude, views and knowledge of performance data and cost data were not 
reported in three of the included studies. Farley47 reported secondary outcomes as a 
result of a survey. Farley47 used a ratio of 3:1 (report versus no report) to send the 
survey. They had problems with differential sampling and response rates: therefore the 
data become difficult to interpret. We decided to exclude these results and so do not 
report these outcomes. 
 
Data syntheses 
We have summarised the outcome data extracted from papers in a narrative format in 
the section ‘Characteristics of interventions’. We did not synthesise any quantitative 
data. 
 
DISCUSSION 
Summary of main results 
In four studies interventions consisting of either direct (mailed) or indirect (internet) 
release of performance data were focused on changes in selection or changes in care. 
For changes in selection, from two studies we found no impact on choice of health plan 
in Medicaid populations. From one study there was a small effect of the public release 
of mortality and complication data on patient volumes for CABG surgery, and lumbar 
discectomy; however, these effects did not persist for more than two months after 
each release. There were no effects of releasing mortality data on patient volumes for 
AMI outcomes. The changes of care were evaluated for the indirect release of 
performance data for patients with AMI and CHF in one study. There were no effects on 
composite process-of-care indicators for either condition, but there were some 
improvements in individual process-of-care indicators for both AMI and CHF. There was 
also an effect on 30 day AMI mortality rates, and more quality improvement activities 
were initiated in response to the publicly-released report cards. 
 
Overall completeness and applicability of evidence 
The three studies that took place in the USA involved only a small proportion of the 
numerous major reporting systems available. We included one new study from Canada49 
that was published after the last systematic reviews by Shekelle,40 Fung8 and Faber.41 
We excluded many of the more recent studies because they did not have a rigorous 
study design or did not report the defined primary outcome measures. 
 
Regarding overall completeness, we conclude that evaluations of public reporting 
system are scarce. Only a few current reporting systems have been subjected to 
scientific evaluation to determine the effects of public disclosure of quality information 
Public release of performance data in changing behaviour 
95 
in various stakeholders.40,93 Studies that compare different reporting systems are 
lacking, as are studies of purchaser behaviour. 
 
Despite evidence that secondary outcome measures (e.g. awareness, attitude, 
knowledge of performance data) are crucial since public reporting can only change 
behaviour if the target population (healthcare consumers, providers or purchasers of 
care) understand the provided information,21 these measures are lacking in the 
included studies. Because of that it is difficult to explain the lack of effect. Faber41 
demonstrated that effect of performance data was higher for those who understand the 
information. Damman28 showed that comparative performance information is complex, 
and consumers had difficulties in interpreting and using performance data. 
 
One type of performance information included in our studies was about patients 
experiences (CAHPS), items e.g. regarding doctor-patient communication, long waits, 
respect. Other included types of performance information were mortality, and 
complication data. Patient-Reported outcome measures (PROMs) were not included, 
nor was performance information about services. Mortality and complication data were 
included, but only for two conditions (AMI, CHF) and two surgical procedures (CABG, 
discectomy). 
 
Quality of the evidence 
The quality of the evidence in this review appears to be low based on the analysis with 
the Grades of Recommendations Assessment, Development and Evaluation (GRADE) 
system. We downgraded the quality of the evidence for the outcomes due to some 
concerns with risk of bias in the studies, loss to follow-up, and very sparse data. 
 
There is one more source of concern regarding the quality of the included studies: we 
did not have access to the complete study protocols for two of the studies, so we could 
not judge the risk of selective reporting definitively. 
 
The issue of contamination is difficult to tackle for a public reporting intervention 
because it is often impossible to prevent control groups from seeing information that is 
publicly available on websites and in the media. Control of exposure can be gained if 
the information is only posted to consumers personally or if the control and 
intervention groups are geographically separated. In one study,49 there was extensive 
media coverage when hospitals in the early feedback group received their baseline 
performance data. A survey among hospitals in the delayed feedback group confirmed 
that these control hospitals were affected by the release of performance data in the 
early feedback group. 
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Potential biases in the review process 
Although our search was comprehensive, we cannot exclude the possibility of having 
missed relevant studies. We were unable to retrieve and assess four possibly relevant 
studies in full text. Two review authors independently examined all the references we 
found in our search. Two review authors independently extracted detailed data and 
assessed the risk of bias and a third review author settled any disagreements. We did 
this to exclude bias in the review process. 
 
Agreements and disagreements with other studies or reviews 
There are three relevant publications: an article by Kolstad10 and two systematic 
reviews by Faber41 and Fung 2008.8 Our conclusion agrees with those of Kolstad10 and 
Faber;41 we do not know the extent to which quality reporting leads to improvement of 
health care quality. We also agree with the conclusion of Fung 2008;8 despite the 
existence of major public reporting systems, we lack rigorous evaluations of the effects 
of these systems. 
 
AUTHORS’ CONCLUSIONS 
Implications for practice 
The results of this review do not enable us to make any strong recommendations for 
practice. Whilst performance data may be publicly released for many reasons, we 
cannot conclude from the limited evidence whether disclosure of performance 
information can reliably change the behaviour of consumers, providers, purchasers or 
professionals. 
 
Implications for research 
In order to understand the effectiveness of the public release of performance data, we 
need more longitudinal studies with robust evaluation designs and, in particular, 
studies that test for delayed or cumulative effects with continuing measurements. To 
improve our insight into the current and potential impacts of public reporting, we need 
to evaluate a variety of reporting systems in the USA and other countries. 
 
As the lack of effect might be due to a missing of actual exposure to performance data, 
a specific implication for future studies targeting the consumer’s choice behaviour is 
that the intervention group (i.e. those provided with performance data) should actually 
read and understand the performance data. Additional interventions might enhance the 
impact on consumers with limited health literacy in the intervention group.25 Studies 
targeting improvements effected by changes in care might benefit from baseline 
performance data for the intervention group that is released repeatedly instead of only 
once. 
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Berwick’s model suggests that public release of performance data may improve quality 
of care by means of a pathway of change or selection.3 The studies we included focused 
on either one or the other of these pathways exclusively. We suggest a study design 
that combines the two pathways to assess the relationship between them. 
 
A basic assumption underlying the provision of report cards is that provider choice is a 
rational decision. In other words, consumers prefer the healthcare provider or health 
plan rated as the best. Evidence that confirms this assumption is limited.10,41 However, 
several factors that influence the choice of consumers are known, such as established 
relationships with local physicians, health plans, 9,94 hospitals, distance, and opinions of 
friends, and family.29,30 Future studies should address the range, and relative impact of 
factors such as these.  
5 
 Chapter 5 
98 
REFERENCES 
1. Smith PC, Mossialos E, Papanicolas I, Leatherman S. Performance measurement for health system 
improvement. Experiences, Challenges and Prospects. Cambridge: Cambridge University Press, 
2009. 
2. Marshall MN, Shekelle PG, Leatherman S, Brook RH. The public release of performance data: what 
do we expect to gain? A review of the evidence. JAMA 2000;283(14):1866-74. 
3. Berwick DM, James B, Coye MJ. Connections between quality measurement and improvement. Med 
Care 2003;41(1 Suppl):I30-38. 
4. Bentley JM, Nash DB. How Pennsylvania hospitals have responded to publicly released reports on 
coronary artery bypass graft surgery. Jt Comm J Qual Improv 1998;24(1):40-49. 
5. Hendriks M, Spreeuwenberg P, Rademakers J, Delnoij DM. Dutch healthcare reform: did it result in 
performance improvement of health plans? A comparison of consumer experiences over time. BMC 
Health Serv Res 2009;9167. 
6. Longo DR, Land G, Schramm W, Fraas J, Hoskins B, Howell V. Consumer reports in health care. Do 
they make a difference in patient care? JAMA 1997;278(19):1579-84. 
7. Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, et al. Public reporting and 
pay for performance in hospital quality improvement. N Engl J Med 2007;356(5):486-96. 
8. Fung CH, Lim YW, Mattke S, Damberg C, Shekelle PG. Systematic review: the evidence that 
publishing patient care performance data improves quality of care. Ann Intern Med 2008;148(2): 
111-23. 
9. Hibbard JH. Using systematic measurement to target consumer activation strategies. Med Care Res 
Rev 2009;66(1 Suppl):9S-27S. 
10. Kolstad JT, Chernew ME. Quality and consumer decision making in the market for health insurance 
and health care services. Med Care Res Rev 2009;66(1 Suppl):28S-52S. 
11. Werner RM, Konetzka RT, Kruse GB. Impact of public reporting on unreported quality of care. 
Health Serv Res 2009;44(2 Pt 1):379-98. 
12. Marshall MN, Romano PS, Davies HT. How do we maximize the impact of the public reporting of 
quality of care? Int J Qual Health Care 2004;16 (Suppl 1):i57-63. 
13. Fotaki M, Roland M, Boyd A, McDonald R, Scheaff R, Smith L. What benefits will choice bring to 
patients? Literature review and assessment of implications. J Health Serv Res Policy 2008;13(3): 
178-84. 
14. Berwick DM, Wald DL. Hospital leaders’ opinions of the HCFA mortality data. JAMA 1990;263(2): 
247-49. 
15. Sirio CA, McGee JL. Public reporting of clinical outcomes--the data needs of health care 
stakeholders. Am J Med Qual 1996;11(1): S78-81. 
16. Rosenthal GE, Hammar PJ, Way LE, Shipley SA, Doner D, Wojtala B, et al. Using hospital 
performance data in quality improvement: the Cleveland Health Quality Choice experience. Jt 
Comm J Qual Improv 1998;24(7):47-60. 
17. Schut FT, Van de Ven WP. Rationing and competition in the Dutch health-care system. Health Econ 
2005;14(Suppl 1):S59-74. 
18. Brook RH. Health care reform is on the way: do we want to compete on quality? Ann Intern Med 
1994;120(1):84-86. 
19. Hibbard JH, Jewett JJ, Legnini MW, Tusler M. Choosing a health plan: do large employers use the 
data? Health Aff (Millwood) 1997;16(6):172-80. 
20. Mukamel DB, Mushlin AI. Quality of care information makes a difference: an analysis of market 
share and price changes after publication of the New York State Cardiac Surgery Mortality Reports. 
Med Care 1998;36(7):945-54. 
21. Hibbard JH, Greene J, Daniel D. What is quality anyway? Performance reports that clearly 
communicate to consumers the meaning of quality of care. Med Care Res Rev 2010;67(3):275-93. 
22. Hibbard JH, Peters E, Slovic P, Finucane ML, Tusler M. Making health care quality reports easier to 
use. Jt Comm J Qual Improv 2001;27(11):591-604. 
23. Magee H, Davis LJ, Coulter A. Public views on healthcare performance indicators and patient 
choice. J R Soc Med 2003;96(7):338-42. 
24. O’Meara J, Kitchener M, Collier E, Lyons M, de Billwiller-Kiss A, Simon LP, et al. Case study: 
development of and stakeholder responses to a nursing home consumer information system. Am J 
Med Qual 2005;20(1):40-50. 
Public release of performance data in changing behaviour 
99 
25. Hibbard JH, Peters E, Dixon A, Tusler M. Consumer competencies and the use of comparative 
quality information: it isn’t just about literacy. Med Care Res Rev 2007;64(4):379-94. 
26. Harris-Kojetin LD, Uhrig JD, Williams P, Bann C, Frentzel EM, McCormack L, et al. The “choose 
with care system” - development of education materials to support informed Medicare health plan 
choices. J Health Commun 2007;12(2):133-56. 
27. Peters E, Dieckmann N, Dixon A, Hibbard JH, Mertz CK. Less is more in presenting quality 
information to consumers. Med Care Res Rev 2007;64(2):169-90. 
28. Damman OC, van den Hengel YK, van Loon AJ, Rademakers J. An international comparison of web-
based reporting about health care quality: content analysis. J Med Internet Res 2010;12(2):e8. 
29. Dixon A, Robertson R, Appleby J, Burge P, Devlin N, Magee H. Patient choice. How patients choose 
and providers respond. In, London: The King’s Fund, 2010. 
30. Harris KM, Beeuwkes Buntin M, Cooperation. TR. Research Synthesis Report. Choosing a healthcare 
provider: the role of quality information. Princeton: Robert Wood Johnson Foundation, 2008. 
31. Giuffrida A, Gravelle H, Roland M. Measuring quality of care with routine data: avoiding confusion 
between performance indicators and health outcomes. BMJ 1999;319(7202):94-98. 
32. Kerr EA, Hofer TP, Hayward RA, Adams JL, Hogan MM, McGlynn EA, et al. Quality by any other 
name?: a comparison of three profiling systems for assessing health care quality. Health Serv Res 
2007;42(5):2070-87. 
33. Parry GJ, Gould CR, McCabe CJ, Tarnow-Mordi WO. Annual league tables of mortality in neonatal 
intensive care units: longitudinal study. International Neonatal Network and the Scottish Neonatal 
Consultants and Nurses Collaborative Study Group. BMJ 1998;316(7149):1931-35. 
34. Rixom A. Performance league tables. BMJ 2002;325(7357):177-78. 
35. Werner RM, Asch DA. The unintended consequences of publicly reporting quality information. JAMA 
2005;293(10):1239-44. 
36. Dranove D, Sfekas A. Start spreading the news: a structural estimate of the effects of New York 
hospital report cards. J Health Econ 2008;27(5):1201-7. 
37. Bardach NS, Cabana MD. The unintended consequences of quality improvement. Curr Opin Pediatr 
2009;21(6):777-82. 
38. Loeb JM. The current state of performance measurement in health care. Int J Qual Health Care 
2004;16(Suppl 1)i5-9. 
39. Jamtvedt G, Young JM, Kristoffersen DT, O’Brien MA, Oxman AD. Audit and feedback: effects on 
professional practice and health care outcomes. Cochrane Database Syst Rev 2006(2):CD000259. 
40. Shekelle PG, Lim Y-W, Mattke S, Damberg C, Southern California Evidence-based Practice Centre, 
Corporation. R. Does public release of performance results improve quality of care? A systematic 
review. London: The Health Foundation, 2008. 
41. Faber M, Bosch M, Wollersheim H, Leatherman S, Grol R. Public reporting in health care: how do 
consumers use quality-of-care information? A systematic review. Med Care 2009;47(1):1-8. 
42. Harris KM. Can high quality overcome consumer resistance to restricted provider access? Evidence 
from a health plan choice experiment. Health Serv Res 2002;37(3):551-71. 
43. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 
The Cochrane Collaboration, 2011. www.cochrane-handbook.org, 2011. 
44. EPOC. EPOC risk of bias guideline. http://epoc.cochrane.org/epoc-resources-review-authors. 
2009. 
45. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of 
meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of 
Meta-analyses. Lancet 1999;354(9193):1896-900. 
46. Farley DO, Elliott MN, Short PF, Damiano P, Kanouse DE, Hays RD. Effect of CAHPS performance 
information on health plan choices by Iowa Medicaid beneficiaries. Med Care Res Rev 2002;59(3): 
319-36. 
47. Farley DO, Short PF, Elliott MN, Kanouse DE, Brown JA, Hays RD. Effects of CAHPS health plan 
performance information on plan choices by New Jersey Medicaid beneficiaries. Health Serv Res 
2002;37(4):985-1007. 
48. Romano PS, Zhou H. Do well-publicized risk-adjusted outcomes reports affect hospital volume? 
Med Care 2004;42(4):367-77. 
49. Tu JV, Donovan LR, Lee DS, Wang JT, Austin PC, Alter DA, et al. Effectiveness of public report 
cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA 2009; 
302(21):2330-37. 
5 
 Chapter 5 
100 
50. Alteras TT. Health plan report cards may influence insurers more than consumers: their effect on 
insurer behavior in Minnesota. Find Brief 2000;3(3):1-2. 
51. Dean Beaulieu N, Epstein AM. National Committee on Quality Assurance health-plan accreditation: 
predictors, correlates of performance, and market impact. Med Care 2002;40(4):325-37. 
52. Beaulieu ND. Quality information and consumer health plan choices. J Health Econ 2002;21(1):43-
63. 
53. Bundorf MK, Chun N, Goda GS, Kessler DP. Do markets respond to quality information? The case of 
fertility clinics. J Health Econ 2009;28(3):718-27. 
54. Dawson D, Gravelle H, Jacobs R, Martin S, Smith PC. The effects of expanding patient choice of 
provider on waiting times: evidence from a policy experiment. Health Econ 2007;16(2):113-28. 
55. Ettinger WH, Hylka SM, Phillips RA, Harrison LH, Jr., Cyr JA, Sussman AJ. When things go wrong: 
the impact of being a statistical outlier in publicly reported coronary artery bypass graft surgery 
mortality data. Am J Med Qual 2008;23(2):90-95. 
56. Fanjiang G, von Glahn T, Chang H, Rogers WH, Safran DG. Providing patients web-based data to 
inform physician choice: if you build it, will they come? J Gen Intern Med 2007;22(10):1463-66. 
57. Fine A. The effect of grading and publicizing the physician groups' performance. Exec Solut Healthc 
Manag 1998;1(9):2-3. 
58. Fong J, Marsh GM, Stokan LA, Weilian S, Vinson C, Ruhl L. Hospital quality performance report: an 
application of composite scoring. Am J Med Qual 2008;23(4):287-95. 
59. Fox MH, Moore J, Zimmerman M, Hill S, Foster CH. The effectiveness of CAHPS among women 
enrolling in Medicaid managed care. J Ambul Care Manage 2001;24(4):76-91. 
60. Goldstein E, Fyock J. Reporting of CAHPS quality information to medicare beneficiaries. Health 
Serv Res 2001;36(3):477-88. 
61. Goss JR, Maynard C, Aldea GS, Marcus-Smith M, Whitten RW, Johnston G, et al. Effects of a 
statewide physician-led quality-improvement program on the quality of cardiac care. Am Heart J 
2006;151(5):1033-42. 
62. Hannan EL, Sarrazin MS, Doran DR, Rosenthal GE. Provider profiling and quality improvement 
efforts in coronary artery bypass graft surgery: the effect on short-term mortality among Medicare 
beneficiaries. Med Care 2003;41(10):1164-72. 
63. Hibbard JH, Sofaer S, Jewett JJ. Condition-specific performance information: assessing salience, 
comprehension, and approaches for communicating quality. Health Care Financ Rev 1996;18(1): 
95-109. 
64. Hibbard JH, Harris-Kojetin L, Mullin P, Lubalin J, Garfinkel S. Increasing the impact of health plan 
report cards by addressing consumers' concerns. Health Aff (Millwood) 2000;19(5):138-43. 
65. Hibbard JH, Berkman N, McCormack LA, Jael E. The impact of a CAHPS report on employee 
knowledge, beliefs, and decisions. Med Care Res Rev 2002;59(1):104-16. 
66. Hibbard JH, Slovic P, Peters E, Finucane ML. Strategies for reporting health plan performance 
information to consumers: evidence from controlled studies. Health Serv Res 2002;37(2):291-313. 
67. Hibbard JH, Stockard J, Tusler M. Does publicizing hospital performance stimulate quality 
improvement efforts? Health Aff (Millwood) 2003;22(2):84-94. 
68. Hibbard JH, Stockard J, Tusler M. It isn’t just about choice: the potential of a public performance 
report to affect the public image of hospitals. Med Care Res Rev 2005;62(3):358-71. 
69. Hibbard JH, Stockard J, Tusler M. Hospital performance reports: impact on quality, market share, 
and reputation. Health Aff (Millwood) 2005;24(4):1150-60. 
70. Hollenbeak CS, Gorton CP, Tabak YP, Jones JL, Milstein A, Johannes RS. Reductions in mortality 
associated with intensive public reporting of hospital outcomes. Am J Med Qual 2008;23(4):279-86. 
71. Howgill M, Blaza J, Cunningham L, Foster KL. The ratings game. How important are hospital 
rankings to consumers? Interview by Joyce Jensen. Mark Health Serv 2004;24(1):40-45. 
72. Jha AK, Epstein AM. The predictive accuracy of the New York State coronary artery bypass surgery 
report-card system. Health Aff (Millwood) 2006;25(3):844-55. 
73. Jian W, Huang Y, Hu M, Zhang X. Performance evaluation of inpatient service in Beijing: a 
horizontal comparison with risk adjustment based on Diagnosis Related Groups. BMC Health Serv 
Res 2009;972. 
74. Knutson DJ, Kind EA, Fowles JB, Adlis S. Impact of report cards on employees: a natural 
experiment. Health Care Financ Rev 1998;20(1):5-27. 
Public release of performance data in changing behaviour 
101 
75. Krupat E, Hsu J, Irish J, Schmittdiel JA, Selby J. Matching patients and practitioners based on 
beliefs about care: results of a randomized controlled trial. Am J Manag Care 2004;10(11 Pt 1): 
814-22. 
76. Mannion R, Goddard M. Public disclosure of comparative clinical performance data: lessons from 
the Scottish experience. J Eval Clin Pract 2003;9(2):277-86. 
77. McCormack LA, Garfinkel SA, Hibbard JH, Norton EC, Bayen UJ. Health plan decision making with 
new medicare information materials. Health Serv Res 2001;36(3):531-54. 
78. McCormack LA, Anderson WL, Uhrig JD, Garfinkel SA, Sofaer S, Terrell SA. Health plan decision 
making in the Medicare population: results from a national randomized experiment. Health Serv 
Res 2001;36(6 Pt 2):133-49. 
79. Moscucci M, Eagle KA, Share D, Smith D, De Franco AC, O’Donnell M, et al. Public reporting and 
case selection for percutaneous coronary interventions: an analysis from two large multicenter 
percutaneous coronary intervention databases. J Am Coll Cardiol 2005;45(11):1759-65. 
80. Norem J, Moen MA. The Websites of Norwegian hospitals: do they meet national guidelines and 
patient’s expectations? J Telemed Telecare 2004;10(5):272-76. 
81. O’Connor SJ, Shewchuk RM, Bowers MR. A model of service quality perceptions and health care 
consumer behavior. J Hosp Mark 1991;6(1):69-92. 
82. Petersen LA, Woodard LD, Henderson LM, Urech TH, Pietz K. Will hypertension performance 
measures used for pay-for-performance programs penalize those who care for medically complex 
patients? Circulation 2009;119(23):2978-85. 
83. Schoenbaum M, Spranca M, Elliott M, Bhattacharya J, Short PF. Health plan choice and information 
about out-of-pocket costs: an experimental analysis. Inquiry 2001;38(1):35-48. 
84. Scott IA, Ward M. Public reporting of hospital outcomes based on administrative data: risks and 
opportunities. Med J Aust 2006;184(11):571-75. 
85. Spranca M, Kanouse DE, Elliott M, Short PF, Farley DO, Hays RD. Do consumer reports of health 
plan quality affect health plan selection? Health Serv Res 2000;35(5 Pt 1):933-47. 
86. Spranca MD, Elliott MN, Shaw R, Kanouse DE. Disenrollment information and Medicare plan choice: 
is more information better? Health Care Financ Rev 2007;28(3):47-59. 
87. Swaminathan S, Chernew M, Scanlon DP. Persistence of HMO performance measures. Health Serv 
Res 2008;43(6):2033-49. 
88. Tai-Seale M. Does consumer satisfaction information matter? Evidence on member retention in 
FEHBP plans. Med Care Res Rev 2004;61(2):171-86. 
89. Uhrig JD, Short PF. Testing the effect of quality reports on the health plan choices of Medicare 
beneficiaries. Inquiry 2002;39(4):355-71. 
90. Uhrig JD, Harris-Kojetin L, Bann C, Kuo TM. Do content and format affect older consumers’ use of 
comparative information in a Medicare health plan choice? Results from a controlled experiment. 
Med Care Res Rev 2006;63(6):701-18. 
91. Wedig GJ, Tai-Seale M. The effect of report cards on consumer choice in the health insurance 
market. J Health Econ 2002;21(6):1031-48. 
92. Werner RM, Asch DA, Polsky D. Racial profiling: the unintended consequences of coronary artery 
bypass graft report cards. Circulation 2005;111(10):1257-63. 
93. Smith PC, Mossialos E, Papanicolas I. Performance measurement for health system improvement: 
experiences, challenges and prospects. World Health Organization, 2008. 
94. Schwartz LM, Woloshin S, Birkmeyer JD. How do elderly patients decide where to go for major 
surgery? Telephone interview survey. BMJ 2005;331(7520):821. 
5 
 Chapter 5 
102 
APPENDICES 
 
Appendix 1. MEDLINE search strategy 
MEDLINE (OVID) 
 
Syntax guide 
/ - index term (MeSH heading) 
exp - explode: includes narrower terms to the index term being exploded 
.tw. - text word in title or abstract fields 
$ - truncation/wild card: adds no or more characters 
? - truncation/wild card: adds no or one character 
# - truncation/wild card: retrieves alternative single character 
adjx - adjacency: required words are adjacent to each other, or within x words of each other 
.pt. - publication type 
 
Description of search strategy 
1. random$.tw. 
2. multicenter study.pt. 
3. randomized controlled trial.pt. 
4. randomized controlled trial.pt. 
5. clinical trial.pt. 
6. intervention studies/ 
7. experiment$.tw. 
8. (time adj series).tw. 
9. (pre test or pretest or (posttest or post test)).tw. 
10. random allocation/ 
11. impact.tw. 
12. intervention?.tw. 
13. chang$.tw. 
14. evaluation studies/ 
15. evaluat$.tw. 
16. effect?.tw. 
17. comparative studies/ 
18. compar$.tw. 
19. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 
20. editorial.pt. 
21. letter.pt. 
22. comment.pt. 
23. 20 or 21 or 22 
24. animals/ 
25. humans/ 
26. 24 not 25 
27. 23 or 26 
28. 19 not 27 
29. (public release of performance data and healthcare providers).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word] 
30. exp Primary Health Care/ 
31. exp Hospitals/ 
32. physicians/ 
33. health professionals.ab,ti. 
34. health personnel/ 
35. health plans.ab,ti. 
36. health plan.ab,ti. 
37. insurance.ab,ti. 
38. *Physician’s practice patterns/ 
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39. *Group Practice/ 
40. *Institutional Practice/ 
41. *Private Practice/ 
42. *Family Practice/ 
43. *Physicians/ 
44. *Physicians, Family/ 
45. *Professional Practice/ 
46. *Nurses/ 
47. *Nurse Clinicians/ 
48. *Nurse practitioners/ 
49. *Pharmacists/ 
50. *Pharmacies/ 
51. *Pharmacy/ 
52. *Hospitals/ 
53. (physician$ or GP? or doctor? or general pract$ or prescriber? or group pract$ or institutional pract$ 
or partnership pract$ or family pract$ or general pract$ or office pract$ or private pract$ or primary 
pract$ or nurse or nurses).tw. 
54. (pharmacist? or pharmacies or pharmacy).tw. 
55. hospital?.tw. 
56. physiotherapist.mp. 
57. midwife.mp. 
58. health care centre.mp. 
59. dietician.mp. 
60. health care provider.mp. 
61. *Allied Health Personnel/ 
62. *Dental Clinics/ 
63. *Dentists/ 
64. *Outpatient Clinics, Hospital/ 
65. general pract$.tw. 
66. psychologist.mp. 
67. psychiatrist.mp. 
68. 35 or 36 or 37 
69. or/38-67 
70. or/30-35 
71. 69 or 70 
72. 68 or 71 
73. quality assurance, health care/ 
74. *benchmarking/ 
75. *“process assessment (health care)”/ 
76. *“outcome assessment (health care)”/ 
77. exp Quality Indicators, Health Care/ 
78. performance outcome.ab,ti. 
79. (quality adj2 indicator?).tw. 
80. (quality adj (criteria or criterion or standard? or norm)).tw. 
81. (performance adj (indicator? or measure? or data or rating)).tw. 
82. disclosure/ 
83. Information Services/ 
84. report card.ab,ti. 
85. quality information.ab,ti. 
86. public information.ab,ti. 
87. consumer information.ab,ti. 
88. patient information.ab,ti. 
89. 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82 or 83 or 84 or 85 or 86 or 87 or 88 
90. exp Consumer Satisfaction/ 
91. patient preferences.ab,ti. 
92. public reporting.tw. 
93. consumer reports.ab,ti. 
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94. decision making.ab,ti. 
95. choice behaviour.ab,ti. 
96. choice behaviour.ab,ti. 
97. exp “Patient Acceptance of Health Care”/ 
98. ’provider profiling’.ab,ti. 
99. 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97 or 98 
100. 28 and 72 and 89 and 99 
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Appendix 2. EMBASE search strategy 
EMBASE (OVID) 
 
Syntax guide 
/ - index term (EMTREE heading) 
exp - explode: includes narrower terms to the index term being exploded 
.tw. - text word In title or abstract fields 
$ - truncation/wild card: adds no or more characters 
? - truncation/wild card: adds no or one character 
# - truncation/wild card: retrieves alternative single character 
adjx - adjacency: required words are adjacent to each other, or within x words of each other 
.pt. - publication type 
 
Description of search strategy 
1. exp consumer/ or *consumer health information/ 
2. patient preferences.ab,ti. 
3. *patient attitude/ 
4. *patient participation/ 
5. *decision making/ 
6. *patient decision making/ 
7. 6 or 4 or 1 or 5 or 3 or 2 
8. *total quality management/ 
9. *performance measurement system/ 
10. public reporting.mp. 
11. *decision making/ 
12. *outcome assessment/ 
13. *interpersonal communication/ 
14. *health care quality/ or exp clinical indicator/ or exp “quality of nursing care”/ 
15. *quality control/ 
16. report card.ab,ti. 
17. public information.mp. 
18. consumer information.mp. 
19. 13 or 18 or 10 or 14 or 16 or 9 or 15 or 8 or 11 or 17 or 12 
20. random$.tw. 
21. multicenter study.mp. 
22. randomized controlled trial.mp. 
23. randomized controlled trial.mp. 
24. clinical trial.mp. 
25. intervention studies/ 
26. experiment$.tw. 
27. (time adj series).tw. 
28. (pre test or pretest or (posttest or post test)).tw. 
29. random allocation/ 
30. impact.tw. 
31. intervention?.tw. 
32. chang$.tw. 
33. evaluation studies/ 
34. evaluat$.tw. 
35. effect?.tw. 
36. comparative studies/ 
37. compar$.tw. 
38. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 
39. editorial.pt. 
40. letter.pt. 
41. comment.pt. 
42. 39 or 40 or 41 
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43. animals/ 
44. humans/ 
45. 43 not 44 
46. 42 or 45 
47. 38 not 46 
48. exp Primary Health Care/ 
49. exp Hospitals/ 
50. physicians/ 
51. health professionals.ab,ti. 
52. health personnel/ 
53. health plans.ab,ti. 
54. health plan.ab,ti. 
55. insurance.ab,ti. 
56. (physician$ or GP? or doctor? or general pract$ or prescriber? or group pract$ or institutional pract$ 
or partnership pract$ or family pract$ or general pract$ or office pract$ or private pract$ or primary 
pract$ or nurse or nurses).tw. 
57. (pharmacist? or pharmacies or pharmacy).tw. 
58. hospital?.tw. 
59. physiotherapist.mp. 
60. midwife.mp. 
61. health care centre.mp. 
62. dietician.mp. 
63. health care provider.mp. 
64. general pract$.tw. 
65. psychologist.mp. 
66. psychiatrist.mp. 
67. exp Group practice/ 
68. exp benchmarking/ 
69. exp Institutional practice/ 
70. exp Physician’s Practice Patterns/ 
71. exp private practice/ 
72. exp family practice/ 
73. exp physicians/ 
74. exp Physicians, family/ 
75. exp professional practice/ 
76. exp nurses/ 
77. exp nurse clinicians/ 
78. 67 or 63 or 53 or 71 or 70 or 68 or 48 or 77 or 72 or 65 or 55 or 74 or 50 or 75 or 64 or 57 or 61 or 51 
or 58 or 69 or 52 or 59 or 60 or 49 or 56 or 73 or 66 or 76 or 62 or 54 
79. 7 and 19 and 78 and 47 
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Appendix 3. PsycINFO search strategy 
(OVID) 
 
Syntax guide 
/ - index term (APA thesaurus) 
exp - explode: includes narrower terms to the index term being exploded 
.tw. - text word in title or abstract fields 
$ - truncation/wild card: adds no or more characters 
? - truncation/wild card: adds no or one character 
# - truncation/wild card: retrieves alternative single character 
adjx - adjacency: required words are adjacent to each other, or within x words of each other 
.pt. - publication type 
 
Description of search strategy 
1. random$.tw. 
2. multicenter study.tw. 
3. randomized controlled trial.tw. 
4. clinical trial.tw. 
5. intervention studies.mp. 
6. experiment$.tw. 
7. (time adj series).tw. 
8. (pre test or pretest or (posttest or post test)).tw. 
9. random allocation.mp. 
10. impact.tw. 
11. intervention?.tw. 
12. chang$.tw. 
13. evaluation studies.mp. 
14. evaluat$.tw. 
15. effect?.tw. 
16. compar$.tw. 
17. comparative studies.mp. 
18. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 
19. editorial.tw. 
20. letter.tw. 
21. comment.tw. 
22. 21 or 19 or 20 
23. animals.mp. 
24. humans.mp. 
25. 23 not 24 
26. 22 or 25 
27. 18 not 25 
28. Consumer Satisfaction.mp. 
29. patient preferences.ab,ti. 
30. public reporting.tw. 
31. consumer reports.ab,ti. 
32. decision making.ab,ti. 
33. choice behaviour.ab,ti. 
34. 33 or 32 or 28 or 30 or 31 or 29 
35. quality assurance, health care.mp. 
36. benchmarking.mp. 
37. process assessment.mp. 
38. outcome assessment.mp. 
39. Quality Indicators.mp. 
40. performance outcome.ab,ti. 
41. (quality adj2 indicator?).tw. 
42. (quality adj (criteria or criterion or standard? or norm)).tw. 
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43. (performance adj (indicator? or measure? or data or rating)).tw. 
44. disclosure.mp. 
45. Information Services.mp. 
46. report card.ab,ti. 
47. quality information.ab,ti. 
48. public information.ab,ti. 
49. consumer information.ab,ti. 
50. patient information.ab,ti. 
51. 35 or 50 or 39 or 40 or 36 or 41 or 48 or 47 or 38 or 42 or 49 or 46 or 45 or 37 or 43 or 44 
52. 27 and 34 and 51 
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Appendix 4. CINAHL search strategy 
EBSCO 
 
Syntax guide 
MH - CINAHL subject heading 
MM - CINAHL major subject heading 
+ - explode: includes narrower terms to the index term being exploded 
TI - word in the title field 
AB - word in the abstract field 
* - truncation/wild card: adds no or more characters 
Nx - adjacency: required words are adjacent to each other, or within x words of each other 
PT - publication type 
 
Description of search strategy 
1. MM “Clinical Trials” 
2. TI control* or AB control* 
3. TI random* or AB random* 
4. MM “Comparative Studies” 
5. TI experiment* OR AB experiment 
6. TI time N2 series or AB time N2 series 
7. TI impact OR AB impact 
8. TI intervention* OR AB intervention* 
9. Ti evaluat* OR AB evaluat* 
10. TI effect? OR AB effect?* 
11. “Pretest-Posttest Design+” 
12. “quasi-experimental studies+” 
13. or/1-12 
14. SO cochrane database of systematic reviews 
15. 13 not 14 
16. MM “Quality of Health Care” or MM “Quality of Nursing Care” 
17. MM “Benchmarking” 
18. MM “Process Assessment (Health Care)” 
19. MM “Outcome Assessment” 
20. TI performance outcome OR AB performance outcome 
21. TI quality information OR AB quality information 
22. TI patient information OR AB patient information 
23. TI consumer information OR AB consumer information 
24. TI public information OR AB public information 
25. TI public reporting OR AB public reporting 
26. TI disclosure OR AB disclosure 
27. MM “Quality of Health Care” 
28. MM “Consumer Satisfaction” 
29. TI patient preferences OR AB patient preferences 
30. TI consumer reports OR AB consumer reports 
31. TI decision making OR AB decision making 
32. TI choice behaviour OR AB choice behaviour 
33. Ti ’provider profiling’ or AB ‘provider profiling’ 
34. TI report card or AB report card 
35. S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24 or S25 or S26 or S34 
36. S27 or S28 or S29 or S30 or S31 or S32 or S33 
37. S15 and S35 and S36 (exclude Medline records) 
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Appendix 5. DARE & CENTRAL search strategy 
COCHRANE 
 
(PrimaryHealthCare)OR (Hospitals)OR (Health Personnel)OR (physicians)OR (Nurses)OR (Professional 
Practice/)OR (Physician‘s Practice Patterns) OR (Institution Practice) OR (Nurse Clinicians)OR 
(Pharmacists) OR (Pharmacy) OR (Physiotherapist) OR (Midwife):ti,ab,kw, in Clinical Trials 
AND 
(Consumer Satisfaction/ OR patient preferencesOR public reporting OR consumer reportsOR decision 
making OR choice behaviour OR choice behaviour OR exp “Patient Acceptance of Health Care”/ OR 
’provider profiling’), in Clinical Trials 
AND 
(quality assurance, health care/)OR(benchmarking)OR(Quality Indicators,HealthCare/) 
OR(disclosure/)OR(Information Services/) OR (report card.ab,ti.) OR (performance outcome.ab,ti.) OR 
(“Outcome Assessment (Health Care)”/) in Clinical Trials, in Clinical Trials 
 
Public release of performance data in changing behaviour 
111 
Appendix 6. Criteria for full-text screening 
 
Nr: 
Review author: 
 Yes No Doubt Comments 
Design: randomised controlled trials, quasi-randomised 
trials, controlled before-after studies, interrupted time 
series 
   Crucial; score: ‘no’ or 
‘doubt’ = exclusion 
Types of participants: health care providers and 
professionals, including organisations e.g. hospitals, 
practice, patients, health care insurance companies, 
health plans 
   All participants are 
important for us, at least 
1 type should be central in 
the study 
Types of intervention: participant is exposed to 
performance information (see*) 
 Process measures (e.g. waiting times) 
 Healthcare outcomes (e.g. mortality) 
 Structure measure (e.g. presence of waiting rooms) 
 Patient experiences (like CAHPS) 
 Expert of peer-assessed measures 
    
Types of outcome measures: 
Primary outcomes: 
 Consumer choice of healthcare provider (public and 
patients) 
 Healthcare professional choice of healthcare provider 
 Purchasers choice of healthcare provider 
 Objective measures of provider performance, including 
those that were made public and others that were not 
 Valid measures of staff morale or behaviour (“valid” 
defined as having the development of the assessment 
tool reported in a peer reviewed journal) 
Secondary outcomes:  
 Awareness, attitude, views, knowledge in all target 
groups 
 Costs 
   There should be a 
description of at least one 
primary outcome. Only 
one secondary outcome 
measure is insufficient. 
 
TEMPORARILY INCLUSION    Hypothetical behaviour = 
exclusion 
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Appendix 7. Data collection form 
 
Systematic review: the effectiveness of the public release of performance data in changing 
consumer, healthcare professional or organisational behaviour 
(Comments can be made either at the question itself or on a separate sheet (please specify question 
number) 
 
Name review author: 
Date: 
 
Article: 
ID article: 
Title: 
Authors: 
Source + year: 
Article found in: 
MEDLINE 
EMBASE 
CINAHL 
PsycINFO 
Cochrane 
Other (please specify): 
Unclear 
Study period: 
 
Study design: 
The design of the study is (state which): 
Controlled experimental: randomised controlled trial (RCT) 
If the author(s) state explicitly (usually by some variant of the term ‘random’ to describe the 
allocation procedure used) that the groups compared in the trial were established by random 
allocation, then the trial is classified as a ‘RCT’ (randomised controlled trial). 
Controlled experimental: controlled clinical trial (CCT) or quasi-randomised studies 
If the author(s) do not state explicitly that the trial was randomised, but randomisation cannot be 
ruled out, the report is classified as a ‘CCT’ (controlled clinical trial). The classification ‘CCT’ is where 
the method of allocation is known but is not considered strictly random, and possibly quasi-randomised 
trials. Examples of quasi-random methods of assignment include alternation, date of birth and medical 
record number. 
Controlled experimental: controlled before-after study (CBA) 
Involvement of intervention and control groups other than by random process, and inclusion of baseline 
period of assessment of main outcomes. 
There are two minimum criteria for inclusion of CBAs in EPOC reviews: at least two intervention sites 
and two control groups are chosen to be similar in respect of the main outcome measures at baseline. 
Study and control sites are comparable with respect to dominant reimbursement 
system, level of care, setting of care and/or academic status. 
Uncontrolled observational: interrupted time series (ITS) 
A change in trend attributable to the intervention. There are two minimum criteria for inclusion of ITS 
designs in EPOC reviews: clearly defined point in time when the intervention occurred. At least three 
data points before and three after the intervention. 
Classification of study quality: 
For all study designs 
Quality criteria  N/A 
a) The objective measurement of performance/provider behaviour or patient (health) outcomes 
 Done  Not clear  Not done  Page: 
b) Relevant and interpretable data presented or obtained 
 Done  Not clear  Not done  Page: 
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For RCT and CCT 
Quality criteria  N/A 
1. Concealment of allocation (protection against selection bias) (the unit of allocation was by 
institution, team or professional and any random process is described explicitly, e.g. the use of random 
number tables, OR the unit of allocation was by patient or episode of care and there was some form of 
centralised randomisation scheme, an on-site computer or sealed opaque envelopes were used) 
 Done  Not clear  Not done   
2. Follow-up of professionals (if outcome measures obtained for 80% to 100% of health professionals 
randomised in the study, do not assume 100% follow-up unless stated explicitly) 
 Done  Not clear  Not done   
3. Follow-up of patients (if outcome measures obtained for 80% to 100% of subjects randomised or for 
patients who entered the trial, do not assume 100% follow-up unless stated explicitly) 
 Done  Not clear  Not done  Page: 
4. Blinded assessment of primary outcome(s)∗ (if the authors state explicitly that the primary 
outcome variables were assessed blindly OR the outcome variables are objective, e.g. length of hospital 
stay, drug levels assessed by a standardised test, medical records used) 
 Done  Not clear  Not done  Page: 
5. Baseline measurement (if performance or patient outcomes were measured prior to the 
intervention, and no substantial differences were present across study groups) 
 Done  Not clear  Not done   
 N.A.    
6. Reliable primary outcome measures (if two or more raters with at least 90% agreement or kappa $ 
0.8 OR the outcome is obtained form some automated system, e.g. length of hospital stay, drug levels 
assessed by a standardised test) 
 Done  Not clear  Not done  Page: 
7. Protection against contamination (if allocation was by community, institution or practice and it is 
unlikely that the control group received the intervention) 
 Done  Not clear  Not done  Page: 
∗ If it is a self administered questionnaire: than it is not blinded. Not clear: contact authors 
 
For CBA 
Quality criteria  N/A 
1. Contemporaneous data collection (if data collection was conducted at the same time as pre and 
postintervention periods for study and control activities or sites) 
 Done  Not clear  Not done  Page: 
2. Baseline measurement (if performance or patient outcomes were measured prior to the 
intervention, and no substantial differences were present across study groups) 
 Done  Not clear  Not done  Page: 
3. Baseline characteristics are similar for two intervention sites &two control groups in respect of 
the main outcome measures 
 Done  Not clear  Not done  Page: 
i. Characteristics for studies using second site (if characteristics of study and control providers (or 
patients) are reported and similar) 
 Done  Not clear  Not done 
 N.A.  
Page: 
ii. Characteristics for studies using untargeted activities as controls (if study and control activities are 
comparable with respect to characteristics of targeted behaviour) 
 Done  Not clear  Not done  
 N.A. 
Page: 
iii. Characteristics for studies using patients as control (if characteristics of study and control 
providers (or patients) are reported and similar) 
 Done  Not clear  Not done 
 N.A.  
 
 
 
Page: 
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Quality criteria  N/A 
4. Reliable primary outcome measures (if two or more raters with at least 90% agreement or kappa $ 
0.8 OR the outcome is obtained form some automated system, e.g. length of hospital stay, drug levels 
assessed by a standardised test) 
 Done  Not clear  Not done  Page: 
5. Follow-up of professionals (if outcome measures obtained for 80% to 100% of health professionals 
randomised in the study, do not assume 100% follow-up unless stated explicitly) 
 Done  Not clear  Not done  Page: 
6. Follow-up of patients (if outcome measures obtained for 80% to 100% of subjects randomised or for 
patients who entered the trial, do not assume 100% follow-up unless stated explicitly)  
 Done  Not clear  Not done  Page: 
7. Protection against contamination (if allocation was by community, institution or practice and it is 
unlikely that the control group received the intervention) 
 Done  Not clear  Not done  Page: 
i. Characteristics for studies using second site (if characteristics of study and control providers (or 
patients) are reported and similar) 
 Done  Not clear  Not done  Page: 
ii. Characteristics for studies using untargeted activities as controls (if study and control activities are 
comparable with respect to characteristics of targeted behaviour) 
 Done  Not clear  Not done  Page: 
iii. Characteristics for studies using patients as control (if characteristics of study and control 
providers (or patients) are reported and similar) 
 Done  Not clear  Not done  Page: 
 
For ITS 
Quality criteria  N/A 
1. Clearly defined point in time when the intervention occurred. 
 Done  Not clear  Not done 
 N.A.  
Page: 
2. Protection against secular changes: 
i. Intervention is independent of other changes (if the intervention occurred independent of other 
changes in time) 
 Done  Not clear  Not done  Page: 
ii. Sufficient data points to enable reliable statistical inference (if at least 3 data points are recorded 
before and 3 data points recorded after the intervention) 
 Done  Not clear  Not done  Page: 
iii. Formal test for trend (if formal test for change in trend using appropriate method is reported (e.g. 
Cook & Campbell ’79) 
 Done  Not clear  Not done Page: 
3. Protection against detection bias: 
iv. Data collection is identical before and after intervention (if reported that sources and methods of 
data collection identical before and after intervention) 
 Done  Not clear  Not done  Page: 
v. Intervention unlikely to affect/bias data collection ( if reported that the intervention unlikely to 
affect data collection directly) 
 Done  Not clear  Not done Page: 
vi. Blinded assessment of primary outcome(s) (if the authors state explicitly that the primary outcome 
variables were assessed blindly OR the outcome variables are objective, e.g. length of hospital stay, 
drug levels assessed by standardised test) 
 Done  Not clear  Not done  Page: 
4. Completeness of data set (if data set covers 80% to 100% of total providers and episodes of care in 
study area) 
 Done  Not clear  Not done  Page: 
5. Reliable primary outcome measure(s) (if two or more raters with at least 90% agreement or kappa $ 
0.8 OR the outcome is obtained from some automated system, e.g. length of hospital stay, drug levels 
assessed by standardised test) 
 Done  Not clear  Not done  Page: 
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Risk of bias tables of studies with a separate control group (RCTs, CCTs, CBAs) 
Risk of bias Item Judgement Description 
Sequence generation Y/N/?  
Allocation concealment Y/N/?  
Baseline outcome measurements similar Y/N/?  
Baseline characteristics similar Y/N/?  
Incomplete outcome data Y/N/?  
Knowledge of the allocated interventions 
adequately prevented during the study 
Y/N/?  
Protection against contamination Y/N/?  
Selective outcome reporting Y/N/?  
Free of other bias Y/N/?  
 
Risk of bias tables of interrupted time series studies 
Risk of bias Item Judgement Description 
Intervention independent of other changes Y/N/?  
Shape of the intervention effect pre-specified Y/N/?  
Intervention unlikely to affect data collection Y/N/?  
Knowledge of the allocated interventions 
adequately prevented during the study 
Y/N/?  
Incomplete outcome data adequately addressed Y/N/?  
Selective outcome reporting Y/N/?  
Free of other bias Y/N/?  
 
Characteristics of study 
Type of participants 
 Patients/consumers/providers/purchasers (Medicaid enrollees) 
  Page 
Number   
Patient/consumer/client  patient  Client/consumer  
Gender  Male 
 Mixed 
 Female  
Age   
Clinical problem   
Other characteristics 1.1.1.1  
 
 Hospitals   
  page 
Number   
Size   
   
Other characteristics 1.1.1.2  
 
 Referring physicians  
  page 
Number   
Gender   
Age   
Clinical specialty   
Referring to  Primary care  Secondary and/or tertiary care 
Other characteristics   
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 Purchasers of health care: insurance companies  
  page 
Private or state?  private 
 state 
 
HMO  yes  
 nol 
 
Collective  yes 
 no 
 
Company that buys care 
from employees 
 yes 
 no 
 
Other    
 
Setting of care 
 General practice 
 Outpatient clinic 
 Community care 
 Hospital/inpatient 
 Disabled/inpatient 
 Elderly 
 Any care setting 
 Other (please specify): Medicaid health plans 
Country 
 North America, including USA and Canada 
 South America 
 Europe 
 Australia or New Zealand 
 Asia 
 Africa 
 Unclear/not specified 
 
Type of control intervention 
 Usual setting 
 Other efforts on quality improvement 
 
Type of intervention: participant is exposed to performance information 
All based on actual data 
Content of performance information 
 Process measures (e.g. waiting times) 
 Patient outcomes (e.g. mortality) 
 Structure measure (e.g. presence of waiting rooms) 
 Patient experiences (like CAHPS ) 
 Expert or peer-assessed measures 
 Other, specify…(‘report cards’) 
 
Description of intervention for both intervention and control groups 
Intervention group: Control group: 
Duration of the intervention: Duration of the intervention: 
Intensity: Intensity: 
Duration of follow-up: Duration of follow-up: 
 Not clear  Not clear 
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Information dissemination 
  Intervention Page Control Page 
Way of data presentation (numerical, graphical, pictorial summary, star 
ratings...) 
        
How is information made available to the participants 
(personal mailing, journal article, active or passive dissemination) 
        
Who disseminated the data?         
 
Outcome measures 
Selection: 
 Changes in the healthcare utilisation decisions of consumer (public and patients) 
 Changes in the healthcare utilisation decisions of healthcare professional 
 Changes in the healthcare utilisation decisions of purchasers 
Specify: 
 Choosing the best health plans 
 Choosing the best healthcare provider (individual physician) 
 Choosing the best healthcare provider (organisation) 
 Referring to high quality care provider (individual physician) 
 Referring to high quality care provider (organisation) 
 Other….. 
Changes in care: 
 Objective measures of provider performance, including those that were made public and others 
that were not 
 Valid measures of staff morale or behaviour (’valid’ defined as having the development of the 
assessment tool reported in a peer 
 reviewed journal) 
 Other (for example: number of quality improvement efforts): 
......................................................... 
Attitudes/knowledge/views/understanding/beliefs etc.: 
 Awareness of information (recall receiving & seen information) 
 Comprehension of quality of care information (do they understand 
the information?) 
 Knowledge about quality of care (’know who is best’) 
 Believes regarding quality of care information (e.g. trust, 
usefulness, appreciation) 
 Costs versus quality consideration 
 Other………………………………….. 
            
 
Data analyses and results 
How is outcome data collected? 
Number of observations for primary outcome measure 
Proportion of subjects of study who 
participate out of the total number in 
the sampling frame (response rate) 
100%  Not clear (information is not available 
Number of drop-outs   Not clear  Not applicable 
Reason for drop-out mentioned?  yes  no  Not clear  N.A. 
Confounder or case-mix correction 
applied? 
 yes  no  Not clear  partially 
If Yes: for which variables was corrected? (for example: hospital size) 
Data analysis technique (s): 
State the main results of the main outcome measure(s), for each group (pre- and post values; 
intervention and control groups), in natural units (mean, SD, n) 
State the corrected intervention effects (mean, 95% confidence interval, P values) 
Describe the main study conclusion 
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1.Were the conclusions made by the author(s) supported by 
the data and/or the analysis reported in the article? 
Yes 
  
No 
  
Can’t tell/partially 
  
2.What of the following is applicable to this study? 
a) Conclusions inconsistent with results 
b) Conclusions go beyond the data 
c) No evidence interpreted as no effect 
d) Implications for research inconsistent with identified 
shortcoming 
Yes 
  
  
  
  
 
No 
  
  
  
  
 
Can’t tell/partially 
  
  
  
  
 
3.Overall (1-2), how would you rate the methods used to 
analyse the findings relative to the primary question addressed 
in the study? 
 Major limitations 
 Moderate limitations 
 Minor limitations 
  
Comments  
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ABSTRACT 
Background: Comparative performance information (CPI) about the quality of hospital 
care is information used to identify high-quality hospitals and providers. As the 
gatekeeper to secondary care, the general practitioner (GP) can use CPI to reflect on 
the pros and cons of the available options with the patient and choose a provider best 
fitted to the patient’s needs. We investigated how GPs view their role in using CPI to 
choose providers and support patients. 
Method: We used a mixed-method, sequential, exploratory design to conduct 
explorative interviews with 15 GPs about their referral routines, methods of referral 
consideration, patient involvement, and the role of CPI. Then we quantified the 
qualitative results by sending a survey questionnaire to 81 GPs affiliated with a 
representative national research network. 
Results: Seventy GPs (86% response rate) filled out the questionnaire. Most GPs did not 
know where to find CPI (87%) and had never searched for it (94%). The GPs reported 
that they were not motivated to use CPI due to doubts about its role as support 
information, uncertainty about the effect of using CPI, lack of faith in better outcomes, 
and uncertainty about CPI content and validity. Nonetheless, most GPs believed that 
patients would like to be informed about quality-ofcare differences (62%), and about 
half the GPs discussed quality-of-care differences with their patients (46%), though 
these discussions were not based on CPI. 
Conclusion: Decisions about referrals to hospital care are not based on CPI exchanges 
during GP consultations. As a gatekeeper, the GP is in a good position to guide patients 
through the enormous amount of quality information that is available. Nevertheless, it 
is unclear how and whether the GP’s role in using information about quality of care in 
the referral process can grow, as patients hardly ever initiate a discussion based on 
CPI, though they seem to be increasingly more critical about differences in quality of 
care. Future research should address the conditions needed to support GPs’ ability and 
willingness to use CPI to guide their patients in the referral process. 
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BACKGROUND 
As comparative performance information (CPI) about healthcare service, patient 
experiences, and quality of clinical care becomes increasingly available, questions 
about its use arise, as do questions about general practitioner (GP) views of CPI at the 
time of referral. In healthcare systems where the GPs are the gatekeepers of secondary 
care, which they are in the Netherlands and the UK, GPs refer their patients to 
specialists for further examination, diagnosis, or treatment. In doing so, they play an 
important intermediary role between patient and hospital.1-3 International studies have 
shown that the referral is traditionally affected by previous experiences with 
specialists, perceptions of specialists’ interactions with patients, office location, 
specialists’ medical skills, and patient preferences.4-7 These traditional considerations 
are all understandable. The current focus on the patient’s choice of healthcare 
provider, with CPI for identifying the quality of provider performance8,9, calls for GPs 
to reflect anew on the current referral process. 
 
The patient’s involvement in choosing a healthcare provider in the Netherlands has 
been encouraged since regulated competition was introduced during the 2006 
healthcare system reform. Publicly available CPI introduced to encourage this 
competition, contains information about the performance, quality of care and is 
available for various providers10, also patient experiences plays an increasingly 
important role. The information covers items at the hospital level (patient volumes, 
inspection scores defined by the Dutch Health Care Inspectorate, which includes 
specific conditions such as waiting lists, treatment volumes, treatment methods, 
methods of anaesthesia, number of specialists treating a given condition, and patient 
experiences11.  
 
The CPI can make an impact when patients select providers of high-quality care on the 
basis of this kind of information. However, patients hardly use such information for 
selectively choosing a provider.12,13 Bringing such a choice into practice is a difficult 
and complex task for patients; e.g. they do not know how to set their own values.14,15 
The CPI can be difficult to interpret, especially when it contains conflicting criteria, 
shows multiplicity formats, or the presentation makes it difficult to understand.14,16,17 
Given the lack of CPI usage among patients for selectively choosing a provider, we are 
looking for ways to provide additional support for the patients. Schlesinger and 
colleagues advise providing advocates who can help patients with their choices of 
hospital and who can act on their behalf if they have difficulties putting their choices 
into practice.18 From the patient’s perspective, this advocate could be the GP. Patients 
do not seem to search for CPI themselves, but they do ask for advice when choosing a 
healthcare provider. The GP is an important advisor for about half the Dutch patients.19 
because patients consider their GP to be a reliable source of quality information.20 
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Dutch research confirms that GPs have significant influence in directing patients: 68% 
of the patients who searched for information to select a hospital noted that they based 
their final decision on GP advice.21 
 
Several studies have revealed how providers respond to performance information.22-25 A 
1996 study among cardiologists and cardiac surgeons shows that the publication of 
report cards for grafts bypassing the coronary artery has little credibility and therefore 
little influence on referral recommendations.25 A mixed group of physicians described 
several issues that made them sceptical of the data and concerned about using the 
information with patients.23 Further, it appears that quality-of-care data have little 
impact on referral decisions.22 This paper addresses the following research questions: 
 Can the GP be a choice-supporting advocate for helping patients use comparative 
performance information? 
 What are the current referral considerations? 
 What is the GP’s perception of patient involvement in referral decisions and the use 
of comparative performance information? 
 What factors constrain GPs in using comparative performance information in the 
referral process?  
 
We conducted explorative interviews to review their referral routines in which we 
included the current considerations, patient involvement, and the role of CPI in 
referral decisions. Using the results of these interviews, we designed and conducted a 
quantitative survey with a representative sample of Dutch GPs. 
 
METHODS 
Design 
We used a mixed-method, sequential, exploratory design.26 In this design, the 
qualitative element is considered first for exploring the research area, then the 
quantitative element is used to extend and quantify the qualitative results.26 The 
methods are integrated in three ways. First we focused on building, while the interview 
results are used in the data collection to build the survey.27 The second way was 
merging: we used both databases for analysis and comparison. Thirdly, we transformed 
qualitative data to quantitative data, then integrated the results with illustrative 
quotes28. A small part of the qualitative data was not transformed in the survey, though 
it will be used in the results. 
 
Participants 
For the explorative interviews, we recruited GPs from the Nijmegen University Network 
of General Practitioners and from a network of innovative primary care projects 
financed by a Dutch healthcare insurance company. The resulting survey questionnaire, 
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designed to quantify the issues raised in these interviews, was distributed among a 
sample of 81 primary care practices affiliated with a representative national network of 
general practices. Participation was voluntary, and no incentives were offered. The 
study has been carried out in the Netherlands in accordance with the applicable rules 
concerning the review of research ethics committees and informed consent. 
 
Explorative interviews 
We conducted explorative interviews with 15 GPs that focussed on referral routines 
related to three main issues, namely (1) referral considerations (which and why), (2) 
patient involvement in the referral process in general, and (3) the role of comparative 
performance information during referral in terms of knowledge about CPI, attitudes 
towards it, and actual usage behaviour. The first author (NK) interviewed all the GPs. 
The interviews lasted from 30 to 45 minutes. The interviews were audio-recorded and 
transcribed verbatim. Two researchers (NK and MF) analysed the transcripts. First, they 
read the interviews to obtain a comprehensive impression of the material. Second, the 
data were extensively and inductively coded. Indexing the data created a large number 
of codes that were repeatedly refined and reduced in several rounds.29 Third, with 
regard to the role of comparative performance information, a framework analysis was 
used to approach the data deductively. Cabana and colleagues developed the general 
guidelines for this framework for improvement.30 The use of CPI and the use of 
professional guidelines differ, though there is a resemblance in the way they both could 
be implemented. The successive steps helped us analyse the interviews, and we used 
them as a guide to present the results in the section ‘Use of comparative performance 
information’. Figure 1 shows the findings for this part of the interviews. We used the 
analysis software Atlas.ti.5.2 to facilitate the coding process.31 
 
Survey 
We built on the issues that arose in the interviews and transformed them into a survey 
questionnaire. The CPIrelated questions were added to the annual survey of the Dutch 
National Information Network of General Practice (LINH). The LINH has a nationally 
representative database maintaining longitudinal data derived from patients’ electronic 
medical records about consultations, morbidity, drug prescriptions, and referrals.32 The 
LINH consists of 81 general practices with approximately 335,000 patients. The data 
were collected between September and December 2012. The survey focused on GP 
considerations in the current referral process, GPs’ views towards patient involvement, 
GPs’ current experiences with patient involvement, and the role of comparative 
performance information in referral decisions. The seven items in GP considerations in 
current referrals were patient preferences, experiences of other patients, waiting lists, 
quality of care, specific treatment or techniques, patient travelling distance, and 
personal contact with a specialist. The question ‘to what extent did the GP consider 
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these items in the decision to refer a patient’ was to be answered on a five-point Likert 
scale ranging from 1 (never) to 5 (always). 
Five points for patient involvement were formulated: (1) to what extent did GPs agree 
with patients’ needs for information about quality differences, (2) how often did 
patients refer to comparative performance information during consultations, (3) what 
were GPs’ evaluations of patients’ use of quality information about hospitals, (4) how 
did GPs perceive the ability of patients to decide on a hospital themselves, and (5) 
what about the GPs’ view that the use of CPI is the patient’s own responsibility? A five-
point rating scale ranging from 1 (totally disagree) to 5 (totally agree) was used. 
 
The main part was about the role of comparative performance information in referral 
decisions (21 items). The findings of Figure 1 about knowledge, attitude, and behaviour 
were listed in the items. The GPs were asked if they knew where to find information 
about quality of care, and whether they searched for CPI (both dichotomous variables). 
Ten statements about comparative performance information, containing the elements 
of attitude and behaviour, were developed. They included elements of quality-of-care 
differences between hospitals, GP use of comparative performance information to 
select a hospital, the GPs’ role and responsibility regarding the use of comparative 
performance information, effects of CPI on the continuity of care, time management 
regarding comparative performance information, and GP views of the use of CPI in the 
next 5 years. For the descriptive analyses, the ratings of these items were transformed 
into the percentages of GPs who agreed (rating of 4 or 5 on the Likert scale). Finally, 
GPs were asked to express their opinions about the currently available CPI with respect 
to credibility, transparency about how information was gained, contradictory sources, 
user friendliness, is it up to date, comprehensibility, the ability of CPI to show quality 
of care differences, connection to patients’ wishes, and the information content. A 
five-point scale ranging from 1 (totally disagree) to 5 (totally agree) was used; ‘Do not 
know’ was a separate option in a separate column. We gathered general practice 
characteristics about the locality of the practice (urbanization), number of patients in 
the practice, and the practice type (single or group practice). Background information 
about the GP included gender and the number of days a week the GP was available in 
the practice (part time or full time). The data are presented in terms of means (s.d.) or 
percentages (%). 
 
RESULTS 
The response rate of the survey was 86%. Table 1 presents the characteristics. 
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Table 1.  Characteristics of the 70 participating general practitioners and their practices 
 
 Number % 
GP characteristics   
 Male 55 80 
 Full-time GP 66 52 
Practice characteristics   
 Single-handed practice 38 54 
 Duo practice 12 17 
 Group practice 12 17 
 Healthcare centre   8 12 
Urbanization level   
 Very high 20 29 
 High 11 16 
 Moderate 14 20 
 Low 14 20 
 Rural 11 16 
 
Current referral considerations 
In the interviews, GPs spoke in great detail about their preference for using their own 
prior experiences and personal contacts with specialists or hospitals when considering 
their referral. Personal contacts were important to the GPs because they provide an 
opportunity to ask medical questions and to estimate colleagues’ interactions with 
patients. In contrast, the surveyed GPs stated that, in deciding about a referral, they 
primarily considered patients preferences for a hospital or a provider, then the quality 
of care, and then the distance from the patient’s home (Table 2). 
 
‘I mainly refer on personal grounds and experiences. This might be a really 
bad thing to do. Still, I think it works this way.’ (N 1) 
 
Table 2.  The importance of factors in the referral process for selecting a hospital or a specialist 
 
 Mean (SD) of the 70 responses 
Patients’ preferences for a hospital or provider 4.3 (0.7) 
Quality of care 3.8 (1.0) 
Patient’s travel distance to a hospital or provider 3.8 (0.9) 
GP’s personal contact with a specialist 3.6 (0.9) 
Waiting list 3.5 (0.8) 
Specific treatment or techniques 3.5 (0.8) 
Experiences of other patients 3.4 (1.0) 
The responses were given on a five-point Likert scale, with ‘5’ representing ‘always taken into 
consideration’, and ‘1’ as ‘never taken into consideration’. Sd: Standard deviation 
 
Patient involvement 
During the interviews, the GPs said that they always started by asking what the patient 
wanted, and they repeatedly highlighted the fact that when selecting a healthcare 
provider, patients valued other choice attributes than those reflected in CPI. The GPs 
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also noted that comparing providers and making a rational trade-off based on CPI are 
difficult tasks for patients. 
 
‘Familiarity with a hospital, distance, and knowing where to go: these are 
much stronger arguments for the patient than quality of care.’ (N 10) 
 
‘The mortality rates in hospital A are better than in hospital B, but A is a 
generic hospital while B is a top clinical one with an intensive care unit. For 
that reason, there is a greater chance that people will die in hospital B. The 
mortality rates show you the data, but you need to interpret them with the 
background information in your head. As a doctor I can do that, but 
patients?’ (N 6) 
 
There was a high level of agreement between the surveyed GPs about the importance 
of patients making their own hospital choice and needing to be informed about 
differences in quality of care (for both items, M=4.0; SD=0.8). There was less 
agreement about the statements that quality information about hospitals has added 
value for patients (M=3.0; SD=0.8) and that the use of CPI is a patient’s own 
responsibility (M=3.0; SD=0.7). There was little GP agreement about how often patients 
refer to CPI during consultations (M=2.3; SD=0.9). Approximately half the GPs (47%) 
agreed that they were ‘sceptical about patient use of CPI’ (M=3.0; SD=0.9). 
 
Use of CPI 
Knowledge 
Most GPs (83%) reported that they did not know where to find performance information 
to compare their regional hospitals. 
 
Attitude: motives 
The GPs varied widely in their attitude towards CPI. We distinguished four motives that 
shaped GPs’ negative attitudes towards the use of CPI. First, the GPs want the best 
care for their patients, and they doubt the role that CPI plays in supporting referral 
choices. They suggested that they would like to have a ‘tailored’ referral process 
because the extent of patient involvement in choosing a hospital varies. About half of 
the surveyed GPs (47%) agreed that they have a task in supporting patients’ hospital 
choice based on CPI. They recognized CPI as a type of information that can facilitate 
patient involvement in choosing a hospital. 
 
‘Patients want to steer their decisions.... When they are old and weak they 
say,‘Put me in the back seat and drive me to the nearest hospital.’ Other 
patients say,‘Sit next to me and tell me how, but I am the one who’s 
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driving.’ And there is a group of patients who ask,‘Where is the highway to 
the best specialist in this area?’ (N 14) 
 
A second motive reported in the interviews was that the use of CPI interferes with the 
GP’s professional role. The GPs felt responsible for an optimal referral and emphasized 
their role as coordinators. They expected patients to rely on their referral advice. 
Therefore, they needed to adjust to the idea that patients can now propose 
alternatives. They were afraid that patients could decide to go to hospitals outside 
their professional network as a result of CPI. This could increase the number of medical 
specialists GPs have to deal with and thereby impede communication since it is easier 
to talk to someone you know. The GPs also greatly valued patients’ anecdotal reports, 
so if the size of the professional network were to increase, these patient reports would 
become more difficult to interpret. 
 
‘When people came up with propositions to go elsewhere, I was unprepared. 
The way I was educated to deal with my profession as a GP - it was all about 
personal contact with specialists and providers, not about the arguments of 
performance information gathered elsewhere or waiting lists.’ (N 13) 
 
As a third motive in the interviews, the GPs expressed concerns regarding unintended 
consequences of using CPI during the referral process. This might limit the accessibility 
of certain types of care for those patients who could not easily choose to go elsewhere. 
Almost half the GPs surveyed (46%) agreed that referral based on CPI could increase 
fragmentation of care and threaten the continuity of care. 
 
‘You can be treated in many hospitals for all kinds of things, but you need 
to have some sort of continuity in your treatment, which often means you 
end up in the same hospital.’ (N 15) 
 
Fourth, during the interviews several GPs said that it would take too much time to 
remain up to date about the CPI for multiple conditions and for a range of patient 
groups, even though only a minority (23%) of surveyed GPs agreed that ‘the use of CPI 
takes too much time’. 
 
Attitude: outcome expectancy 
The GPs had doubts about the outcome expectancy for CPI. In the interviews, some 
questioned whether using CPI would lead to an improvement in quality of care. The 
surveyed GPs were also divided in their opinions about the differences in quality of care 
in hospitals: 66% disagreed with the statement that the quality of care varies greatly 
between hospitals. 
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Attitude: self-efficacy 
During the interviews, some GPs said they were unsure whether they could interpret 
CPI information and make a trade-off based on all the available information. The 
results in Table 3 show that it is difficult for GPs to interpret CPI information. 
 
‘It is really difficult to assess the quality of care provided by my colleagues, 
and they are in the same building! Not to mention colleagues elsewhere or 
specialists in the hospital. It is almost impossible to make good judgements 
about that.’ (N 8) 
 
Lack of agreement with content and validity elements 
The GPs had their doubts regarding both the content itself and the validity of CPI 
(Table 3). A fairly large proportion of the GPs said ‘I do not know’ when they were 
asked about various CPI elements. 
 
In the interviews, some GPs mentioned conflicts of interest. They felt that the sources 
on which CPI is based should include disclaimers about various aspects of data 
collection and validity, and that the sources should declare any conflicts of interest.  
 
‘I do not know about using CPI for referral decisions, but I get the feeling 
that I’m promoting a particular hospital.’ (N 9) 
 
Table 3.  General practitioners’ level of agreement about statements concerning outcome 
expectancy, content, and validity of comparative performance information 
 
Statements Totally agree/ disagree Do not know 
Mean (SD) % 
CPI is not transparent about how information is determined 3.6 (0.7) 18 
CPI is not clear because of contradictory sources 3.6 (0.7) 20 
CPI is not credible 3.2 (0.7) 20 
CPI is not in line with patients’ wishes 3.2 (0.6) 27 
CPI is difficult for patients to understand 3.3 (0.7) 21 
CPI is not specific enough 3.3 (0.7) 21 
CPI is not user friendly 3.3 (0.7) 23 
CPI gives the wrong choice attributes 3.2 (0.6) 20 
CPI is not up to date 3.1 (0.6) 28 
CPI has no ability to show differences in quality of care 3.0 (0.6) 20 
The 68 responses were given on a five-point Likert scale, with ‘5’ representing ‘Totally agree’ and ‘1’ 
representing ‘Totally disagree’. ‘Do not know’, was a separate sixth answer possibility. 
SD: Standard deviation 
 
Behaviour 
Most of the GPs (94%) declared that they had never searched for hospital performance 
information in their region; however, 12% reported that they had used CPI for selecting 
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a hospital. Further, approximately half the GPs agreed that they had discussed quality-
of-care differences between hospitals with their patients (M=3.2; SD=0.8). The GPs 
were undecided regarding the expectation that CPI will becomes a part of their referral 
advice within 5 years – only a minority agreed with this statement (M=3.0; SD=0.8). 
 
Interviewer: ‘Do you believe that patients will make more informed choices 
in the future?’ GP: ‘Frankly? No, I do not think so.’ (N 4) 
 
Environmental factors 
A lack of reimbursement, time to search for CPI, the small number of hospitals to 
choose from, and not having an electronic referral system containing CPI were 
mentioned in the interviews. About half the surveyed GPs (48%) noted that they lacked 
an electronic system to help them use CPI in the referral process. 
 
DISCUSSION 
Can the GP be a choice-supportive advocate for patients to overcome patients’ lack of 
CPI usage? Our study shows that we cannot expect that a GP can play an advocate’s 
role in the use of CPI. Currently, GP considerations at the point of referral are patient 
preferences, quality of care, and travel distance, and there is no role for CPI as an 
additional source. The GPs feel that patients should become more aware of quality 
differences in general. They do not believe that current CPI has any added value for 
patients. The GPs rarely see patients initiating a discussion about CPI during 
consultations, and most are sceptical about the ability of patients to use CPI. The GPs’ 
own use of CPI is hindered by several barriers, including indecisiveness about their role 
in supporting patients’ choices and their task in addressing CPI during consultations. 
 
Comparison with existing literature 
The healthcare reforms in north-western European countries have been designed to 
encourage a greater role for patients in choosing a provider and to spur providers on to 
support this choice. The purpose of this design is to increase the competition between 
providers for the benefit of the patients.33,34 Our results show that current practice 
does not yet support the concept of GPs acting as agents of patient choice and users of 
CPI. The GPs in our study rarely had patients who mentioned CPI during a consultation. 
To decide on a referral, the GPs focus on patient preferences informal sources (e.g. 
connections with specialists), their own previous experiences, and hospital distance 
from the patient’s home. Our study confirms various findings from the UK, Denmark, 
and the Netherlands.24,35-37 
 
The GPs feel responsible for coordinating care for their patients, but see no need for 
using CPI during the referral process. This is partly due to not knowing where to find 
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CPI, but there is also some ignorance regarding the content and outcome expectancy 
for CPI. This ignorance may influence the ratings they gave. In another study, GPs did 
not view CPI as a source of information.37 A precondition for this kind of CPI usage is 
the reliability of the information and its sources. As in other studies, our GPs reported 
distrust of the content and validity of CPI.16,23,25 As long as GPs do not trust CPI, other 
sources of information will remain more important in their referral considerations. 
 
Because CPI makes clear statements on quality differences and providers of high-
quality care, it can be seen as a powerful source of information for GPs in selectively 
choosing a provider as well as in being the patient’s advocate while interpreting and 
discussing the available data. Regarding selective choice of a provider, a recent Dutch 
study showed that GP referral patterns were unaffected by report cards, with the 
exception of outcome indicators for breast cancer.38 Thus, even if CPI highlights 
differences in the quality of care, GP referral decisions are not, or are hardly, 
affected. Consequently, the intended impact of CPI in enabling a selective choice of a 
provider is not achieved. 
 
Regarding the GP’s role as an advocate, it seems that patients hardly ever introduced 
CPI. On the basis of our results, we can question whether the GP would use CPI if the 
patient suggested it. A lack of knowledge and a certain unwillingness both seem to 
contribute to the GP’s not using this kind of information during the referral process. A 
recent study37 suggests an interaction between the GP’s use of CPI and patients’ use of 
publicly available CPI in the decision-making discussion about referral with their GPs. 
Hence, if patients were to approach their GPs with publicly available information about 
quality more often, their GPs would be more likely to have consulted CPI themselves. 
However, because the patients hardly use CPI, and GPs do not either, the status quo 
continues. A UK study has shown that none of their participating GPs initiated a 
discussion of differences between services with patients.18 Approximately half the GPs 
in our study said that they discussed quality of care differences with their patients. 
Given their responses, we see that these discussions are not based on publicity 
available CPI. It may be that patients, despite their not using CPI, may become 
increasingly critical about differences in quality of care. Ensuring that care quality 
becomes an issue in the patient consultation can be considered a ‘tipping point’ in the 
path towards the use of CPI in the referral process. 
 
Despite the GPs’ restraint towards CPI, leaving the choice of provider in the hands of 
the patient alone worried some GPs as well. In relation to the coordinator role, the GPs 
in our study feared a further fragmentation of care, as patients might, as a result of 
CPI, choose providers outside the reach of their professional network. This reasoning 
has been described in another study as well39, and it makes sense because it is difficult 
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to predict how and in which cases the benefits of using CPI and the choice of high-
quality providers outweigh the threats to continuity of care. New in our study is that 
GPs link this concern to their own professional role and to the potential  weakening of 
their professional network – they like to keep an overview in their role as the 
coordinators in the Dutch ‘gatekeeper’ system. 
 
Implications 
Our study has various implications: 
 GPs should discuss whether and how to act as supportive agents for their patients 
using CPI in a way that does justice to their feelings of responsibility, concerns, and 
practical conditions 
 Education of GPs about CPI, its measures, the methodology on which information is 
based, and the possible better outcomes, as well as teaching them how to discuss 
CPI with patients 
 CPI should be publicized and made available to GPs so that they become aware of 
the information, can access it easily, and recognize practice variation between 
hospitals 
 Time is required to improve patient engagement in referral discussions (e.g. longer 
consultations). 
 
Strengths and limitations 
One of this study’s strengths is the use of both qualitative and quantitative data. The 
GPs interviewed came from innovative and frontrunner general practices. Even though 
this might have affected the interview results, the participants were drawn from a 
representative sample of Dutch general practices.40 We therefore used the survey 
results to draw a picture of how Dutch GPs use CPI, while the interview results were 
used mainly to illustrate the quantitative findings. A limitation was the number of CPI-
related questions that could be added to the annual LINH survey. Therefore, not every 
item highlighted in the interviews could be added to the survey in order to quantify our 
findings. We focussed on the barriers that the GPs encountered without explicitly 
discussing facilitating factors. The GPs noted their intention to act in the patient’s best 
interests in the referral considerations, the importance of the free choice of provider 
for patients, and the discussion of quality of care with patients, though none of these 
factors included facilitators for the use of CPI. 
 
Conclusions 
General practitioners play a key role in referring patients to hospital care. Their 
decisions about referrals to hospital care are not based on systematically collected CPI 
because other referral considerations are more important. CPI is assumed to be an 
important factor in selective-referral behaviour, as is supporting the patient’s ability to 
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choose a provider of high-quality care by offering more transparency. Despite policy 
measures that encourage selectively choosing a provider and the expectations that both 
patients and GPs will make an active and informed choice based on the increasing 
availability of CPI, both are in a preliminary phase of using this data. Whether and how 
the GP’s roles in CPI use and patient support should be actively stimulated and 
supported is still to be determined. 
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This thesis focuses on the conditions that affect healthcare consumers’ search for and 
use of comparative performance information (CPI). Healthcare consumers that are 
often imperfectly informed and make choices that are inconsistent with their 
preferences. CPI has been developed and introduced to help consumers choose a 
healthcare provider that matches their needs and preferences. Such information can be 
simultaneously used to drive healthcare providers to improve the quality of care. We 
address three themes in this thesis: search triggers, choice behaviour, and professional 
guidance.  
 
Figure 1. Three themes in this thesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The research questions are:  
 What are the barriers and facilitators for healthcare consumers to search for and 
use CPI? 
 To what extent does publicly released performance information change the choice 
behaviour of healthcare consumers, providers, and purchasers? 
 To what extent do GPs advocate choice and encourage patients to choose providers 
on the basis of CPI? 
 
SEARCH TRIGGERS  
Main findings 
Consumers and their choice of healthcare providers (Chapter 2) 
 Most consumers are unfamiliar with CPI. 
 After CPI has been introduced, consumers indicate that they value other sources 
more than CPI, e.g. personal experience. 
search  
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 Consumers doubt the reliability of CPI because the information from different 
sources is often inconsistent. 
Patients choosing a hospital for a primary hip or knee surgery (Chapter 3) 
 A minority of patients search for CPI. 
 Patients who expect differences in quality of care are significantly more likely to 
search for CPI than those who do not expect such differences. 
 Patients expect quality differences (mainly in general hospital characteristics such as 
reputation, distance, and accessibility) rather than treatment differences (in hip 
and knee surgery, for example). 
Referral of patients with Parkinson disease to a physiotherapist (Chapter 4) 
 Most participants with Parkinson disease take the referring provider’s advice, though 
this advice is rarely accompanied by supporting arguments or data.  
 The willingness to switch to an expert physiotherapist increases significantly when 
patients recognize the added value of the specific expertise. 
 About half of the patients consider their own physiotherapist to be an expert, which 
probably reduces their motivation to search for CPI. 
 
Only a minority of the healthcare consumers search for CPI about hospitals or 
healthcare providers.1-6 The literature reports some factors that do not stimulate a 
search for CPI; some of these factors can be addressed with an adequate intervention, 
while others are more or less fixed. Modifiable factors include the lack of awareness 
that CPI is available7-13 and the availability of an acceptable alternative provider in the 
proximity of one’s community. Fixed factors include the characteristic that women are 
more prone to search than men and the fact that a long-term health condition 
correlates with more consumer searching.6  
 
The results of this thesis highlight three triggers that affect searching for CPI: the value 
of CPI versus the importance of other sources, consumers’ expectations of variation of 
care quality, and consumers’ recognition of expertise differences among providers. 
These three search triggers can be helpful in understanding why CPI is underused. 
Other studies that sought reasons for the lack of CPI usage focus on how CPI is 
presented or what the content of CPI should be from the consumer’s point of view. In 
this thesis, the focus is on an earlier phase, namely the search triggers. Knowing that 
consumers have an interest in choosing the best doctor makes one wonder why CPI is 
used so little. 
 
The value of CPI versus the importance of other sources 
As consumers hardly value CPI, they likely feel no need to search for it (Chapter 2). 
People are inclined to ignore less meaningful information.14 In choosing healthcare, 
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consumers seem to value other sources more than CPI. Existing research already states 
that the impact of informal views of quality of care views of family members and 
friends as well as familiar authorities such as the GP, and local reputation counts more 
for most people than CPI does.15-21 The consumers use often their own personal 
experience to choose a healthcare provider, and also habit plays an obvious role in 
this.13,22-24 A new information source such as CPI should be perceived as a source with 
added value. New in our focus group study is the extent of and insight into many of the 
consumers’ underlying values and principles. Our findings suggest that the consumers 
were not really interested in CPI, and the currently formulated CPI was too abstract 
and not very relevant, so it seemed invaluable for them. It is debatable whether and 
how CPI can be become a source alongside other sources that is meaningful. Some 
studies illustrate the power of anecdotal narratives and suggest that the CPI should  be 
given a more story-telling form25,26, in which case the information would reflect more 
of the information from the informal network. Then it would be richer in meaning and 
emotional nuance.27 There is a growing interest in testing how to collect and insert 
these narratives into healthcare providers’ CPI as well as how to display this material 
on websites.13 Consumers are apparently only minimally aware that CPI exists, and CPI 
as currently formulated seems to be irrelevant to them.  
 
Consumers’ expectations about differences in care quality 
Healthcare consumers search more for CPI when they expect to find variations in care 
quality (Chapter 3). Our study is one of the first that shows how patients’ expectations 
of quality of care affect the search for CPI. The finding is consistent with two other 
studies that suggest that a key component in public reporting is showing consumers that 
variation in quality is meaningful.28,29 So far, patients’ expectations of healthcare and 
variation in quality of care seem to be underexposed in public reporting. We found that 
the quality differences patients expected were oriented less toward the treatment-
related performance indicators and more toward general issues such as reputation, 
distance, and accessibility. Thus, the trigger to search could become stronger if the 
patient were more aware of differences in treatment quality. The previous examination 
of consumers’ interest in different types of indicators produced mixed results. Some 
report that consumers are far more likely to focus on technical aspects of care than on 
interpersonal skills and services30, while others suggest the opposite pattern31, or no 
pattern at all; in short, all aspects seem equally important.7 Perhaps the clinical setting 
or the specific condition as suggested in a narrative review of the concept and 
measurement of patient expectations of quality32 could explain some of these 
differences. The authors also question the robustness of the measurement and plead 
for more research into the measurement itself. Although we do need more research 
into the measurement and the determinants of consumers expectations about 
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differences in quality of care, awareness of quality differences is a trigger for the 
search for quality information.  
 
Consumers’ recognition of expertise among providers  
An interesting finding of our study of patients with Parkinson’s disease is that the 
recognition of the value of an expert physiotherapist motivated some patients to search 
for CPI (Chapter 4). As described in Chapters 2 and 3, most patients did not use CPI to 
choose a healthcare provider, or in this study, specifically a physiotherapist. Chapter 3 
reveals that expert awareness, just as knowledge, of quality differences motivates 
consumers to search for quality information. This awareness also seems to lead to 
actual behaviour. Although recognizing the value of an expert physiotherapist increased 
their willingness to switch physiotherapists, half the patients still wanted to continue 
the visits to their own current physiotherapist. Moreover, they characterized their own 
physiotherapist as an expert. The phenomenon is linked to the consideration presented 
elsewhere that your ‘own’ hospital or provider is the best.5,33 It is unlikely and 
unrealistic that patients think critically about possible mistakes in ‘their’ hospital.17 
Even when they are confronted with quality differences in healthcare services, being 
aware of that motivated only half the patients with Parkinson disease to search for CPI. 
 
The studies of search triggers show that awareness of quality differences and 
availability of expertise can be a trigger for consumers to search for CPI, but when they 
were confronted with the currently available CPI, they were sceptical. The consumers 
see current CPI as rather abstract and irrelevant (low value), so they prefer more local 
patterns and use reputation to choose between healthcare services. To increase its 
value, CPI should be adjusted more towards the needs of the consumers. In exploring 
this direction, the following finding should be taken into account. The study in Chapter 
2 reveals that becoming doubtful about the quality of certain aspects of care that 
consumers originally thought was good causes anxiety and distrust. This issue has been 
pointed out.34 It stirs up the discussion about trust versus control in healthcare. 
Transparency gives a certain kind of control, but it can also harm certain aspects of 
trust.35 This is not a plea to abolish public availability of quality information, but to 
balance the kind of quality information published publicly against the trust of 
healthcare consumers in the competencies of the healthcare provider.  
 
CHOICE BEHAVIOUR 
Main findings (Chapter 5) 
 The review of the literature shows almost no effect of CPI on behaviour neither via 
selection nor via improving the quality of care. The effects shown lasted no longer 
than two months. 
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 The level of evidence from the prospective studies was low: only four of 6839 studies 
were eligible for inclusion. 
 
CPI and behavioural changes in healthcare performance: the underlying mechanism 
Much has been invested in the development and provision of CPI since the early 1990s. 
However, a systematic review as presented in Chapter 5 about the effects of the public 
release of CPI on changing behaviour of healthcare consumers, providers, and 
purchasers was lacking. It is often assumed that the information will affect and 
facilitate decisions and behaviours of various parties and will ultimately improve the 
healthcare system. Berwick and colleagues describe two pathways of how public 
reporting can lead to performance change, improvement of quality of care.36 The first 
pathway, ‘selection’, represents the mechanism in which consumers can vote with their 
feet. Since consumers choose healthcare services on the basis of quality, healthcare 
providers are tempted to improve their performance to avoid losing customers. The 
second pathway, ‘change’, represents the mechanism of benchmarking and mutual 
comparison. Knowing that their group is lagging behind motivates healthcare providers 
to improve work procedures and professional culture.  
 
New material 
Since the review was published in 2011 and most studies were conducted in a rather 
dynamic era of early development, we wondered whether more recent studies were 
available able to produce additional insights. In the context of the general discussion of 
this thesis, we started a narrative search of the MEDLINE (Ovid) database (15 January 
2015) with the same search strategy as used earlier in Chapter 5. Only one database 
was searched instead of five in the original review process. The search identified 996 
relevant papers in the period of April 2011 to January 2015. Eleven studies qualified for 
a full text analysis, and five of them will most likely fit in an update of the Cochrane 
review. Thus, the narrative search shows that, despite a growing number of papers 
published in recent years, the number of new studies that bring us additional evidence-
based information is still limited. The two main reasons for exclusion were once again a 
lack of description of the primary outcome measure and deficiencies in the study 
design. Four studies we found in this narrative search focused on only one of the 
pathways. Only one paper focussed on a combination of both pathways. The five 
studies included are listed in Table 1. Two papers studied the pathway of selection. 
One study of the impact of public reporting of surgery performance for coronary artery 
bypass shows a decrease in the mortality rate after the release of public performance 
data. The same study also states that public reporting may have caused that high-risk 
patients avoid high-mortality hospitals either by provider choice or selective referral 
behaviour (risk avoidance). As well that public reporting might cause an increase of 
patients who went more often to low-mortality hospitals.37 
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The other study of cardiac arrest shows no effect of physician-quality data on 
consumers’ behaviour in choosing their primary-care physicians.38 Two studies present 
findings about the second pathway of change.39,40 One study shows the impact of public 
reporting on hospital care, though hospitals that performed better with regard to 
publicly reported outcomes for common medical conditions did not necessarily have 
better survival rates for cardiac arrest.39 Another study looks at the impact of public 
reporting on an increased proportion of patients with myocardial infarction who 
received timely treatment with a percutaneous coronary intervention. The number of 
patients receiving this treatment increased significantly in the regions with public 
reporting compared to other regions without public reporting.40 
 
One study examines the effect of the public reporting of both pathways either on the 
hospital’s improving the publicly reported measures (patient mortality), or on patients 
changing from lower-quality to higher-quality hospitals. They show no evidence that 
patients or physicians changed to high-quality hospitals nor showed they any evidence 
that public reporting reduced mortality due to heart attack or pneumonia.41  
 
Overall, the findings hint at an effect on behaviour change, although we should 
probably conclude that more sound studies are needed in this area. Many studies in this 
field have been conducted in the last few years, though only a few of them appear to 
meet the strict criteria of the Cochrane Reviews. For the purpose of this general 
discussion, we have been quite compliant about the inclusion of studies that we found 
in the narrative search, but we expect that there might be one or two studies that will 
not be included when the review is updated. The authors of the six recent studies 
emphasize the facts that the evidence for the effectiveness of public reporting is 
limited and the outcomes should be interpreted with care. Several authors of these 
studies point out the difficulties of well-designed studies on public reporting, and their 
attempts to design the studies as well as possible. All in all, this update and scan of the 
literature is in line with the results of our review published in 2011. We conclude that 
so far no firm conclusions can be drawn about the effect of CPI. 
 
PROFESSIONAL GUIDANCE  
Main findings  
GPs experience of choice-supporting behaviour in the referral process (Chapter 6). 
Most GPs do not know where to find CPI and have never used it before. The decisions 
GPs make in the current process for referring patients to hospital care are not, or 
hardly, based on CPI exchanges during consultations. Other referral considerations and 
sources (e.g. personal contact with specialists, their own and patients’ experiences 
with providers, and other patient experiences) are more important.  
 
 General discussion  
143 
Most GPs are sceptical about the ability of patients to use CPI. Several barriers also 
hinder their own use of CPI. These barriers include indecisiveness about their role in 
supporting patient choices, doubts about responsibility, feelings of uncertainty about 
the interpretation of the information, doubts about the content of the information and 
its reliability, and fear of weakening existing networks.  
 
Our findings make two things clear. First, the pathway of selection that Berwick and 
colleagues advocate as the mechanism to improve quality of care via public reporting36 
does not seem to work effectively for either healthcare consumers or referring 
providers. Like consumers, GPs find other sources, such as patient preferences, 
personal contacts, pervious experiences with a hospital, and mouth-to-mouth 
information, all of which are more important to them than CPI.42-47 Second, there is a 
gap between assumptions and practice regarding professional guidance for consumers. 
Ideally, GPs discuss the information and elucidate patient values before referring a 
patient to a hospital.5 However, the results do not confirm the assumption that even 
though patients hardly use CPI, they will benefit from performance information via 
their GPs, who will bring the options for hospital choice to their attention. Other 
studies find GPs similarly reluctant to make patients aware of performance 
information.11,44 In general, the discussion of CPI between patients and referring 
healthcare providers – researched via GPs and cardiologists – is rare.11,34,48,49 Given the 
increased emphasis on a healthcare system that encourages active patient involvement 
in their care process, it is remarkable that even the discussion of these quality data 
with patients is so uncommon.  
 
Discussion of GPs’ limited guidance 
Consumer engagement does not come easily. There are several explanations for the 
GPs limited engagement in helping patients make choices and for their lack of selective 
referral behaviour.  
 
One explanation is the lack of patient pressure on the GP.44 We found that GPs rarely 
have patients initiating discussions about CPI. Others suggest that if more patients 
approached their GPs with questions about this kind of information, GPs might pay 
more attention to CPI themselves.44,50 The second explanation for the limited impact on 
referral patterns is the lack of awareness of CPI45,51, though recent findings from the 
USA43 show that even if almost every provider is aware of CPI, use does not necessarily 
increase. For example, wider exposure did not convince referring cardiologists to trust 
these data and use the information for referrals. The third explanation is that GPs are 
reluctant to share information with which they are not familiar themselves.12 This 
clashes with the claim that GPs should be capable of understanding and interpreting 
data such as CPI, given their training and experience.46 This thesis reveals that GPs 
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criticize the content of the current information for both their patients and themselves. 
A recent study of Dutch GPs’ referral behaviour finds that referral patterns overall 
remain unaffected by the available CPI about medical effectiveness and patient 
experiences for the conditions of cataract surgery, breast cancer, and hip and knee 
replacement. Nonetheless, referral patterns for the condition of breast cancer were 
affected because GPs make more referrals to hospitals with a higher rating for medical 
effectiveness. In line with qualitative statements, CPI about breast cancer appeared to 
contain the most valid, reliable, and differentiating data.46 This calls for CPI based on 
outcome indicators that shows relevant differences. Furthermore, referring providers 
generally consider such data untrustworthy and not up to date; they judge the sources 
as unreliable or the data as inaccurately assessing the quality of providers.43,44,52 The 
findings in this thesis stress the importance of reliable performance information for 
GPs. A final explanation for the limited guidance is that the findings reveal the GPs’ 
indecisiveness about their role in assisting patients in making choices. Further, these 
explanations lead to the question of whether there are any people or professionals 
other than the GPs to guide patients in using CPI.  
 
Patients might benefit from having an advocate who makes sense of patients’ 
circumstances, helps them use CPI to make their choices, and advises them about their 
future choices.34,53 The benefits of support have been demonstrated for other choices, 
such as healthcare insurance plans and treatment.54-56 Helping consumers understand 
insurance coverage conditions and supporting appeals for coverage denials are called 
‘consumer assistance programmes’. In the USA, the assistance initiative has altered the 
way consumers engage with healthcare insurers. It enhances their capacity for self-
advocacy and involvement, though many disempowered consumers still fail to seek 
assistance.54 The effectiveness of decision coaching for patients who face a decision 
between at least two treatment options has been reviewed. The findings, based on 
several studies, show that decision coaching improves patient’s knowledge; such 
knowledge is an important element in decision-making. However, decision coaching in 
clinical care is still a novelty.55,56 As in other settings, the use of a ‘coach’, a ‘consumer 
assistant’, or an ‘advocate’ in helping consumers make decisions based on CPI remains 
open to debate.  
 
METHODOLOGICAL CONSIDERATIONS 
One strength of this thesis is the variety of research methods that we have used to 
examine the research questions, namely, a systematic literature review, a qualitative 
focus group, quantitative cross-sectional questionnaires, and a mixed-method study 
with interviews and a questionnaire. Here we present our general reflections on the 
methodological limitations and strengths of our work in the context of our research 
methods.  
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The first limitation is the number of healthcare consumers who participated in the 
different studies. The small sample sizes threaten the validity of the outcomes. The 
recruitment problem was not limited to healthcare consumers (Chapter 2); it was also 
difficult to attract GPs (Chapter 6). From this we conclude that CPI is indeed not high 
on the agenda of either healthcare consumers or providers.  
 
The second limitation concerns the relatively high age (> 65 years) of the participating 
consumers. The rationale for focusing on rather older participants was that these 
people were more likely to make actual choices in healthcare (hip and knee 
replacements for those confronted with Parkinson’s disease), and we wanted to find 
out why this group of consumers had trouble seeking and using CPI. Still, to use the 
words of Meinow and colleagues, ‘results suggest that those elderly people who are 
most dependent on care and who could benefit most from a “good choice” are also the 
ones who have the highest prevalence rates of cognitive, physical, and sensory 
limitations’ p.1289.  
 
The fact that this study used real and openly available CPI can be seen as a third 
limitation. It limited us in terms of content, volume, distinctiveness, and reliability of 
CPI. Though some of the attributes were not yet public, we added them because we 
knew they would soon become available and we wanted to know whether people would 
search for this information. At the same time, this limitation is a strength of the study: 
the information was closely connected to the current practice of patient choice and the 
use of CPI.  
 
The fourth and last limitation of this study is the strict inclusion criteria we used in 
conducting our systematic review (Chapter 5). We prefer to use these criteria to 
measure the impact on real behaviour rather than hypothetical behaviour, and to make 
a judgement based on the highest level of evidence. However, we are aware of the 
large number of studies that are being published and the limited number of studies that 
were suitable for inclusion in the systematic review and in the narrative search. These 
elements force us to rethink our strict design criteria and consider other designs or 
combinations of design for this type of research. The design must do justice to the 
complex reality as well.  
 
IMPLICATIONS  
Taken together, this study and past work suggest that the provision of CPI to engage 
patients and consumers in healthcare and to direct provider choice while 
simultaneously driving the improvement of quality of healthcare has not shown to be 
effective thus far. Nevertheless, the area of public reporting and the use of CPI do not 
seem to be at a dead end. On the contrary, researchers, policy makers, insurers, and 
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consumers maintain a continuous desire to keep moving in the direction of CPI and help 
consumers improve the quality of the healthcare system by their choices of high-quality 
providers despite the disappointing results.58 By far the most important reason why CPI 
remains attractive is that we will not go back to the time when patients and consumers 
had minor roles in the healthcare system. The source of CPI lies in accountability, the 
transparency of quality performance of healthcare services, which has been positioned 
as the consumer’s fundamental right to know one’s care, care options, and quality of 
care.59 Even though three decades have passed since the beginning of public reporting, 
we are just getting started. At the same time, there are signs that freedom of choice 
for consumers might be under pressure and may become limited as the geographical 
concentration of care increases. We see that the healthcare insurers are already 
offering contracts that limit the number of available healthcare providers on 
beforehand. 
 
Based on findings in this thesis, we formulate several implications for those undertaking 
future research, policy-makers, and consumer organizations.  
 
Finding-based implications for future research  
This thesis reveals that consumer expectation and recognition of quality differences 
between hospitals and providers play an important role in the search for performance 
information. More research is needed to get a better picture of how robust or fragile 
healthcare consumer expectation and recognition of quality differences are, as well as 
to determine what causes or influences expectation and recognition. Moreover, our 
findings imply that performance information fails in the expectation of triggering 
consumer interest. Studies that focus on how to strengthen the demand for CPI as well 
as on finding an effective way to increase healthcare consumers’ knowledge about the 
underlying concepts of quality of care and the purpose of performance information are 
needed.  
 
Our findings further reveal that performance information remains difficult to 
understand. It may be that data currently presented in CPI fail to resonate with the 
values and feelings that matter to consumers. It has been recently suggested that 
anecdotal information from consumers13,60 or online reviews on social media sites and 
commercial rating sites may be useful.61 These types of information may be better 
understood than the current CPI, so they would be more valuable to consumers and 
more likely to gain interest and satisfy a need. Giving consumers the ability to share 
their experiences and views directly other than in patient experience surveys can be an 
important aim in itself. Future research that focuses on how consumers can effectively 
balance and integrate these personal commentaries would therefore be a necessary 
addition to the literature of public reporting.13  
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This study shows that most consumers still have difficulties using performance 
information to choose a provider. Help and support from a professional nearby, such as 
the GP, seem lacking. The GPs reported various barriers to their use of CPI in the 
process of referral and to their taking a choice-supporting role. Future research into 
the effectiveness of consumer support by a trusted agent is needed. Furthermore 
studies that focus on the interaction between consumers and GPs or another trusted 
agent while using CPI would fill a gap in the literature.  
 
Research into the public reporting published over the last three decades is mainly 
about the impact on improving the quality of care or selection of good practices in care 
rather than about comparing and evaluating specific report designs to sort out the 
effective and ineffective ones. A classical RCT design is not useful for capturing the 
impact of public reporting. Given the public character of performance information, it is 
complex and too difficult to determine whether control groups get access to CPI or 
have ideas about it. Because of this, interrupted time series design and controlled 
before-and-after studies are more suitable, though a lot of studies with either of these 
designs do not satisfy the requirement of the multiple time points. At least three time 
points are required. One task for future research is to gather more evidence about 
which designs, or combinations of designs, can provide reliable information about the 
impact of CPI on choice behaviour. 
 
Finding-based implications for policy-makers and consumer organizations 
This thesis contributes to the developing literature about the complex reasons why 
most consumers are not prone or not eager to use CPI. The current results show that 
the lack of demand for public reporting depends on the availability of other important 
and more valued sources, lack of routine in using the information, outcome expectancy 
of using CPI, and barriers to using the information (e.g. too much responsibility, 
choosing is a burden, and questioning trustworthiness). The outcome expectancy may 
be the biggest reason for some healthcare consumers’ lack of perceived need, whereas 
the personal restraints of others may be their most prominent reason. Knowledge and 
recognition of quality differences can probably motivate some consumers to search for 
CPI. The consumers perceived professional guidance as helpful, but not necessarily 
based on CPI. The GPs in our study questioned the current CPI, and they preferred 
other sources to help the consumer select a healthcare provider. A series of initiatives 
should counteract the concerns about the lack of information, insight, and 
understanding for good quality of care. Starting to increase the urgency for consumers 
and GPs, CPI need to address variation in quality of care, and visualize clearly these 
differences. An issue that concerns not only for consumers and GPs, but for all 
stakeholders is the design of publicly reported data. Much more effort is needed to get 
more sophisticated information products.  
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Further, providing more time in the referral process for both GPs and consumers would 
be very helpful. More time might make informed choice possible for consumers and 
improve the ability of GPs to help them. Currently, consumers receive referrals from 
their GPs, and within minutes the choice for a hospital has been made. The moment of 
actual choice has passed before the consumer has had a chance to catch up with it, let 
alone actually use performance data or discuss their informed choice with their GP. We 
invite policy-makers, GPs, and insurance companies to find the financial support for 
extending the 10-minute standard GP consultation to allow a valuable discussion of 
choice.  
 
FINAL REMARK 
CPI has been developed to help healthcare consumers choose a healthcare provider 
that matches their needs and preferences and to drive healthcare providers to improve 
the quality of their care. However, the evidence that CPI has an actual impact on 
behaviour is still scant. Consumers say that the current CPI is novel, not well designed, 
too abstract, too vague, meaningless, and too difficult to use. From this perspective, 
the consumers’ non-use of the information might be reasonable, as might be their 
sticking to their current selection routines. Help and support from a trusted agent can 
overcome some of these issues. However, the GPs pointed out that the current state of 
the CPI, fear of discontinuity and fragmentation in healthcare are important things that 
stops them from using it. The promise of CPI remains attractive because of the 
underlying principles of more transparency and increasing consumer involvement in 
healthcare. The current state of affairs can be seen as an ongoing train, but the 
current design of CPI seems to be more appropriate for policy reasons than for the 
individual selection process of a healthcare provider.  
 
CPI seems inadequate for consumers. Perhaps this is partly attributable to the fact that 
consumers hardly play a role in the development of CPI. The production and 
dissemination of CPI is also meant to encourage a more central position for consumers 
in healthcare. Of course consumers do not suddenly achieve that position in healthcare 
without effort from anyone. We call for policy-makers, CPI developers, and consumer 
organizations to address the need for changing the format to help develop more 
consumer-friendly and -oriented information. The value of such data might increase 
once consumers become more involved for a longer time in developing performance 
information.  
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Chapter 1 presents an overview of this thesis, which describes the barriers and 
facilitating factors of search behaviour for comparative performance information (CPI) 
and healthcare consumers’ selective behaviour in choosing healthcare providers. 
Providing CPI for healthcare services and healthcare providers is one way of giving 
healthcare consumers insight into the quality of care. Then they can use this 
information to make an informed choice of healthcare provider. The underlying idea is 
that consumers who have good and reliable performance information will choose the 
best healthcare provider, which will pressure healthcare providers to improve the 
quality of care. Whether consumers are rational decision-makers who base their choices 
of healthcare providers on cognitive considerations is the question. However, it is much 
more important to provide consumers with good information so that they have more 
control, influence, and power to make their own decisions. Although consumers strive 
for more involvement and wish to have such information, they hardly use it. This thesis 
explores three research themes: search triggers that affect the search behaviour, 
choice behaviour, and professional guidance to support choice behaviour. First, we 
explore why healthcare consumers do not yet use this type of information, why they 
neglect it, misunderstand it, or have trouble searching for it. Second, we examine the 
effect of CPI on the behaviour of various parties. Third, we examine the effect of 
performance information on the behaviour of these parties. Fourth, we focus on the 
GPs and their use of CPI in the current referral process, as well as their role in helping 
patients make an informed choice.  
 
Chapter 2 presents the findings of a qualitative focus group study among healthcare 
consumers. Our aim was to get insight into consumers’ attitudes, opinions, value 
received, and appreciation concerning CPI. Six focus groups were conducted with 
27 healthcare consumers. The results showed that most consumers were unfamiliar 
with the information and had not used it before. We used clear examples of CPI to help 
consumers understand it. The consumers very ably put into words why they did not 
search for this information. They valued other sources, including personal experience, 
more than CPI. Information from different sources was often inconsistent, which cast 
doubt on its reliability. This study led to new and extended insight into consumers’ 
distrust. There was a fear of disrupting existing relationships, loss of faith in certain 
aspects of care that consumers had thought were good, and the pressure of insecurity 
due to new responsibilities. This study also reveals that consumers noted positive 
effects of CPI such as: more freedom of choice, more involvement for healthcare 
consumers, the potential effect of benchmarking, and a new-found awareness of 
quality of care in their own perception. A possible negative side-effect of CPI is that it 
might cause a dichotomy in society between those who search for CPI and use it and 
those who do not. Nonetheless, we conclude that the consumers valued the CPI only 
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marginally. Different values and principles limit the search for CPI, which often 
precludes its use.  
 
Chapter 3 examines the patients’ expectations concerning differences in care quality 
and their search for CPI. Questionnaires were distributed among 475 patients who 
underwent primary hip or knee surgery in a university, teaching, or community 
hospital. Of the 302 patients who responded (response rate 63%), only a small minority 
(13%) searched for CPI after they had found out they needed surgery. Most of those who 
did not search for CPI felt no need of more information. Most patients (67%) expected 
to find differences in the quality of care. These were the ones who were significantly 
more likely to search for CPI (OR=3.18 [95% CI: 1.02–9.89]; p<0.04) than those who did 
not expect such differences. The search trigger was even greater for patients expecting 
large differences (OR=5.05 [95% CI: 1.44-17.77]; p<0.01). The patients expected 
differences especially in general qualities such as reputation, distance, and 
accessibility. They expected more differences in general performance than in specific 
factors related to the patient’s disorder.  
 
Chapter 4 reports the findings of a quantitative study about the ability of people with 
Parkinson’s disease to recognize expertise, and it considers to what extent their 
recognition and evaluation of this expertise triggers their search and selective choice of 
experts. This survey study in a chronic-care setting focuses on physiotherapists’ 
expertise. Five hundred eligible respondents were invited to participate. This sample 
was based on claim data of the Dutch insurance company CZ. We analysed 320 surveys 
(response rate 64%). Healthcare providers’ expertise is based on a quality accreditation 
for special training to work according to evidence-based recommendations as well as 
structured referrals to increase the volume of patients with Parkinson’s disease whom 
they treat. Most participants (89%) with Parkinson’s disease took the referring 
provider’s advice, though this advice was rarely accompanied by supporting arguments. 
Not many looked for additional information (11%), but the participants did recognize 
some qualities of expertise. The respondents who did recognize the added value of 
specific expertise were significantly more likely to search (3.28 times more often) for 
performance information than those who did not. The willingness to switch to an expert 
physiotherapist increased significantly (p<0.01) once patients recognized the added 
value of specific expertise. About half the people with Parkinson’s disease did not 
recognize the added value, and they overestimated the expertise of their own 
healthcare providers. Based on the claim data, approximately 28% of the respondents 
received treatment from a physiotherapist with specific expertise in Parkinson’s 
disease, while 70% of the respondents claimed they received treatment from 
specialized physiotherapists. Considering their own physiotherapists (without special 
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training) to be experts in Parkinson’s disease might reduce their motivation to search 
for CPI or to search for another physiotherapist.  
 
Chapter 5 presents a systematic review that estimates the effects of the public release 
of CPI about changing the behaviour of healthcare consumers, providers, and 
purchasers. Much has been invested in the development and provision of performance 
information since the early 1990s in the USA. However, England and, in more recent 
years, the Netherlands, along with many other countries, have produced no systematic 
reviews about the effectiveness of such information. Because of the lack of evidence, 
we analysed studies of the effects of public performance information on changing 
behaviour. It is often assumed that the information will affect and facilitate decisions 
and behaviours of various parties and will ultimately improve the healthcare system. 
Various mechanisms in the public release of performance information may increase the 
quality of care. Berwick and colleagues describe mechanisms that work via two 
pathways: 1) the behaviour in choosing the best healthcare provider or organization 
and 2) improving performance by changing work procedures or professional culture. We 
used these two pathways as our primary outcome measures. We found 6839 relevant 
studies by using an extended search strategy to search five databases for studies 
published up to early 2011. Ultimately, after a strict selection procedure, as applied to 
the Cochrane review (Chapter 5), we included four studies. Two studies focused on the 
first pathway (selection by choice behaviour) and two studies focused on the second 
pathway (improvements in care). The findings show almost no effect of CPI on 
behavioural changes in either pathway. Selection and improving quality of care had 
virtually no effect. Any impact we found did not persist longer than 2 months. The level 
of evidence, however, was low, given the inclusion of only four studies and the analysis 
based on the GRADE1 system.  
 
Our mixed-method study with 15 interviews with GPs and a subsequent survey in 81 
general practices (Chapter 6) aimed to examine the position of the GP in terms of 
guidance and support of patients making choices. We explored the barriers to GPs’ 
search for and use of CPI. Most GPs did not know where to find CPI (87%) and had never 
used it before (94%). The findings show that the decisions GPs make in the current 
process for referring patients to hospital care are not, or hardly, based on CPI 
exchanges during consultations. Other referral considerations and sources (e.g. 
personal contact with specialists, their own and patients’ experiences with providers, 
and other patient experiences) are still more important than patient choice, and there 
is no role for CPI as an additional source. According to the GPs, patients hardly ever 
                                                     
1 Grading of Recommendations, Assessment, Development and Evaluations 
http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665072.html 
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initiate a discussion of CPI during consultations, though they seem to be increasingly 
critical about differences in care quality. Most GPs are sceptical about the ability of 
patients to use CPI; they find the current information too difficult for most patients. 
Asking GPs about this matter taught us that several barriers also hinder their own use 
of CPI. These barriers include indecisiveness about their role in supporting patient 
choices, their task in addressing CPI during consultations, doubts about whose 
responsibility this is, feelings of uncertainty about the interpretation of the 
information, doubts and distrust of the content of the information and its reliability, 
and fear of weakening their networks. Whether GPs can fulfil a role in providing 
patients with guidance in the use of CPI is still undecided. First there must be more 
clarity about the conditions.  
 
In Chapter 7, the final chapter of this thesis, the most important findings and 
conclusions of the studies in Chapters 2–6 are discussed. The results are placed in wider 
perspectives and compared with other studies. The most relevant methodological 
limitations are considered, practical implications are presented, and recommendations 
are put forward for further research.  
 
The purpose of CPI is 1) to facilitate the consumer’s choice of a healthcare provider 
based on their requirements and personal preferences and 2) to force providers to 
improve the care. However, we see little proof that CPI achieves this purpose. Both 
consumers and GPs criticize the current CPI and therefore do not use it. Policy reasons 
seem to be the foundation of the current design of CPI, but the promise of CPI that 
provides more transparency and enables better choices can still be fulfilled and has 
therefore value in itself. 
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Hoofdstuk 1 presenteert een overzicht van de inhoud van dit proefschrift dat de 
belemmerende en bevorderende factoren van zoekgedrag naar kwaliteitsinformatie en 
het keuzegedrag naar zorgaanbieders door consumenten beschrijft. Het beschikbaar 
stellen van kwaliteitsinformatie over zorgaanbieders is een manier om 
zorgconsumenten inzicht te geven in de kwaliteit van zorg, zodat zij een geïnformeerde 
keuze kunnen maken voor een zorgaanbieder. Het onderliggende idee is dat 
consumenten met goede informatie kunnen kiezen voor de beste zorgaanbieder, 
waarmee zij druk uitoefenen op zorgaanbieders om de kwaliteit van zorg te 
verbeteren. Of consumenten zich zo rationeel gedragen om de keuze voor een 
zorgaanbieder te maken op basis van cognitieve overwegingen is de vraag. Los daarvan 
is het een veel belangrijker doel consumenten van goede informatie te voorzien en hen 
hierdoor meer controle, invloed en kracht te geven om hun eigen keuzes te maken. 
Hoewel zorgconsumenten meer eigen regie nastreven en ook aangeven deze informatie 
te wensen, gebruiken zij de informatie die hen daartoe in de gelegenheid stelt niet of 
in zeer beperkte mate. In dit proefschrift exploreren we drie onderzoeksthema’s, 
namelijk: prikkels die zoekgedrag beïnvloeden, keuzegedrag en ondersteuning bij het 
maken van keuzes. Allereerst kijken we naar de onderliggende redenen waarom 
consumenten deze informatie (nog) niet gebruiken, negeren, of moeite hebben om 
deze informatie te begrijpen en om op zoek te gaan naar deze informatie. Vervolgens 
kijken we naar het effect van kwaliteitsinformatie op gedrag bij diverse partijen. En 
tot slot focussen we op de rol van de huisarts om consumenten te helpen bij het maken 
van een geïnformeerde keuze en het gebruik van kwaliteitsinformatie tijdens het 
verwijsproces.  
 
In het tweede hoofdstuk presenteren we de bevindingen van een focusgroepstudie 
onder consumenten. Het doel van deze studie was om inzicht te krijgen in waardering, 
begrip, opinie en beoordeling van kwaliteitsinformatie. Zes focusgroepen vonden plaats 
met consumenten (n=27). De meeste deelnemers waren niet bekend met dergelijke 
informatie en hadden het niet eerder gebruikt bij het maken van een keuze binnen de 
zorg. De consumenten gaven aan niet de noodzaak te voelen om te zoeken naar 
kwaliteitsinformatie. Tijdens de focusgroepen gebruikten we diverse voorbeelden van 
kwaliteitsinformatie om de discussie verder op gang te helpen. Als reactie daarop 
konden consumenten sneller hun twijfels, terughoudendheid en kritische vragen onder 
woorden brengen waarom ze niet op zoek gingen naar deze informatie. Zo gaven zij 
aan andere bronnen (familie/vrienden, eigen ervaring en de huisarts) belangrijker te 
vinden dan kwaliteitsinformatie. Barrières ten aanzien van de waarde van 
kwaliteitsinformatie betroffen: gebrek aan toepasbaarheid omdat kwaliteitsinformatie 
vanuit diverse bronnen elkaar soms tegenspreken, onzekerheid omdat dit type 
informatie een beroep doet op een nieuw soort verantwoordelijkheidsgevoel waarvan 
ze de gevolgen (nog) niet overzien en angst om het vertrouwen te verliezen in bepaalde 
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aspecten van zorg waarvan ze dachten dat die goed zijn. Een ander belangrijk punt was 
de betrouwbaarheid van de informatie. Ook liet deze studie zien dat consumenten 
positieve effecten ervaren van kwaliteitsinformatie, zoals: meer keuzevrijheid, meer 
betrokkenheid van en regie voor consumenten, een toename in bewustzijn over 
kwaliteit, als ook (mogelijk) nadelige effecten, zoals tweedeling tussen mensen die wel 
in staat zijn om de informatie te gebruiken en zij die dit niet kunnen. Op basis hiervan 
kunnen we concluderen dat consumenten kwaliteitsinformatie slechts marginaal 
waarderen. Verschillende waarden en principes beperken het zoeken naar 
kwaliteitsinformatie, en dus ook het gebruik ervan.  
 
In het derde hoofdstuk is onderzocht of de verwachtingen die patiënten hebben over 
verschillen in kwaliteit van zorg van invloed kunnen zijn op het zoekgedrag naar 
kwaliteitsinformatie. Vragenlijsten werden uitgezet onder 475 patiënten die een 
electieve heup- of knieoperatie ondergingen in een academisch, topklinisch of 
streekziekenhuis. Van de 302 (respons 63%) patiënten die de vragenlijst invulden, liet 
een kleine minderheid weten (13%) op zoek te zijn gegaan naar kwaliteitsinformatie 
nadat zij hadden gehoord een vervangende heup-of knieoperatie te moeten ondergaan. 
Voor patiënten die niet op zoek gingen naar kwaliteitsinformatie was de belangrijkste 
reden dat ze simpelweg geen behoefte hadden aan meer informatie. Een meerderheid 
van de patiënten (67%) gaf aan verschillen te verwachten in de kwaliteit van zorg, zij 
gingen vaker op zoek naar kwaliteitsinformatie (OR=3.18 [95% BI: 1.02-9.89]; p <0.04) 
dan patiënten die geen verschillen in kwaliteit verwachtten. Voor patiënten die grote 
verschillen verwachtten was deze relatie nog sterker ten opzichte van patiënten die 
geen verschillen verwachtten (OR=5.05 [95% BI: 1.44-17.77]; p<0.01). Patiënten 
verwachtten voornamelijk verschillen in reputatie, afstand en toegankelijkheid. Deze 
aspecten hebben meer betrekking op algemene kenmerken dan specifieke, 
aandoeninggerelateerde aspecten. Wanneer de kennis over het concept kwaliteit van 
zorg toeneemt, kunnen ook de aspecten waarin patiënten verschillen in verwachtingen 
mogelijk veranderen.  
 
In hoofdstuk 4 rapporteren we de bevindingen van een kwantitatieve studie waarin we 
onderzocht hebben of patiënten in staat zijn om specifieke expertise bij hun 
zorgverleners te herkennen en of deze herkenning een stimulerende rol speelt bij 
zoekgedrag naar informatie over een zorgverlener. Om dit doel te bereiken, hebben we 
een studie opgezet binnen de chronische zorg. Rondom de Ziekte van Parkinson is de 
afgelopen jaren een multidisciplinair netwerk opgezet waarin zorgverleners 
(neurologen, verpleegkundigen, ergotherapeuten, fysiotherapeuten, huisartsen) 
intensief met elkaar samenwerken. Zorgverleners aangesloten bij dit netwerk worden 
extra getraind in het behandelen van mensen met de ziekte van Parkinson. Door het 
volgen van specifieke richtlijnen en het behandelen van een hoger patiëntenvolume van 
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patiënten met de ziekte van Parkinson krijgen zorgverleners meer specifieke expertise. 
In deze studie hebben we ons gericht op de expertise van fysiotherapeuten. De vraag is 
of mensen met de ziekte van Parkinson deze expertise herkennen en waarderen en ook 
of zij deze expertise meenemen in het zoeken naar kwaliteitsinformatie om een keuze 
te maken voor een fysiotherapeut. Op basis van declaratiegegevens van 
zorgverzekeraar CZ nodigden we 500 mensen uit om een vragenlijst in te vullen, 
waarvan we 320 ingevulde vragenlijsten (response 64%) retour kregen. Veruit de 
meeste mensen met Ziekte van Parkinson in onze studie (89%) volgden het advies op 
van hun verwijzer, dit advies was zelden onderbouwd met argumenten. Een kleine 
groep mensen (11%) ging op zoek naar extra informatie. Respondenten bleken 
verschillende aspecten van expertise te herkennen. De groep die specifieke Parkinson 
expertise herkende, ging 3.28 keer vaker op zoek naar informatie dan zij die deze 
toegevoegde expertise niet herkenden. Ook de bereidheid om te wisselen van 
fysiotherapeut naar een in Parkinson gespecialiseerde fysiotherapeut bleek groter (p < 
.001) te zijn bij respondenten die de expertise onderschreven. Op basis van de 
declareergegevens zou ongeveer 28% van de respondenten onder behandeling zijn van 
een gespecialiseerde fysiotherapeut, terwijl 70% van de respondenten aangaf onder 
behandeling te zijn van een gespecialiseerde fysiotherapeut. Deze (mogelijke) 
overschatting van de specifieke expertise in Parkinson bij de eigen fysiotherapeut kan 
ook een rol spelen in het op zoek gaan naar kwaliteitsinformatie. Mensen gaan er al 
vanuit dat zij bij de beste zitten en zien daarom geen noodzaak om op zoek te gaan 
naar kwaliteitsinformatie en met die informatie op te zoek te gaan naar een andere 
fysiotherapeut.  
 
In het vijfde hoofdstuk presenteren we een systematische literatuurstudie naar de 
effecten van openbare kwaliteitsinformatie op gedrag van zorgconsumenten, 
zorgaanbieders en zorginkopers. Hoewel er sinds begin jaren ’90 in de Verenigde Staten 
en Engeland - en in recente jaren in veel andere landen, waaronder Nederland - veel 
geïnvesteerd is in de ontwikkeling van kwaliteitsinformatie en het beschikbaar maken 
van die informatie, waren er tot dusverre geen reviews uitgevoerd naar de 
effectiviteit. Daarom analyseerden we studies naar de effecten van openbaar 
beschikbare kwaliteitsinformatie op gedrag. Het achterliggende idee van het openbaar 
maken van kwaliteitsinformatie is dat patiënten deze informatie inzetten om de 
kwaliteit van te zorg te verbeteren. Uit de literatuur gebruikten we een model met 
twee paden dat laat zien hoe kwaliteitsinformatie een effect zou kunnen uitoefenen 
om de zorg te verbeteren namelijk door: 1) keuzegedrag voor de beste zorgaanbieder 
en 2) verbeterinitiatieven vanuit zorgaanbieders om de kwaliteit van zorg te 
verbeteren. Wij gebruikten deze twee paden als gedragsuitkomstmaten. Met een 
uitgebreide zoekstrategie, waarmee vijf databanken werden doorzocht tot 2011, werd 
een groot aantal studies (n=6839) gevonden. Uiteindelijk konden na een strenge 
 Samenvatting  
163 
selectieprocedure vier studies geïncludeerd worden. Twee studies richtten zich op het 
eerste pad (selectie door middel van keuzegedrag) en twee studies focusten zich op het 
tweede pad (verbeteringen in de zorg). De impact van kwaliteitsinformatie op gedrag 
was niet of nauwelijks aanwezig en die impact die wél gevonden werd, was van korte 
duur. Concluderend kunnen we stellen dat kwaliteitsinformatie niet of nauwelijks een 
effect heeft op gedrag. Maar, het bewijs waarop we deze conclusie baseren is beperkt 
met slechts vier studies, en de analyse van de studies met het GRADE1 systeem laat 
zien dat de kwaliteit van de studies laag is. Daarbij zijn alle vier studies uitgevoerd in 
een relatief nieuw onderzoeksveld en in een sterk veranderende context. Concluderend 
kunnen we stellen dat het effect nog weinig op een goede wijze is onderzocht en dat er 
dus nog geen harde conclusie getrokken kan worden over het effect van 
kwaliteitsinformatie op gedrag.  
  
In het zesde hoofdstuk beschrijven we een mixed-method studie met als doel te 
onderzoeken welke rol kwaliteitsinformatie speelt in het huidige verwijsbeleid van 
huisartsen en welke rol de huisarts speelt bij het stimuleren van keuzegedrag, 
gebaseerd op kwaliteitsinformatie door patiënten. We hebben gekeken welke barrières 
huisartsen ondervinden bij het zoeken en gebruiken van kwaliteitsinformatie. Vijftien 
diepte-interviews vonden plaats met huisartsen over verwijsroutines, 
patiëntbetrokkenheid en de rol van kwaliteitsinformatie tijdens het verwijsproces. De 
interviews werd letterlijk uitgewerkt, geanalyseerd en de resultaten werden vervolgens 
verwerkt in een vragenlijst die werd uitgezet onder 81 huisartsen die verbonden waren 
aan het Landelijke Informatie Netwerk Huisartsenzorg 70 huisartsen (86% respons) 
vulden de vragenlijst in. De meeste huisartsen wisten niet waar ze kwaliteitsinformatie 
zouden moeten zoeken (87%) en hadden het nooit eerder gebruikt (94%). 
Kwaliteitsinformatie speelt geen tot een minimale rol bij het verwijzen van patiënten 
naar een ziekenhuis of andere professionals, terwijl andere bronnen zoals het 
persoonlijk contact met artsen, eigen ervaringen, patiëntervaringen en 
patiëntvoorkeuren voor huisartsen belangrijke bronnen zijn in het verwijsproces. 
Huisartsen noemden veel verschillende barrières die ervoor zorgden dat ze niet 
gemotiveerd worden om kwaliteitsinformatie te gebruiken. Ze twijfelden aan hun rol 
om patiënten te stimuleren in keuzegedrag, en vroegen zich af of het gebruik van 
kwaliteitsinformatie niet behoort tot de eigen verantwoordelijkheid van de patiënt, 
terwijl ze zich tegelijk zeer verantwoordelijk voelden voor een goed verwijsproces. 
Daarnaast twijfelden ze aan de toegevoegde waarde van kwaliteitsinformatie en aan de 
mogelijk positieve uitkomsten voor patiënten. Ten aanzien van het eigen gebruik van 
kwaliteitsinformatie voelden huisartsen zich onzeker of zij in staat zijn om de 
                                                     
1 Grades of Recommendations Assessment Development and Evaluation (GRADE) 
http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665072.html 
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informatie op een goede manier te interpreteren. Zij bekritiseerden ook de inhoud van 
de informatie, omdat het volgens hen inhoudelijk gezien niet de belangrijkste 
informatie bevat waaraan patiënten behoefte hebben en zij waren kritisch over de 
validiteit van de informatie, waardoor ze de betrouwbaarheid ervan in twijfel trokken. 
Daarnaast gaven ze aan weinig noodzaak te voelen om het te gebruiken, aangezien zij 
nauwelijks geconfronteerd worden met vragen vanuit patiënten over 
kwaliteitsinformatie. Volgens huisartsen is een keuze maken op basis van 
kwaliteitsinformatie een erg moeilijke opgave voor patiënten. Tot slot noemden zij dat 
het gebruik van kwaliteitsinformatie tot een (te) grote verwijsregio (meer ziekenhuizen 
en zorgverleners) zou kunnen leiden, waarmee ze aangaven daarmee ook overzicht en 
belangrijke informatiebronnen te verliezen. Of huisartsen een stimulerende rol kunnen 
vervullen in het gebruik van kwaliteitsinformatie door patiënten staat nog niet vast, 
eerst moet meer duidelijk worden welke voorwaarden voor huisartsen gerealiseerd 
moeten worden om deze rol vorm te geven.  
 
In hoofdstuk 7, het laatste hoofdstuk van dit proefschrift, worden de belangrijkste 
bevindingen van dit proefschrift uit de voorgaande hoofdstukken samengevat en 
bediscussieerd. De resultaten worden in een groter perspectief geplaatst en vergeleken 
met andere studies. De meest relevante methodologische overwegingen en beperkingen 
worden besproken, praktische implicaties voor beleidsmakers, ontwikkelaars van 
kwaliteitsinformatie worden gepresenteerd en er worden aanbevelingen gedaan voor 
vervolgonderzoek.  
 
Vergelijkende kwaliteitsinformatie is ontwikkeld om 1) consumenten en patiënten te 
helpen bij het kiezen van een zorgverlener die past bij hun behoeften en voorkeuren 2) 
en indirect zorgverleners hiermee te stimuleren om de kwaliteit van zorg (verder) te 
verbeteren. Echter, er is weinig bewijs dat de presentatie van kwaliteitsinformatie aan 
consumenten en patiënten een effect heeft op gedrag. Zowel consumenten als 
huisartsen bekritiseren huidige kwaliteitsinformatie en gebruiken het mede daarom niet 
of nauwelijks. Toch kan de belofte dat kwaliteitsinformatie meer transparantie biedt 
en mensen in staat stelt betere keuzes te maken nog steeds vervuld worden en heeft in 
dat opzicht waarde in zichzelf. 
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Een ware uitdaging om het grote aantal mensen dat mij geholpen heeft hier kort te 
bedanken. In de eerste plaats wil ik alle respondenten (zorgconsumenten, patiënten en 
huisartsen) bedanken die een bijdrage hebben geleverd.  
 
Veel dank ben ik verschuldigd aan mijn promotoren prof. dr. Gert Westert, prof. dr. 
Glyn Elwyn en copromotoren dr. Marjan Faber, dr. Jozé Braspenning. 
 
Beste Marjan, het duurde even voordat wij met elkaar de juiste modus hadden 
gevonden en goed op elkaar ingespeeld raakten. Ik in mijn rol als promovendus, jij in je 
rol als copromotor voor wie ik de eerste promovendus was. Jouw inhoudelijke 
expertise, schrijfkunsten, parate kennis van de literatuur en werklust zijn een bron van 
inspiratie. Veel dank voor je oneindige precisie en het immer secuur lezen van de 
zoveelste versie van mijn artikelen.  
 
Beste Jozé, op heldere wijze wist je onvolkomenheden in de structuur onder de 
aandacht te brengen en mij te voorzien van scherpe analyses, zodat ik nieuwe stappen 
kon zetten in het schrijfproces. Heel veel dank voor je inzet de afgelopen jaren.  
 
Beste Gert, je volgde prof. Richard Grol op als directeur van IQ en als promotor, 
hierdoor stapte je iets later in het traject. Je feedback was altijd constructief en dit 
zorgde voor betere artikelen. Veel dank voor je adviezen en je tijd om dit tot een 
succesvol einde te brengen.  
 
Dear Glyn, many thanks for your efforts and time spend traveling to Nijmegen. It was a 
privilege to work with you.  
 
Beste Richard, kort na de start van mijn promotietraject besloot je dat ik niet bij de 
club met promovendi zat die je nog ging begeleiden ná je emeritaat. Helaas, maar het 
doet me genoegen dat ik met je heb mogen werken. Ik dank je voor de start van het 
traject en het gestelde vertrouwen in mij.  
 
Dit proefschrift had niet tot stand kunnen komen zonder de medewerking en financiële 
steun van zorgverzekeraar CZ, dank voor de samenwerking en support. Speciale dank 
gaat uit naar Wiro Gruisen, Jolyn van Vuuren, Marjolein Morres en Linda van Mierlo.  
 
Een woord van dank gaat uit naar de poli’s Orthopedie van de deelnemende 
ziekenhuizen Radboudumc, Slingeland Ziekenhuis en Elizabeth Ziekenhuis Eindhoven.  
Externe co-auteurs: Martin Eccles, Katherine Deane, Signe Flottorp, Liv Rygh, Marten 
Munneke en Bas Bloem, bedankt voor jullie bijdragen en correcties bij de betreffende 
artikelen.  
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Collega’s van IQ healthcare 
Anita Huis, Hilly Calsbeek en Simone van Dulmen, mijn drie geweldige kamergenoten, 
wil ik heel hartelijk bedanken voor het meeleven van de hele rit van begin tot eind. 
Goede adviezen en praktische tips bij het organiseren en plannen van de 
onderzoeksactiviteiten. Hilly en Simone, wat was het bijzonder om drie gelijktijdige 
zwangerschappen met elkaar te delen, gevolgd door goede pedagogische adviezen bij 
het jonge moederschap. Anita, jouw ‘24 uur-crisisdienst verhalen’ en bizarre voorvallen 
bezorgden mij regelmatig de slappe lach. En wat ben ik blij dat onze goede traditie van 
de ‘R&A etentjes’ blijven doorgaan. Maud Heinen en Betsie van Gaal, wat ontzettend 
fijn dat jullie zijn aangeschoven, input leveren voor de ‘R&A’ en meedelen in deze 
traditie. Hopelijk houden we die nog heel lang vast.  
 
Onderzoeksondersteuning en praktische hulp kreeg ik van Marc Padros, Ellen Keizer en 
Reinier Akkermans, veel dank voor jullie hulp! Alice Tillema, mijn dank is groot voor je 
hulp om alle databases te doorzoeken en bij het opstellen van de juiste zoektermen. 
Sylvia van Roosmalen, veel dank gaat uit naar je werk van het redigeren van mijn 
artikelen en je inzet bij de totstandkoming van dit manuscript. Jolanda van Haren, 
dankjewel voor je hulp, het meekijken en je adviezen in de totstandkoming van het 
manuscript en uiteindelijke boekje.  
 
Speciale dank gaat uit naar mijn intervisie collega’s van IQ; Anke Oerlemans, Karin 
Neeleman-van der Steen, Geertje van de Ven, Gijs Hesselink en Irene van de Glind. 
Irene, dank ook voor je tijd dat we samen medevoorzitter waren van Schil. Ik kijk uit 
naar jouw promotie!  
 
Renate Jansink en Kirsten Kirschner, jullie waren al bezig met jullie promoties toen ik 
bij IQ kwam. We hadden meteen een ‘klik’ en ik blij dat we die ondanks de drukke 
levens proberen vast te houden. Dank voor jullie meeleven en spreekwoordelijke 
dansjes bij grote en kleine lichtpuntjes. Arna van Doorn–Klomberg wil ik bedanken voor 
het prettig sparren en meelezen in een fase waarin het schrijven even op slot zat.  
 
Renske Keizer, oud studiegenote van ASW, al lang gepromoveerd en al ruim een jaar 
hoogleraar. Geweldig! Hartelijk dank voor je hulp en adviezen bij het schrijven van de 
discussie.  
 
Collega’s Windesheim  
Mijn aanstelling bij Windesheim combineerde ik met de afronding van mijn 
proefschrift. Heel fijn om herkenbare hobbels en heuglijke feiten met jullie te kunnen 
delen. Speciale dank gaat uit naar Leontine Groen–van de Ven, Marijke Span, Monique 
Mensen, Jan Jukema en Carolien Smits: jullie wijsheden en aanmoedigingen ‘Trust the 
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process’ en ‘Shut up and write’ zorgden ervoor dat ik ondanks de drukke 
werkzaamheden bij Windesheim moedig voortwaarts bleef gaan.  
 
Collega’s Saxion  
Geen bijdrage in het traject, maar wél de vreugde van de afronding vieren. Ik ben blij 
dat ik met zo’n geweldige club mensen mag werken!  
 
Paranimfen  
Mirjam, het is niet meer haalbaar om te carpoolen nu we in Nijmegen en Enschede 
werken, maar wat kijk ik goed terug op onze dagelijkse evaluatiemomenten in de auto. 
Jouw nuchtere blik en pragmatische houding, gecombineerd met een 
wetenschappelijke analyse is onovertroffen. Veel dank dat je vandaag naast mij wilt 
staan.  
Lieve Anne, onze levens zijn innig met elkaar verbonden. Mijn dierbare vriendin en 
schoonzus waarmee ik keihard kan lachen, kan relaxen, kan mopperen over de 
dagelijkse beslommeringen en met wie ik de meest ambitieuze plannen kan ontvouwen. 
Wat een eer dat je naast mij staat!  
 
Familie  
Het afronden van een promotie naast een andere baan en een gezin heeft ook één en 
ander gevraagd van de mensen die dicht bij mij staan.  
Lieve schoonfamilie, Anne & Roy, Els & Joop, heel erg bedankt voor het intensief 
meeleven, het blijven vragen en al die extra oppasmomenten van de afgelopen tijd!  
Lieve zusjes en zwagers, Marloes & Frank, Janneke & Rick, we beleefden met elkaar de 
afgelopen twee jaar op z’n zachtst gezegd ‘roerige tijden’. Dank voor alle gezellige 
momenten en steun.  
Lieve papa en mama, wat de toekomst brengen zal is nog ongewis, maar de basis die 
jullie mij hebben meegegeven is van jullie samen. Veel dank voor jullie liefde en steun! 
Mama, dank voor al die onzichtbare en ontelbare dingen die er in de afgelopen tijd 
voor zorgden dat ik rustig heb kunnen schrijven.  
 
Mijn stoere ‘mannen’, Jens en Lars, ik geniet volop van jullie en ben zó blij dat ik vanaf 
nu meer tijd voor jullie heb.  
 
Lieve Martijn, jouw steun is ontzettend belangrijk geweest om dit tot einde te kunnen 
brengen. Dat alles hoeft wat jou betreft niet breed uitgesponnen te worden, dat weten 
is al genoeg. Het levensmotto ‘het zijn de kleine dingen…’ past je als geen ander. 
DANK! 
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Nicole Ketelaar werd geboren op 26 maart 1982 in 
Doetinchem. Na haar VWO-diploma (2001) startte zij aan de 
Universiteit Utrecht met de studie Algemene Sociale 
Wetenschappen. Haar masterthesis werd uitgevoerd binnen 
het Slingeland Ziekenhuis in Doetinchem en richtte zich op de 
transmurale zorg, in het bijzonder op de overdracht van 
farmaceutische zorg van intra- naar extramurale setting. Zij 
behaalde haar Master binnen de afstudeerrichting Cultuur, 
Zorg en Welzijn in 2005.  
 
Na haar studie werkte zij korte tijd (2006-2007) als 
beleidsmedewerker in het Facilitair Bedrijf van het UMC 
Utrecht. Zij combineerde dit met een aanstelling als 
interviewer bij de stichting ‘Cliënt en Kwaliteit’. In 2007 
maakte zij de overstap naar het Radboudumc, bij het Scientific Institute for Quality of 
Healthcare (IQ healthcare). Halverwege 2008 startte haar promotieonderzoek, ‘De 
Kiezende Zorggebruiker’, waarvan de resultaten in dit proefschrift beschreven zijn. Dit 
project werd gesubsidieerd door het CZ Fonds. Naast haar promotieonderzoek was zij 
betrokken bij verschillende onderzoeksprojecten en schreef zij mee aan een handboek 
‘Doen bij Depressie’.   
 
In het najaar van 2012 werd Nijmegen verruild voor Zwolle en werkte zij als 
onderzoeker/docent aan de Hogeschool Windesheim, Lectoraat Innoveren in de 
Ouderenzorg. In samenwerking met de Hogeschool Arnhem en Nijmegen werden er 
praktische tools ontwikkeld voor casemanagers dementie binnen drie dementie- 
netwerken. Momenteel is zij als onderzoeker verbonden aan de Hogeschool Saxion, 
Academie Mens en Maatschappij, waar zij een onderzoek uitvoert naar de transitie van 
het sociale domein en sociale wijkteams binnen drie Twentse gemeenten. Naast dit 
onderzoeksproject neemt zij als onderzoeker deel aan het Expertise Centrum 
Jeugdzorg Twente (EJT) en is zij als hoofddocent betrokken bij de Master Health Care 
and Social Work.  
 
Nicole woont samen met Martijn Kraan. Zij zijn de trotse ouders van Jens (5) en 
Lars (2).  
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Name PhD student: N.A.B.M. Ketelaar 
Department: Scientific Institute for Quality of 
Health 
Graduate School: Radboud Institute for Health 
Sciences 
PhD period: 01-06-2008 – 02-12-2015 
Promotor(s):  
Prof. G.P. Westert, Prof. G. Elwyn 
Co-promotor(s):  
Dr M.J. Faber, Dr J.C. Braspenning 
 
 Year(s) ECTS 
TRAINING ACTIVITIES 
a) Courses & Workshops 
‐ Herregistratie Basiscursus Regelgeving en Organisatie voor 
Klinisch onderzoekers (BROK) 
‐ CaRe annual day ‘International collaboration in Primary 
Health Care Research’ 
‐ Solliciteren en netwerken, Radboud University 
‐ IQ healthcare congress, Radboudumc  
‐ Masterclass Lecture: ‘Planning for future career’ 
‐ Academic writing (one-one-coaching), Radboud in’to 
languages 
‐ Cochrane review / review manager, EMGO 
‐ Hulp bij subsidieaanvragen, ZonMw 
‐ Instruction about literature searches 
‐ Advanced conversation, Radboud in’to languages 
‐ IQ healthcare congress, Radboudumc  
‐ Presenteren eigen onderzoek, Radboud University 
‐ Basiscursus Regelgeving en Organisatie voor Klinisch 
onderzoekers (BROK) 
‐ Cursus SPSS, PAO Heyendael 
‐ Academic writing, Radboud in’to languages  
‐ Introductie cursus CaRe 
‐ PubMed introduction, Medical Library 
‐ Posterpresentatie / opzetten van wetenschappelijke posters, 
NCEBP  
‐ Implementatie. Effectieve strategieën, IQ healthcare 
‐ Wetenschapsjournalistiek, Radboud University 
 
2013  
 
2012 
 
2012 
2012 
2011 
2011 
 
2010 
2010 
2010 
2010 
 
2010 
2009 
2009 
2009 
2009 
2009 
2008 
2008 
 
2007 - 2008 
2007 
 
0.1 
 
0.25 
 
1.75 
0.25 
0.1 
2 
 
0.2 
0.1 
0.1 
2 
0.25 
1.5 
1.75 
 
0.2 
3 
0.5 
0.1 
0.1 
 
2 
2 
b) Seminars & lectures^ 
‐ Netwerkbijeenkomst Bruikbaar Onderzoek, ZonMw 
‐ Patient Preferences in quality improvement research 
(seminar) UMC St Radboud. ^ presentation 
‐ Onderzoek naar keuze van patiënten met de ziekte van 
Parkinson voor een gespecialiseerde fysiotherapeut. UMC St 
Radboud, afdeling neurologie. ^ presentatie 
‐ Zijn er effecten door het gebruik van kwaliteitsinformatie? 
Zorgverzekeraar CZ, Tilburg.  
‐ Wat is er al bekend over de kiezende zorggebruikers? 
Onderzoeksopzet. IQ healthcare. ^ presentatie 
 
2013 
2011 
 
 
2011 
 
2011 
 
 
2008 
 
0.1 
0.25 
 
 
0.25 
 
0.1 
 
 
0.1 
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 Year(s) ECTS 
TRAINING ACTIVITIES 
c) Symposia & congresses^ 
‐ Vascular Symposium, ‘Innovation in time of scarcity. Think 
‘evidence’ and ‘quality’, University Hospitals Leuven, Belgium 
^ presentation 
‐ International Shared Decision Making Conference (ISDM), 
University Maastricht, Maastricht ^ presentation 
‐ International Shared Decision Making Conference (ISDM), 
Harvard Medical School, Boston ^ poster 
‐ Visiting several congress regarding the subject ‘Choosing 
healthcare providers’ (e.e.g. Ede, Erasmus University)  
^ visiting  
‐ Co-organisation symposia: 5 jaar samenwerking van IQ 
healthcare en Zorgverzekeraar CZ 
 
2015 
 
 
2011 
 
2009 
 
 
2008 - 2010 
 
 
2008 
 
 
0.25 
 
 
0.5 
 
0.5 
 
 
0.2 
 
 
1.5 
d) Other 
‐ Te gast bij journal club van NIVEL 
‐ Intervisie met promovendi 
‐ Review scientific publication, journals: Health Expectations, 
Health Services Research, Plos One, International Journal of 
Quality in Healthcare Care, BMC Medical Informatics and 
Decision Making, Evaluation of Clinical Practice 
‐ Lid van Kennisgroep ‘Patient Empowerment’ 
‐ Lid van journal club  
‐ Voorziter van Schil 
‐ Lid van Schil. Overleg orgaan voor junior onderzoekers en 
promovendi binnen IQ healthcare 
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2011 - 2012 
2009 - 2011 
2008 - 2010 
2007 - 2012 
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0.5 
TEACHING ACTIVITIES 
e) Lecturing 
‐ Kiezen in Zorg. Transparantie en kwaliteitsinformatie. UMC St 
Radboud. Onderwijs voor geneeskunde studenten.  
 
2011 
 
0.4 
f) Supervision of internships / other 
‐  
  
TOTAL 28.4 
 
^Indicate oral or poster presentation 
 
 
 
 
 


